<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:40.7pt;left:54.6pt;line-height:18.0pt"><span style="font-family:Arial,serif;font-size:18.0pt">Journal of the American Heart Association</span></p>
<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">1</span></p>
<p style="top:1.1pt;left:44.8pt;line-height:12.0pt"><span style="font-family:STIX,serif;font-size:12.0pt"> </span></p>
<p style="top:93.5pt;left:54.6pt;line-height:18.0pt"><b><span style="font-family:Arial,serif;font-size:18.0pt;color:#66952d">SYSTEMATIC REVIEW AND META-ANALYSIS</span></b></p>
<p style="top:125.3pt;left:54.6pt;line-height:26.0pt"><span style="font-family:Arial,serif;font-size:26.0pt">Efficacy of Physical Exercise to Offset </span></p>
<p style="top:151.3pt;left:54.6pt;line-height:26.0pt"><span style="font-family:Arial,serif;font-size:26.0pt">Anthracycline- Induced Cardiotoxicity: A </span></p>
<p style="top:177.3pt;left:54.6pt;line-height:26.0pt"><span style="font-family:Arial,serif;font-size:26.0pt">Systematic Review and Meta- Analysis of </span></p>
<p style="top:203.3pt;left:54.6pt;line-height:26.0pt"><span style="font-family:Arial,serif;font-size:26.0pt">Clinical and Preclinical Studies</span></p>
<p style="top:240.1pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Willeke R. Naaktgeboren</span></p>
<p style="top:240.1pt;left:175.3pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">, MD*; David Binyam, BSc*; Martijn M. Stuiver</span></p>
<p style="top:240.1pt;left:385.1pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">, PhD; Neil K. Aaronson</span></p>
<p style="top:240.1pt;left:500.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">, PhD; </span></p>
<p style="top:252.1pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Arco J. Teske, MD, PhD; Wim H. van Harten</span></p>
<p style="top:252.1pt;left:258.5pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">, MD, PhD; Wim G. Groen, PhD</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">&#x2020;</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">; Anne M. May</span></p>
<p style="top:252.1pt;left:474.2pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">, PhD</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">&#x2020; </span></sup></p>
<p style="top:276.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">BACKGROUND:</span><span style="font-family:Arial,serif;font-size:9.0pt"> Physical exercise is an intervention that might protect against doxorubicin- induced cardiotoxicity. In this meta- </span></p>
<p style="top:287.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">analysis and systematic review, we aimed to estimate the effect of exercise on doxorubicin- induced cardiotoxicity and to </span></p>
<p style="top:298.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">evaluate mechanisms underlying exercise- mediated cardioprotection using (pre)clinical evidence.</span></p>
<p style="top:317.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">METHODS AND RESULTS:</span><span style="font-family:Arial,serif;font-size:9.0pt"> We conducted a systematic search in PubMed, Embase, and Cochrane Central Register of Controlled </span></p>
<p style="top:328.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">Trials (CENTRAL) databases. Cochrane&#x2019;s and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) </span></p>
<p style="top:339.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">risk- of- bias tools were used to assess the validity of human and animal studies, respectively. Cardiotoxicity outcomes reported </span></p>
<p style="top:350.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">by &#x2265;3 studies were pooled and structured around the type of exercise intervention. Forty articles were included, of which 3 </span></p>
<p style="top:361.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">were clinical studies. Overall, in humans (sample sizes ranging from 24 to 61), results were indicative of exercise- mediated </span></p>
<p style="top:372.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">cardioprotection, yet they were not sufficient to establish whether physical exercise protects against doxorubicin- induced car-</span></p>
<p style="top:383.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">diotoxicity. In animal studies (n=37), a pooled analysis demonstrated that forced exercise interventions significantly mitigated </span></p>
<p style="top:394.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">in vivo and ex vivo doxorubicin- induced cardiotoxicity compared with nonexercised controls. Similar yet slightly smaller effects </span></p>
<p style="top:405.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">were found for voluntary exercise interventions. We identified oxidative stress and related pathways, and less doxorubicin </span></p>
<p style="top:416.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">accumulation as mechanisms underlying exercise- induced cardioprotection, of which the latter could act as an overarching </span></p>
<p style="top:427.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">mechanism.</span></p>
<p style="top:446.9pt;left:54.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">CONCLUSIONS:</span><span style="font-family:Arial,serif;font-size:9.0pt"> Animal studies indicate that various exercise interventions can protect against doxorubicin- induced cardiotoxic-</span></p>
<p style="top:457.9pt;left:54.7pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">ity in rodents. Less doxorubicin accumulation in cardiac tissue could be a key underlying mechanism. Given the preclinical </span></p>
<p style="top:468.9pt;left:54.7pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">evidence and limited availability of clinical data, larger and methodologically rigorous clinical studies are needed to clarify the </span></p>
<p style="top:479.9pt;left:54.7pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">role of physical exercise in preventing cardiotoxicity in patients with cancer.</span></p>
<p style="top:498.9pt;left:54.7pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">REGISTRATION:</span><span style="font-family:Arial,serif;font-size:9.0pt"> URL: https://www.crd.york.ac.uk/prospero; Unique identifier: CRD42019118218.</span></p>
<p style="top:522.9pt;left:173.9pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">Key Words:</span></b><span style="font-family:Arial,serif;font-size:8.0pt"> anthracyclines </span><span style="font-family:Arial,sans-serif;font-size:9.8pt;color:#cd171e">&#x25a0;</span><span style="font-family:Arial,serif;font-size:8.0pt"> cardiotoxicity </span><span style="font-family:Arial,sans-serif;font-size:9.8pt;color:#cd171e">&#x25a0;</span><span style="font-family:Arial,serif;font-size:8.0pt"> exercise </span><span style="font-family:Arial,sans-serif;font-size:9.8pt;color:#cd171e">&#x25a0;</span><span style="font-family:Arial,serif;font-size:8.0pt"> meta- analysis</span></p>
<p style="top:567.2pt;left:54.6pt;line-height:43.6pt"><b><span style="font-family:Arial,serif;font-size:43.6pt;color:#cd171e">A</span></b></p>
<p style="top:570.1pt;left:78.9pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">nthracyclines are a group of antineoplastic anti-</span></p>
<p style="top:582.1pt;left:78.9pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">biotics that play an important role in the treat-</span></p>
<p style="top:594.1pt;left:78.9pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ment of a wide variety of cancers. However, use </span></p>
<p style="top:606.1pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of anthracyclines in clinical practice is associated with </span></p>
<p style="top:570.1pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the development of severe side effects, of which ir-</span></p>
<p style="top:582.1pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">reversible, dose- dependent cardiotoxicity is among </span></p>
<p style="top:594.1pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the most important.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">1,2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> In a pooled analysis of nearly </span></p>
<p style="top:606.1pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">50&#xa0;000 patients with cancer treated with contemporary </span></p>
<p style="top:629.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Correspondence to: Willeke R. Naaktgeboren, MD, Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, 1066 CX </span></p>
<p style="top:638.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Amsterdam, The Netherlands. E- mail: w.naaktgeboren@nki.nl</span></p>
<p style="top:648.9pt;left:54.6pt;line-height:4.6pt"><span style="font-family:Arial,serif;font-size:4.6pt">*</span><span style="font-family:Arial,serif;font-size:7.0pt">W. R. Naaktgeboren and D. Binyam are co- first authors.</span></p>
<p style="top:659.4pt;left:54.6pt;line-height:4.6pt"><span style="font-family:Arial,serif;font-size:4.6pt">&#x2020;</span><span style="font-family:Arial,serif;font-size:7.0pt">W. G. Groen and A. M. May are co- senior authors.</span></p>
<p style="top:670.4pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Supplementary Material for this article is available at https://www.ahajo urnals.org/doi/suppl/ 10.1161/JAHA.121.021580</span></p>
<p style="top:680.9pt;left:54.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">For Sources of Funding and Disclosures, see page 12.</span></p>
<p style="top:691.4pt;left:54.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">&#xa9; 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creat ive </span></p>
<p style="top:700.4pt;left:54.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Commo ns Attri bution-NonCo mmerc ial- NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use </span></p>
<p style="top:709.4pt;left:54.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">is non- commercial and no modifications or adaptations are made. </span></p>
<p style="top:719.9pt;left:54.7pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">JAHA </span></i><span style="font-family:Arial,serif;font-size:7.0pt">is available at: www.ahajournals.org/journal/jaha</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">2</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:569.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">anthracycline- based chemotherapy regimens, the </span></p>
<p style="top:581.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">incidence of clinical and subclinical cardiotoxicity </span></p>
<p style="top:593.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">after a median follow- up of 9&#xa0;years was 6% (95% CI, </span></p>
<p style="top:605.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">3%&#x2013; 9%) and 18% (95% CI, 12%&#x2013; 24%), respectively.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">3</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:617.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Cardiotoxicity of anthracyclines has been most exten-</span></p>
<p style="top:629.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sively studied for doxorubicin, which is currently also </span></p>
<p style="top:641.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the most commonly used anthracycline.</span></p>
<p style="top:653.7pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The pathogenesis of doxorubicin- induced car-</span></p>
<p style="top:665.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">diotoxicity (DIC), although not fully elucidated, is pre-</span></p>
<p style="top:677.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sumably a multifactorial complex with key roles for </span></p>
<p style="top:689.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">topoisomerase- II</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt"> and generation of oxidative stress. </span></p>
<p style="top:701.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">This eventually results in double- strand DNA breaks and </span></p>
<p style="top:713.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mitochondrial dysfunction, leading to cardiomyocyte </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">apoptosis and necrosis, with loss of functional car-</span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">diomyocytes as a result.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">4- 6</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Since the myocardium has </span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">no regenerative capacities, this damage is irreversible. </span></p>
<p style="top:94.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Compared with other cardiomyopathies, doxorubicin- </span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced heart failure has a particularly poor progno-</span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sis, with more than half of patients dying within 2&#xa0;years </span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">after diagnosis.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">7</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> As a result of the increased incidence </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">as well as survival of patients with cancer,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">8</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> DIC still </span></p>
<p style="top:154.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">poses a real clinical challenge.</span></p>
<p style="top:166.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">There is growing awareness of the need to develop </span></p>
<p style="top:178.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">effective strategies to reduce DIC, of which physical </span></p>
<p style="top:190.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">exercise (PE) interventions could be a promising non-</span></p>
<p style="top:202.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pharmacological method.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">9</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The potential of PE inter-</span></p>
<p style="top:214.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ventions to reduce DIC has been demonstrated in </span></p>
<p style="top:226.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">numerous preclinical studies.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">10</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Nevertheless, an es-</span></p>
<p style="top:238.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">timate of the effect of exercise on cardiotoxicity has </span></p>
<p style="top:250.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">never been quantified. Moreover, preclinical studies </span></p>
<p style="top:262.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">often focus on single pathways or molecular/histologi-</span></p>
<p style="top:274.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cal components, thereby targeting only a small fraction </span></p>
<p style="top:286.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of the multifaceted pathogenesis of DIC. To fully under-</span></p>
<p style="top:298.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">stand the relative contribution of these mechanisms, </span></p>
<p style="top:310.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a comprehensive overview incorporating all of the hy-</span></p>
<p style="top:322.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pothesized pathways is necessary.</span></p>
<p style="top:334.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The aim of this meta- analysis and systematic review </span></p>
<p style="top:346.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">is 2- fold: (1) to provide a pooled estimate of the effect of </span></p>
<p style="top:358.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">PE on preventing DIC, and (2) to provide an overview of </span></p>
<p style="top:370.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mechanisms underlying exercise- mediated cardiopro-</span></p>
<p style="top:382.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tection in patients receiving doxorubicin- based che-</span></p>
<p style="top:394.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">motherapy in (pre)clinical studies.</span></p>
<p style="top:427.3pt;left:306.6pt;line-height:13.0pt"><span style="font-family:Arial,serif;font-size:13.0pt;color:#cd171e">METHODS</span></p>
<p style="top:445.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The authors declare that all supporting data are </span></p>
<p style="top:457.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">available within the article and its online supplemen-</span></p>
<p style="top:469.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tary files. This review was prospectively registered </span></p>
<p style="top:481.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in the PROSPERO register (registration number: </span></p>
<p style="top:493.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">CRD42019118218), and the requirements for the </span></p>
<p style="top:505.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Preferred Reporting Items for Systematic Reviews and </span></p>
<p style="top:517.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Meta- Analyses (PRISMA) Statement were followed.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">11</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:529.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The systematic search, selection of articles, internal </span></p>
<p style="top:541.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">validity assessment, and data extraction were per-</span></p>
<p style="top:553.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">formed by 2 independent researchers (W. R. N. and D. </span></p>
<p style="top:565.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">B.). In cases where no consensus was reached, a third </span></p>
<p style="top:577.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">reviewer (A. M. M.) was consulted.</span></p>
<p style="top:603.6pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Search Strategy and Study Selection</span></p>
<p style="top:618.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">A systematic search was conducted in PubMed, </span></p>
<p style="top:630.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Embase, and Cochrane Central Register of Controlled </span></p>
<p style="top:642.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Trials (CENTRAL) databases on August 14, 2020. The </span></p>
<p style="top:654.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">search string was a combination of search terms for </span></p>
<p style="top:666.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">anthracyclines, cardiotoxicity, and exercise and was </span></p>
<p style="top:678.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">developed in collaboration with an information special-</span></p>
<p style="top:690.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ist from the University Medical Center Utrecht, Utrecht, </span></p>
<p style="top:702.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the Netherlands (Data S1). The search was limited </span></p>
<p style="top:714.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to the English language, without a date restriction. </span></p>
<p style="top:71.9pt;left:91.1pt;line-height:14.0pt"><span style="font-family:Arial,serif;font-size:14.0pt;color:#cd171e">CLINICAL PERSPECTIVE</span></p>
<p style="top:96.5pt;left:67.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">What Is New?</span></p>
<p style="top:109.5pt;left:67.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt;color:#cd171e">&#x2022;</span><span style="font-family:Arial,serif;font-size:9.5pt"> This systematic review and meta- analysis in-</span></p>
<p style="top:120.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">dicates that various exercise interventions can </span></p>
<p style="top:131.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">protect against doxorubicin- induced cardiotox-</span></p>
<p style="top:142.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">icity in rodents, with less cardiac doxorubicin </span></p>
<p style="top:153.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">accumulation as a key underlying mechanism.</span></p>
<p style="top:164.5pt;left:67.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt;color:#cd171e">&#x2022;</span><span style="font-family:Arial,serif;font-size:9.5pt"> Evidence from clinical studies is limited, yet the </span></p>
<p style="top:175.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">observed effects are congruent with the hy-</span></p>
<p style="top:186.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">pothesis that physical exercise can yield cardio-</span></p>
<p style="top:197.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">protection in patients with cancer.</span></p>
<p style="top:218.5pt;left:67.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">What Are the Clinical Implications?</span></p>
<p style="top:231.5pt;left:67.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt;color:#cd171e">&#x2022;</span><span style="font-family:Arial,serif;font-size:9.5pt"> The preclinical evidence and lack of availability </span></p>
<p style="top:242.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">of clinical data warrants larger, methodologi-</span></p>
<p style="top:253.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">cal rigorous clinical studies to clarify the role of </span></p>
<p style="top:264.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">physical exercise in preventing cardiotoxicity in </span></p>
<p style="top:275.5pt;left:80.6pt;line-height:9.5pt"><span style="font-family:Arial,serif;font-size:9.5pt">patients with cancer.</span></p>
<p style="top:337.1pt;left:67.6pt;line-height:13.0pt"><span style="font-family:Arial,serif;font-size:13.0pt;color:#cd171e">Nonstandard Abbreviations and Acronyms</span></p>
<p style="top:360.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">DIC </span></b></p>
<p style="top:360.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">doxorubicin- induced cardiotoxicity</span></p>
<p style="top:373.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">FS </span></b></p>
<p style="top:373.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">fractional shortening</span></p>
<p style="top:386.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">FTM </span></b></p>
<p style="top:386.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">forced treadmill</span></p>
<p style="top:399.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">HSP </span></b></p>
<p style="top:399.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">heat shock protein</span></p>
<p style="top:412.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">LVP </span></b></p>
<p style="top:412.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">left ventricular pressure</span></p>
<p style="top:425.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">MD </span></b></p>
<p style="top:425.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">mean difference</span></p>
<p style="top:438.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">MHC </span></b></p>
<p style="top:438.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">myosin heavy chain</span></p>
<p style="top:451.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">mPTP </span></b></p>
<p style="top:451.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">mitochondrial permeability transition </span></p>
<p style="top:462.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">pore</span></p>
<p style="top:475.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">PE </span></b></p>
<p style="top:475.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">physical exercise</span></p>
<p style="top:488.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">PGC- 1</span></b><b><span style="font-family:NotoSans,serif;font-size:9.0pt">&#x3b1;</span></b><b><span style="font-family:Arial,serif;font-size:9.0pt"> </span></b></p>
<p style="top:488.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">peroxisome proliferator- activated </span></p>
<p style="top:499.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">receptor- </span><span style="font-family:NotoSans,serif;font-size:9.0pt">&#x3b3;</span><span style="font-family:Arial,serif;font-size:9.0pt"> coactivator 1</span><span style="font-family:NotoSans,serif;font-size:9.0pt">&#x3b1;</span></p>
<p style="top:512.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">SERCA2a </span></b><span style="font-family:Arial,serif;font-size:9.0pt">sarcoendoplasmic reticulum calcium </span></p>
<p style="top:523.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">ATPase 2a</span></p>
<p style="top:536.3pt;left:67.6pt;line-height:9.0pt"><b><span style="font-family:Arial,serif;font-size:9.0pt">VWR </span></b></p>
<p style="top:536.3pt;left:118.4pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt">voluntary wheel running</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">3</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">References of included full- text articles were checked </span></p>
<p style="top:70.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to identify potentially relevant articles not found through </span></p>
<p style="top:82.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the initial search.</span></p>
<p style="top:94.7pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Eligible studies compared any type of PE interven-</span></p>
<p style="top:106.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion, both single acute bouts and chronic exercise, in </span></p>
<p style="top:118.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">combination with anthracyclines with no intervention </span></p>
<p style="top:130.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(ie, anthracyclines only). Outcomes included any pa-</span></p>
<p style="top:142.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">rameters of cardiotoxicity, such as biomarkers, imag-</span></p>
<p style="top:154.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ing parameters, histopathology, and clinical end points </span></p>
<p style="top:166.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(ie, heart failure). Studies with both humans and ani-</span></p>
<p style="top:178.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mal subjects (with or without cancer) were eligible for </span></p>
<p style="top:190.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">inclusion. Studies in humans, however, had to be ei-</span></p>
<p style="top:202.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ther randomized controlled trials with cardiotoxicity as </span></p>
<p style="top:214.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">one of the outcomes, or mechanistic studies focusing </span></p>
<p style="top:226.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">on underlying pathways in order to be deemed eligi-</span></p>
<p style="top:238.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ble. Since the effect of PE on anthracycline- induced </span></p>
<p style="top:250.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiotoxicity has been previously</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">12</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> documented and </span></p>
<p style="top:262.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">might not be the same in children as in adults, given </span></p>
<p style="top:274.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the relevant differences that exist between children </span></p>
<p style="top:286.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and adults in anthracycline- induced cardiotoxicity (eg, </span></p>
<p style="top:298.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">different pharmacokinetics of anthracyclines)</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">13</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and an </span></p>
<p style="top:310.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">increased susceptibility for cardiotoxicity in patients at </span></p>
<p style="top:322.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a younger age</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">14</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> we excluded children from our study </span></p>
<p style="top:334.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">population. We also excluded studies combining doxo-</span></p>
<p style="top:346.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">rubicin with any other drug or substance, and confer-</span></p>
<p style="top:358.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ence abstracts.</span></p>
<p style="top:391.1pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Data Extraction and Analysis</span></p>
<p style="top:406.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">We collected data using a pretested extraction form </span></p>
<p style="top:418.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">including information about the study population (type </span></p>
<p style="top:430.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of patients, sex, age), study characteristics (number </span></p>
<p style="top:442.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of patients per arm, duration and timing of interven-</span></p>
<p style="top:454.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion), characteristics of the anthracycline administration </span></p>
<p style="top:466.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(timing, dose, and number of doses). Cardiotoxicity </span></p>
<p style="top:478.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">outcomes, along with their corresponding group aver-</span></p>
<p style="top:490.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ages, measures of variability or spread (SD or SE), and </span></p>
<p style="top:502.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">group size (number), were extracted and grouped into </span></p>
<p style="top:514.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in vivo or ex vivo analysis and human or animal stud-</span></p>
<p style="top:526.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ies. In cases where the results were only reported by </span></p>
<p style="top:538.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">means of graphs, we contacted authors for numeric </span></p>
<p style="top:550.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">data. If no response was obtained, the study was ex-</span></p>
<p style="top:562.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cluded for the quantitative analysis.</span></p>
<p style="top:586.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and </span><sup><span style="font-family:Arial,serif;font-size:10.0pt">We compared outcomes between exercising </span></sup></p>
<p style="top:586.2pt;left:83.4pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">nonexercising </span></p>
<p style="top:586.2pt;left:155.2pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin- treated </span></p>
<p style="top:586.2pt;left:251.8pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">patients. </span></p>
<p style="top:598.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Parameters indicative of cardiac function that were de-</span></p>
<p style="top:610.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">scribed in &#x2265;3 studies and were considered sufficiently </span></p>
<p style="top:622.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">clinically and statistically homogeneous were pooled. </span></p>
<p style="top:634.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Random effects models were used to allow for het-</span></p>
<p style="top:646.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">erogeneous underlying treatment effects, yet results </span></p>
<p style="top:658.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">were reanalyzed using fixed- effect models to explore </span></p>
<p style="top:670.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">whether this yielded differences regarding the summary </span></p>
<p style="top:682.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">inferences. Funnel plots with Egger test were used to </span></p>
<p style="top:694.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">detect publication for outcomes that were reported by </span></p>
<p style="top:706.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">&#x2265;10 studies.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">15</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Statistical heterogeneity among studies </span></p>
<p style="top:718.2pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was assessed via forest plots in combination with the </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><i><span style="font-family:Arial,serif;font-size:10.0pt">I</span></i><sup><i><span style="font-family:Arial,serif;font-size:6.5pt">2</span></i></sup><span style="font-family:Arial,serif;font-size:10.0pt"> statistics before undertaking the meta- analysis and </span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">presenting pooled results. Outcomes were structured </span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">around the type of intervention (forced treadmill [FTM] </span></p>
<p style="top:94.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">versus voluntary wheel running [VWR]). If a study had </span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">both an FTM and a VWR intervention arm, a single </span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pairwise comparison (ie, FTM or VWR versus control) </span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was entered in the appropriate analysis. Continuous </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">outcomes were presented as mean differences (MDs) </span></p>
<p style="top:154.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">with corresponding 95% CIs and the variance of the </span></p>
<p style="top:166.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">effect size (</span><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">).</span></p>
<p style="top:178.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In a subanalysis, we tested the effect of timing of the </span></p>
<p style="top:190.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">PE intervention with respect to doxorubicin administra-</span></p>
<p style="top:202.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion (ie, before [preconditioning] or concomitant with </span></p>
<p style="top:214.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin treatment). If a study had multiple interven-</span></p>
<p style="top:226.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion arms, the number of patients in the control group </span></p>
<p style="top:238.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was divided approximately evenly among the com-</span></p>
<p style="top:250.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">parisons (forced or voluntary versus control), which </span></p>
<p style="top:262.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">were entered as single pairwise comparisons into the </span></p>
<p style="top:274.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">analysis. Data were analyzed with R version 3.5.1 and </span></p>
<p style="top:286.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">RStudio version 1.1.456 (RStudio Inc.). A narrative syn-</span></p>
<p style="top:298.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">thesis was used to systematically describe the underly-</span></p>
<p style="top:310.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ing mechanism for exercise- induced cardioprotection.</span></p>
<p style="top:333.1pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Risk- of- Bias Assessment</span></p>
<p style="top:348.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">We assessed risk of bias for animal studies using </span></p>
<p style="top:360.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the Systematic Review Centre for Laboratory animal </span></p>
<p style="top:372.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Experimentation (SYRCLE) risk- of- bias tool.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">16</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> We used </span></p>
<p style="top:384.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the Cochrane risk- of- bias tool (version 1) for human </span></p>
<p style="top:396.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">17</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Per category, studies could score &quot;high,&quot; </span></p>
<p style="top:408.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">&quot;low,&quot; or &quot;unclear&quot; for risk of bias. Authors were con-</span></p>
<p style="top:420.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tacted for further details in case of an unclear score. </span></p>
<p style="top:432.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Further internal validity was assessed via the reporting </span></p>
<p style="top:444.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of quality indicators. The quality indicators were scored </span></p>
<p style="top:456.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">as &quot;yes&quot; or &quot;no,&quot; corresponding to reported or unre-</span></p>
<p style="top:468.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ported, respectively.</span></p>
<p style="top:502.8pt;left:306.6pt;line-height:13.0pt"><span style="font-family:Arial,serif;font-size:13.0pt;color:#cd171e">RESULTS</span></p>
<p style="top:521.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The search yielded 1224 original articles (Figure&#xa0; 1). </span></p>
<p style="top:533.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">One additional article</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">18</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> was identified through other </span></p>
<p style="top:545.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sources. After full- text screening, 40 articles were con-</span></p>
<p style="top:557.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sidered eligible and included in this review. References </span></p>
<p style="top:569.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">for articles that were excluded on the basis of full- text </span></p>
<p style="top:581.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(n=14) are provided in Data S2. Of the 40 studies in-</span></p>
<p style="top:593.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cluded in the analysis, 3 were human randomized con-</span></p>
<p style="top:605.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">trolled trials</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">19- 21</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and the remaining 37 were conducted </span></p>
<p style="top:617.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in rodents. Details of all study protocols are summa-</span></p>
<p style="top:629.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">rized in Table&#xa0;1.</span></p>
<p style="top:655.1pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Characteristics of the Clinical Studies</span></p>
<p style="top:670.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The 3 clinical studies were all conducted in patients </span></p>
<p style="top:682.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">with breast cancer. Two studies by Kirkham et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">19</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> used </span></p>
<p style="top:694.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the same population (n=24), describing the effects of </span></p>
<p style="top:706.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the first exercise bout before the start of doxorubicin </span></p>
<p style="top:718.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and cyclophosphamide&#x2013; based chemotherapy, and </span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">4</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:674.1pt;left:120.5pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Figure 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Flow diagram depicting the search process.</span></b></p>
<p style="top:684.1pt;left:120.5pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">The format provided by Moger et al</span><sup><span style="font-family:Arial,serif;font-size:5.2pt">11</span></sup><span style="font-family:Arial,serif;font-size:8.0pt"> in the Preferred Reporting Items for Systematic Reviews and </span></p>
<p style="top:694.1pt;left:120.5pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Meta- Analyses statement was used.</span></p>
<p style="top:74.5pt;left:313.0pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Addi&#xfffd;onal records </span></i></p>
<p style="top:87.1pt;left:302.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">iden&#xfffd;&#xfb01;ed through other </span></i></p>
<p style="top:99.7pt;left:332.6pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">sources</span></i></p>
<p style="top:112.3pt;left:334.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n = 1)</span></i></p>
<p style="top:177.0pt;left:222.5pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Records a&#xfffd;er duplicates removed</span></i></p>
<p style="top:189.7pt;left:268.2pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n =968)</span></i></p>
<p style="top:269.4pt;left:251.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Records screened</span></i></p>
<p style="top:282.0pt;left:267.2pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n = 968)</span></i></p>
<p style="top:267.4pt;left:371.3pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Records excluded</span></i></p>
<p style="top:280.0pt;left:386.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n = 891)</span></i></p>
<p style="top:423.2pt;left:254.1pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Full-text ar&#xfffd;cles</span></i></p>
<p style="top:435.8pt;left:261.1pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">assessed for </span></i></p>
<p style="top:448.4pt;left:266.8pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">eligibility</span></i></p>
<p style="top:461.0pt;left:269.4pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n = 77)</span></i></p>
<p style="top:335.7pt;left:365.0pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Full-text ar&#xfffd;cles excluded, </span></i></p>
<p style="top:348.2pt;left:389.2pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">with reasons</span></i></p>
<p style="top:360.9pt;left:398.5pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n = 37</span></i><span style="font-family:Calibri,serif;font-size:9.0pt">)</span></p>
<p style="top:382.2pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- Conference abstract (n = 23)</span></p>
<p style="top:399.0pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- Wrong population, model for </span></p>
<p style="top:407.7pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">childhood (n = 3)</span></p>
<p style="top:424.5pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- DOX used in combination with </span></p>
<p style="top:433.2pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">other drug (n = 3)</span></p>
<p style="top:450.0pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- Prospective human trial      (n = </span></p>
<p style="top:458.7pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">3)</span></p>
<p style="top:475.6pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- No appropriate intervention (n = </span></p>
<p style="top:484.3pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">2)</span></p>
<p style="top:501.1pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">- No appropriate outcomes  (n = </span></p>
<p style="top:509.8pt;left:361.9pt;line-height:6.6pt"><span style="font-family:SegoeUI,serif;font-size:6.6pt">1)</span></p>
<p style="top:558.6pt;left:232.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Studies included in analysis</span></i><span style="font-family:SegoeUISymbol,serif;font-size:9.0pt">:</span></p>
<p style="top:592.1pt;left:235.6pt;line-height:9.0pt"><span style="font-family:Calibri,serif;font-size:9.0pt">Preclinical studies</span><i><span style="font-family:Calibri,serif;font-size:9.0pt"> (n = 37)</span></i></p>
<p style="top:612.8pt;left:243.4pt;line-height:9.0pt"><span style="font-family:Calibri,serif;font-size:9.0pt">Clinical studies</span><i><span style="font-family:Calibri,serif;font-size:9.0pt"> (n = 3)</span></i></p>
<p style="top:74.5pt;left:172.1pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">Records iden&#xfffd;&#xfb01;ed through </span></i></p>
<p style="top:87.1pt;left:184.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">database searching</span></i></p>
<p style="top:99.7pt;left:201.7pt;line-height:9.0pt"><i><span style="font-family:Calibri,serif;font-size:9.0pt">(n =1.224)</span></i></p>
<p style="top:300.5pt;left:132.4pt;line-height:10.6pt"><span style="font-family:Calibri,serif;font-size:10.6pt;color:#2e5395">Screening</span></p>
<p style="top:587.7pt;left:132.4pt;line-height:10.6pt"><span style="font-family:Calibri,serif;font-size:10.6pt;color:#2e5395">Included</span></p>
<p style="top:444.1pt;left:132.4pt;line-height:10.6pt"><span style="font-family:Calibri,serif;font-size:10.6pt;color:#2e5395">Eligibility</span></p>
<p style="top:157.0pt;left:132.4pt;line-height:10.6pt"><span style="font-family:Calibri,serif;font-size:10.6pt;color:#2e5395">Iden&#xfffd;&#xfb01;ca&#xfffd;on</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">5</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:720.3pt;left:52.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Characteristics of the Study Protocols</span></b></p>
<p style="top:718.4pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference</span></p>
<p style="top:626.1pt;left:71.5pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study population</span></p>
<p style="top:390.2pt;left:71.5pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study characteristics</span></p>
<p style="top:158.6pt;left:71.5pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin characteristics</span></p>
<p style="top:654.0pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Patients/</span></p>
<p style="top:654.0pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animals*</span></p>
<p style="top:601.0pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sex</span></p>
<p style="top:569.1pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Age</span></p>
<p style="top:536.1pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental </span></p>
<p style="top:536.1pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">groups (n)</span></p>
<p style="top:464.3pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise specifications</span></p>
<p style="top:378.4pt;left:88.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise timing </span></p>
<p style="top:378.4pt;left:97.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with respect </span></p>
<p style="top:378.4pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to doxorubicin </span></p>
<p style="top:378.4pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">infusion</span></p>
<p style="top:321.9pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Control groups (n)</span></p>
<p style="top:220.1pt;left:97.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:220.1pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity </span></p>
<p style="top:220.1pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">assessment</span></p>
<p style="top:168.3pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:168.3pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin</span></p>
<p style="top:119.4pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dose, </span></p>
<p style="top:119.4pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mg/kg</span></p>
<p style="top:85.3pt;left:97.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No. of </span></p>
<p style="top:85.3pt;left:106.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses </span></p>
<p style="top:85.3pt;left:115.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(time)</span></p>
<p style="top:718.6pt;left:130.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Clinical studies</span></p>
<p style="top:711.1pt;left:143.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Kirkham, 2017</span><span style="font-family:Arial,serif;font-size:4.4pt">19</span></p>
<p style="top:654.2pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Patients with </span></p>
<p style="top:654.2pt;left:152.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">stage I&#x2013; III </span></p>
<p style="top:654.2pt;left:161.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">breast cancer, </span></p>
<p style="top:654.2pt;left:170.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">scheduled for </span></p>
<p style="top:654.2pt;left:178.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin- </span></p>
<p style="top:654.2pt;left:187.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">containing </span></p>
<p style="top:654.2pt;left:196.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">therapy</span></p>
<p style="top:601.2pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">50 y</span></p>
<p style="top:536.2pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (13)</span></p>
<p style="top:464.5pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Acute: single bout of </span></p>
<p style="top:464.5pt;left:152.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;min at 70% HRmax</span></p>
<p style="top:378.5pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">No vigorous exercise for 72&#xa0;h </span></p>
<p style="top:322.1pt;left:152.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">before and 48&#xa0;h after treatment </span></p>
<p style="top:322.1pt;left:161.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(11)</span></p>
<p style="top:220.3pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Before first </span></p>
<p style="top:220.3pt;left:152.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treatment </span></p>
<p style="top:220.3pt;left:161.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(baseline) and </span></p>
<p style="top:220.3pt;left:170.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#x2013; 48&#xa0;h After </span></p>
<p style="top:220.3pt;left:178.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin </span></p>
<p style="top:220.3pt;left:187.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treatment</span></p>
<p style="top:168.4pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:152.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">60&#xa0;mg/</span></p>
<p style="top:119.5pt;left:152.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">m</span><span style="font-family:Arial,serif;font-size:4.4pt">2</span></p>
<p style="top:85.5pt;left:143.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:209.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Kirkham, 2018</span><span style="font-family:Arial,serif;font-size:4.4pt">20</span></p>
<p style="top:654.2pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Patients with </span></p>
<p style="top:654.2pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">stage I&#x2013; III </span></p>
<p style="top:654.2pt;left:227.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">breast cancer, </span></p>
<p style="top:654.2pt;left:235.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">scheduled for </span></p>
<p style="top:654.2pt;left:244.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin- </span></p>
<p style="top:654.2pt;left:253.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">containing </span></p>
<p style="top:654.2pt;left:262.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">therapy</span></p>
<p style="top:601.2pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">50 y</span></p>
<p style="top:536.2pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (13)</span></p>
<p style="top:464.5pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 4 bouts of </span></p>
<p style="top:464.5pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;min across 6&#x2013; 9&#xa0;wk </span></p>
<p style="top:464.5pt;left:227.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">before each doxorubicin </span></p>
<p style="top:464.5pt;left:235.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">administration, 70% </span></p>
<p style="top:464.5pt;left:244.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">HRmax</span></p>
<p style="top:378.5pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">No vigorous exercise for 72&#xa0;h </span></p>
<p style="top:322.1pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">before and 48&#xa0;h after treatment </span></p>
<p style="top:322.1pt;left:227.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(11)</span></p>
<p style="top:220.3pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Before first </span></p>
<p style="top:220.3pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treatment </span></p>
<p style="top:220.3pt;left:227.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(baseline) and </span></p>
<p style="top:220.3pt;left:235.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">7&#x2013; 14&#xa0;d after </span></p>
<p style="top:220.3pt;left:244.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">last treatment</span></p>
<p style="top:168.4pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">each treadmill</span></p>
<p style="top:119.5pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Mean </span></p>
<p style="top:119.5pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">total </span></p>
<p style="top:119.5pt;left:227.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">236&#xa0;mg/</span></p>
<p style="top:119.5pt;left:235.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">m</span><span style="font-family:Arial,serif;font-size:4.4pt">2</span></p>
<p style="top:85.5pt;left:209.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4 </span></p>
<p style="top:85.5pt;left:218.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(6&#x2013; 9&#xa0;wk)</span></p>
<p style="top:711.1pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ma, 2018</span><span style="font-family:Arial,serif;font-size:4.4pt">21</span></p>
<p style="top:654.2pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Patients with </span></p>
<p style="top:654.2pt;left:283.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">breast cancer, </span></p>
<p style="top:654.2pt;left:292.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">after operation</span></p>
<p style="top:601.2pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">43.1 y</span></p>
<p style="top:536.2pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (31)</span></p>
<p style="top:464.5pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 3&#xa0;d/wk for 16&#xa0;wk, </span></p>
<p style="top:464.5pt;left:283.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">70% HRmax</span></p>
<p style="top:378.5pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">No guidance in sports, </span></p>
<p style="top:322.1pt;left:283.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">performed normal daily </span></p>
<p style="top:322.1pt;left:292.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">activities (33)</span></p>
<p style="top:220.3pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">After last </span></p>
<p style="top:220.3pt;left:283.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise bout, </span></p>
<p style="top:220.3pt;left:292.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">time NS</span></p>
<p style="top:168.4pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:119.5pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:85.5pt;left:275.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4 (16&#xa0;wk)</span></p>
<p style="top:718.6pt;left:305.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Animal studies</span></p>
<p style="top:711.1pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ahmadian, </span></p>
<p style="top:711.1pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2018</span><span style="font-family:Arial,serif;font-size:4.4pt">22</span></p>
<p style="top:654.2pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">3&#xa0;mo, </span></p>
<p style="top:569.2pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">16&#xa0;mo, </span></p>
<p style="top:569.2pt;left:335.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">and </span></p>
<p style="top:569.2pt;left:344.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">32&#xa0;mo</span></p>
<p style="top:536.2pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (8 per </span></p>
<p style="top:536.2pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">group)</span></p>
<p style="top:464.5pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic : 5&#xa0;d/wk for 3&#xa0;wk, </span></p>
<p style="top:464.5pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15&#x2013; 17&#xa0;m/min, 25&#x2013; 39&#xa0;min/d</span></p>
<p style="top:378.5pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8 per </span></p>
<p style="top:322.1pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">group)  </span></p>
<p style="top:322.1pt;left:335.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (8 per group)</span></p>
<p style="top:220.3pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:327.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:318.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Alihemmati, </span></p>
<p style="top:711.1pt;left:366.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2019</span><span style="font-family:Arial,serif;font-size:4.4pt">23</span></p>
<p style="top:654.2pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wister rats</span></p>
<p style="top:601.2pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (6)</span></p>
<p style="top:464.5pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 6&#xa0;wk, </span></p>
<p style="top:464.5pt;left:366.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">intensity 40%&#x2013; 90% </span></p>
<p style="top:464.5pt;left:375.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">VO</span><span style="font-family:Arial,serif;font-size:4.4pt">2max</span><span style="font-family:Arial,serif;font-size:6.8pt">, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:366.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:375.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">72&#xa0;h After </span></p>
<p style="top:220.3pt;left:366.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">After exercise</span></p>
<p style="top:119.5pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:357.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ascens&#xe3;o, </span></p>
<p style="top:711.1pt;left:396.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2006</span><span style="font-family:Arial,serif;font-size:4.4pt">24</span></p>
<p style="top:654.2pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#x2013; 8&#xa0;wk</span></p>
<p style="top:536.2pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (6)</span></p>
<p style="top:464.5pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 14&#xa0;wk. </span></p>
<p style="top:464.5pt;left:396.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Building up to 90&#xa0;min/d, </span></p>
<p style="top:464.5pt;left:405.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;m/min (grade 6%) by </span></p>
<p style="top:464.5pt;left:414.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">wk 5</span></p>
<p style="top:378.5pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:396.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:405.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:396.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:396.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:388.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ascens&#xe3;o, </span></p>
<p style="top:711.1pt;left:436.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2011</span><span style="font-family:Arial,serif;font-size:4.4pt">25</span></p>
<p style="top:654.2pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;wk</span></p>
<p style="top:536.2pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (5)</span></p>
<p style="top:464.5pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Acute: single bout of </span></p>
<p style="top:464.5pt;left:436.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">60&#xa0;min, &#x2248;5&#xa0;min at 15&#xa0;m/</span></p>
<p style="top:464.5pt;left:444.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">min 0% gradient, &#x2248;10&#xa0;min </span></p>
<p style="top:464.5pt;left:453.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">23&#xa0;m/min 0% gradient, </span></p>
<p style="top:464.5pt;left:462.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">&#x2248;45&#xa0;min 25&#xa0;m/min 5% </span></p>
<p style="top:464.5pt;left:471.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">gradient</span></p>
<p style="top:378.5pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (5)  </span></p>
<p style="top:322.1pt;left:436.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (5)  </span></p>
<p style="top:322.1pt;left:444.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (5)</span></p>
<p style="top:220.3pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:436.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:436.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:427.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ascens&#xe3;o, </span></p>
<p style="top:711.1pt;left:492.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2005</span><span style="font-family:Arial,serif;font-size:4.4pt">26</span></p>
<p style="top:654.2pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#x2013; 8&#xa0;wk</span></p>
<p style="top:536.2pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (10)</span></p>
<p style="top:464.5pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 14&#xa0;wk. </span></p>
<p style="top:464.5pt;left:493.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Building up to 30&#xa0;m/min </span></p>
<p style="top:464.5pt;left:501.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(6% grade), 90&#xa0;min/d</span></p>
<p style="top:378.5pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (10)    </span></p>
<p style="top:322.1pt;left:493.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (10)  </span></p>
<p style="top:322.1pt;left:501.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (10)</span></p>
<p style="top:220.3pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:493.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:493.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:484.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:91.7pt;left:533.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">6</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:718.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference</span></p>
<p style="top:626.1pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study population</span></p>
<p style="top:390.2pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study characteristics</span></p>
<p style="top:158.6pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin characteristics</span></p>
<p style="top:654.0pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Patients/</span></p>
<p style="top:654.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animals*</span></p>
<p style="top:601.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sex</span></p>
<p style="top:569.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Age</span></p>
<p style="top:536.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental </span></p>
<p style="top:536.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">groups (n)</span></p>
<p style="top:464.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise specifications</span></p>
<p style="top:378.4pt;left:89.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise timing </span></p>
<p style="top:378.4pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with respect </span></p>
<p style="top:378.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to doxorubicin </span></p>
<p style="top:378.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">infusion</span></p>
<p style="top:321.9pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Control groups (n)</span></p>
<p style="top:220.1pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:220.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity </span></p>
<p style="top:220.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">assessment</span></p>
<p style="top:168.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:168.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin</span></p>
<p style="top:119.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dose, </span></p>
<p style="top:119.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mg/kg</span></p>
<p style="top:85.3pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No. of </span></p>
<p style="top:85.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses </span></p>
<p style="top:85.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(time)</span></p>
<p style="top:711.1pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ascens&#xe3;o, </span></p>
<p style="top:711.1pt;left:140.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2005</span><span style="font-family:Arial,serif;font-size:4.4pt">27</span></p>
<p style="top:654.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Charles River </span></p>
<p style="top:654.2pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">CD1 mice</span></p>
<p style="top:601.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#x2013; 8&#xa0;wk</span></p>
<p style="top:536.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">ST (11)</span></p>
<p style="top:464.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic 5&#xa0;d/wk for 14&#xa0;wk. </span></p>
<p style="top:464.5pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1&#xa0;h/d</span></p>
<p style="top:378.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (11)  </span></p>
<p style="top:322.1pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (11)  </span></p>
<p style="top:322.1pt;left:149.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">ST+saline (11)</span></p>
<p style="top:220.3pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After ST</span></p>
<p style="top:119.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:161.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ashrafi, 2012</span><span style="font-family:Arial,serif;font-size:4.4pt">28</span></p>
<p style="top:654.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">8&#xa0;wk</span></p>
<p style="top:536.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+doxorubicin </span></p>
<p style="top:536.2pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;mg/kg (8)  </span></p>
<p style="top:536.2pt;left:179.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+doxorubicin </span></p>
<p style="top:536.2pt;left:188.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20&#xa0;mg/kg (8)</span></p>
<p style="top:464.5pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 3&#xa0;wk. </span></p>
<p style="top:464.5pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15&#x2013; 17&#xa0;m/min, 25&#x2013; 39&#xa0;min/d</span></p>
<p style="top:378.5pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (8)  </span></p>
<p style="top:322.1pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 10&#xa0;mg/</span></p>
<p style="top:322.1pt;left:179.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (8)  </span></p>
<p style="top:322.1pt;left:188.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 20&#xa0;mg/</span></p>
<p style="top:322.1pt;left:197.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (8)  </span></p>
<p style="top:322.1pt;left:205.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (8)</span></p>
<p style="top:220.3pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1. 10  </span></p>
<p style="top:119.5pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2. 20</span></p>
<p style="top:85.5pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:218.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chicco, 2005</span><span style="font-family:Arial,serif;font-size:4.4pt">29</span></p>
<p style="top:654.2pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque&#x2013; </span></p>
<p style="top:654.2pt;left:227.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (7)</span></p>
<p style="top:464.5pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic:voluntary for 8&#xa0;wk</span></p>
<p style="top:378.5pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:227.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (7)  </span></p>
<p style="top:322.1pt;left:236.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (8)</span></p>
<p style="top:220.3pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During and </span></p>
<p style="top:220.3pt;left:227.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">after perfusion</span></p>
<p style="top:168.4pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:168.4pt;left:227.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR, ex vivo </span></p>
<p style="top:168.4pt;left:236.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">perfusion</span></p>
<p style="top:119.5pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;&#xb5;M</span></p>
<p style="top:85.5pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">For 1&#xa0;h</span></p>
<p style="top:711.1pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chicco, 2006</span><span style="font-family:Arial,serif;font-size:4.4pt">30</span></p>
<p style="top:654.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (8)</span></p>
<p style="top:464.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 2&#xa0;wk. </span></p>
<p style="top:464.5pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15&#xa0;m/min, 20&#xa0;min/d</span></p>
<p style="top:378.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8)  </span></p>
<p style="top:322.1pt;left:266.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2.5</span></p>
<p style="top:85.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6 (2&#xa0;wk)</span></p>
<p style="top:711.1pt;left:279.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chicco, 2006</span><span style="font-family:Arial,serif;font-size:4.4pt">31</span></p>
<p style="top:654.2pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (15)</span></p>
<p style="top:464.5pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 12&#xa0;wk. </span></p>
<p style="top:464.5pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Building up to 15&#x2013; 27&#xa0;m/</span></p>
<p style="top:464.5pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">min (0&#x2013; 5% gradient), </span></p>
<p style="top:464.5pt;left:306.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20&#x2013; 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (15)  </span></p>
<p style="top:322.1pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15</span></p>
<p style="top:85.5pt;left:279.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dolinsky, 2013</span><span style="font-family:Arial,serif;font-size:4.4pt">32</span></p>
<p style="top:654.2pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">C57BL6 mice</span></p>
<p style="top:601.2pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:536.2pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (9&#x2013; 11)</span></p>
<p style="top:464.5pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 8&#xa0;wk, </span></p>
<p style="top:464.5pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">building up to 18&#xa0;m/min, </span></p>
<p style="top:464.5pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">45&#xa0;min/d</span></p>
<p style="top:378.5pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (9&#x2013; 11)  </span></p>
<p style="top:322.1pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (9&#x2013; 11)  </span></p>
<p style="top:322.1pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin+resver</span></p>
<p style="top:322.1pt;left:345.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">atrol (9&#x2013; 11)</span></p>
<p style="top:220.3pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">8</span></p>
<p style="top:85.5pt;left:318.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4 (4&#xa0;wk)</span></p>
<p style="top:711.1pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Farzanegi, </span></p>
<p style="top:711.1pt;left:366.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2019</span><span style="font-family:Arial,serif;font-size:4.4pt">33</span></p>
<p style="top:654.2pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:569.2pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">40&#x2013; 50&#xa0;wk ST (6)</span></p>
<p style="top:464.5pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 3&#xa0;d/wk for 8&#xa0;wk. </span></p>
<p style="top:464.5pt;left:366.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Building up from 5 to </span></p>
<p style="top:464.5pt;left:375.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;min/d</span></p>
<p style="top:378.5pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:366.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:375.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin+saline </span></p>
<p style="top:322.1pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(6)  </span></p>
<p style="top:322.1pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin+GA (6)  </span></p>
<p style="top:322.1pt;left:402.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">ST+doxorubicin+GA (6)</span></p>
<p style="top:220.3pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:220.3pt;left:366.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">completion of </span></p>
<p style="top:220.3pt;left:375.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During ST in </span></p>
<p style="top:168.4pt;left:366.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">week 1</span></p>
<p style="top:119.5pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">8.5</span></p>
<p style="top:85.5pt;left:358.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:414.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Hall, 2019</span><span style="font-family:Arial,serif;font-size:4.4pt">34</span></p>
<p style="top:654.2pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sprague- </span></p>
<p style="top:654.2pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:536.2pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (8)</span></p>
<p style="top:464.5pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: voluntary for </span></p>
<p style="top:464.5pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">17&#xa0;wk</span></p>
<p style="top:378.5pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+CR (6)  </span></p>
<p style="top:322.1pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Saline+WR (6)  </span></p>
<p style="top:322.1pt;left:441.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Saline+CR+WR (8)  </span></p>
<p style="top:322.1pt;left:450.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Doxorubicin (8)  </span></p>
<p style="top:322.1pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">CR+doxorubicin (8)  </span></p>
<p style="top:322.1pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">CR+doxorubicin+WR (8)</span></p>
<p style="top:220.3pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After WR</span></p>
<p style="top:119.5pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15</span></p>
<p style="top:85.5pt;left:415.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:480.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Hydock, 2008</span><span style="font-family:Arial,serif;font-size:4.4pt">35</span></p>
<p style="top:654.2pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (24)  </span></p>
<p style="top:536.2pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (21)</span></p>
<p style="top:464.5pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 1. 5&#xa0;d/wk for </span></p>
<p style="top:464.5pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk. 20&#x2013; 60&#xa0;min/d, 20&#x2013; </span></p>
<p style="top:464.5pt;left:498.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;m/min (0&#x2013; 18% grade). </span></p>
<p style="top:464.5pt;left:507.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2. voluntary for 10&#xa0;wk</span></p>
<p style="top:378.5pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (30)  </span></p>
<p style="top:322.1pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (28)  </span></p>
<p style="top:322.1pt;left:498.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (24)  </span></p>
<p style="top:322.1pt;left:507.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (20)</span></p>
<p style="top:220.3pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5 Or 10&#xa0;d after </span></p>
<p style="top:220.3pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:489.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR</span></p>
<p style="top:119.5pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10</span></p>
<p style="top:85.5pt;left:480.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:720.3pt;left:52.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">(Continued)</span></b></p>
<p style="top:91.7pt;left:533.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">7</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:718.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference</span></p>
<p style="top:626.1pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study population</span></p>
<p style="top:390.2pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study characteristics</span></p>
<p style="top:158.6pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin characteristics</span></p>
<p style="top:654.0pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Patients/</span></p>
<p style="top:654.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animals*</span></p>
<p style="top:601.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sex</span></p>
<p style="top:569.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Age</span></p>
<p style="top:536.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental </span></p>
<p style="top:536.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">groups (n)</span></p>
<p style="top:464.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise specifications</span></p>
<p style="top:378.4pt;left:89.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise timing </span></p>
<p style="top:378.4pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with respect </span></p>
<p style="top:378.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to doxorubicin </span></p>
<p style="top:378.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">infusion</span></p>
<p style="top:321.9pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Control groups (n)</span></p>
<p style="top:220.1pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:220.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity </span></p>
<p style="top:220.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">assessment</span></p>
<p style="top:168.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:168.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin</span></p>
<p style="top:119.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dose, </span></p>
<p style="top:119.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mg/kg</span></p>
<p style="top:85.3pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No. of </span></p>
<p style="top:85.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses </span></p>
<p style="top:85.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(time)</span></p>
<p style="top:711.1pt;left:131.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Hydock, 2009</span><span style="font-family:Arial,serif;font-size:4.4pt">36</span></p>
<p style="top:654.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (9)</span></p>
<p style="top:464.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: voluntary for 7&#xa0;wk Concomitant</span></p>
<p style="top:322.1pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary (10)  </span></p>
<p style="top:322.1pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8)</span></p>
<p style="top:220.3pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">7&#xa0;d After </span></p>
<p style="top:220.3pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During WR, </span></p>
<p style="top:168.4pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">after wk 1</span></p>
<p style="top:119.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2.5</span></p>
<p style="top:85.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6 (6&#xa0;wk)</span></p>
<p style="top:711.1pt;left:152.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Hydock, 2011</span><span style="font-family:Arial,serif;font-size:4.4pt">37</span></p>
<p style="top:654.2pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (17)  </span></p>
<p style="top:536.2pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (23)</span></p>
<p style="top:464.5pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 10&#xa0;wk. </span></p>
<p style="top:464.5pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;m/min, 60&#xa0;min/d. </span></p>
<p style="top:464.5pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Voluntary for 10&#xa0;wk</span></p>
<p style="top:378.5pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (11)  </span></p>
<p style="top:322.1pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (14)  </span></p>
<p style="top:322.1pt;left:170.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (12)  </span></p>
<p style="top:322.1pt;left:179.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (17)</span></p>
<p style="top:220.3pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4&#xa0;wk After </span></p>
<p style="top:220.3pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:161.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR</span></p>
<p style="top:119.5pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:85.5pt;left:153.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10 (10&#xa0;d)</span></p>
<p style="top:711.1pt;left:192.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Hydock, 2012</span><span style="font-family:Arial,serif;font-size:4.4pt">38</span></p>
<p style="top:654.2pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+doxorubicin</span><span style="font-family:Arial,serif;font-size:4.4pt">dly</span><span style="font-family:Arial,serif;font-size:6.8pt"> (9)  </span></p>
<p style="top:536.2pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+doxorubicin</span><span style="font-family:Arial,serif;font-size:4.4pt">wk</span><span style="font-family:Arial,serif;font-size:6.8pt"> </span></p>
<p style="top:536.2pt;left:209.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(10)</span></p>
<p style="top:464.5pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: voluntary for </span></p>
<p style="top:464.5pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:378.5pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline</span><span style="font-family:Arial,serif;font-size:4.4pt">dly</span><span style="font-family:Arial,serif;font-size:6.8pt"> (8)  </span></p>
<p style="top:322.1pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline</span><span style="font-family:Arial,serif;font-size:4.4pt">wk</span><span style="font-family:Arial,serif;font-size:6.8pt"> (7)  </span></p>
<p style="top:322.1pt;left:209.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin</span><span style="font-family:Arial,serif;font-size:4.4pt">dly</span><span style="font-family:Arial,serif;font-size:6.8pt"> (15)  </span></p>
<p style="top:322.1pt;left:218.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin</span><span style="font-family:Arial,serif;font-size:4.4pt">wk</span><span style="font-family:Arial,serif;font-size:6.8pt"> (10)  </span></p>
<p style="top:322.1pt;left:227.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline</span><span style="font-family:Arial,serif;font-size:4.4pt">dly</span><span style="font-family:Arial,serif;font-size:6.8pt"> (8)  </span></p>
<p style="top:322.1pt;left:236.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline</span><span style="font-family:Arial,serif;font-size:4.4pt">wk</span><span style="font-family:Arial,serif;font-size:6.8pt"> (8)</span></p>
<p style="top:220.3pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:220.3pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">completion of </span></p>
<p style="top:220.3pt;left:209.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During WR</span></p>
<p style="top:119.5pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span><span style="font-family:Arial,serif;font-size:4.4pt">dly</span><span style="font-family:Arial,serif;font-size:6.8pt">  </span></p>
<p style="top:119.5pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2.5</span><span style="font-family:Arial,serif;font-size:4.4pt">wk</span></p>
<p style="top:85.5pt;left:192.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15 (15&#xa0;d)  </span></p>
<p style="top:85.5pt;left:201.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6 (6&#xa0;wk)</span></p>
<p style="top:711.1pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Jensen, 2013</span><span style="font-family:Arial,serif;font-size:4.4pt">39</span></p>
<p style="top:654.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#x2013; 11&#xa0;wk Treadmill (47&#x2013; 58)  </span></p>
<p style="top:536.2pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (40&#x2013; 51)</span></p>
<p style="top:464.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 10&#xa0;wk. </span></p>
<p style="top:464.5pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">13&#x2013; 30&#xa0;m/min (5%&#x2013; 18% </span></p>
<p style="top:464.5pt;left:266.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">grade), 60&#xa0;min/d. Voluntary </span></p>
<p style="top:464.5pt;left:275.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">for 10&#xa0;wk</span></p>
<p style="top:378.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (5&#x2013; 9)  </span></p>
<p style="top:322.1pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (38&#x2013; 61)</span></p>
<p style="top:220.3pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1, 3, 5, 7 </span></p>
<p style="top:220.3pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Or 9&#xa0;d after </span></p>
<p style="top:220.3pt;left:266.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:257.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR</span></p>
<p style="top:119.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10</span></p>
<p style="top:85.5pt;left:249.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:288.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Ji, 1994</span><span style="font-family:Arial,serif;font-size:4.4pt">40</span></p>
<p style="top:654.2pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;mo</span></p>
<p style="top:536.2pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (7)  </span></p>
<p style="top:536.2pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+REC (7)</span></p>
<p style="top:464.5pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Acute: single bout  </span></p>
<p style="top:464.5pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Until exhaustion  </span></p>
<p style="top:464.5pt;left:306.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+REC=30&#xa0;min </span></p>
<p style="top:464.5pt;left:314.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">recovery</span></p>
<p style="top:378.5pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Postconditioning</span></p>
<p style="top:322.1pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (13)  </span></p>
<p style="top:322.1pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (7)  </span></p>
<p style="top:322.1pt;left:306.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)  </span></p>
<p style="top:322.1pt;left:314.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+REC+saline (7)</span></p>
<p style="top:220.3pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:220.3pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h And </span></p>
<p style="top:168.4pt;left:297.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;min before </span></p>
<p style="top:168.4pt;left:306.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/</span></p>
<p style="top:168.4pt;left:314.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill+REC</span></p>
<p style="top:119.5pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4</span></p>
<p style="top:85.5pt;left:288.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2</span></p>
<p style="top:711.1pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Kanter, 1985</span><span style="font-family:Arial,serif;font-size:4.4pt">41</span></p>
<p style="top:654.2pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Swiss White </span></p>
<p style="top:654.2pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">mice</span></p>
<p style="top:601.2pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;wk</span></p>
<p style="top:536.2pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">ST (20)</span></p>
<p style="top:464.5pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 21&#xa0;wk. </span></p>
<p style="top:464.5pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Building up to 1&#xa0;h/d</span></p>
<p style="top:378.5pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary (20)  </span></p>
<p style="top:322.1pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (22)  </span></p>
<p style="top:322.1pt;left:345.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">ST (21)</span></p>
<p style="top:220.3pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">After 9&#xa0;wk of </span></p>
<p style="top:220.3pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise and </span></p>
<p style="top:220.3pt;left:345.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">after 21&#xa0;wk. </span></p>
<p style="top:220.3pt;left:354.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Histology only </span></p>
<p style="top:220.3pt;left:362.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">assessed after </span></p>
<p style="top:220.3pt;left:371.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">21&#xa0;wk</span></p>
<p style="top:168.4pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:336.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill, </span></p>
<p style="top:168.4pt;left:345.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">starting from </span></p>
<p style="top:168.4pt;left:354.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">wk 9</span></p>
<p style="top:119.5pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4</span></p>
<p style="top:85.5pt;left:327.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10 (7&#xa0;wk)</span></p>
<p style="top:711.1pt;left:384.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Kavazis, 2010</span><span style="font-family:Arial,serif;font-size:4.4pt">42</span></p>
<p style="top:654.2pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4&#x2013; 6&#xa0;mo</span></p>
<p style="top:536.2pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (7)  </span></p>
<p style="top:536.2pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill</span><span style="font-family:Arial,serif;font-size:4.4pt">cold</span><span style="font-family:Arial,serif;font-size:6.8pt"> (6)</span></p>
<p style="top:464.5pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 5&#xa0;d. </span></p>
<p style="top:464.5pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;m/min, 60&#xa0;min/d. Both </span></p>
<p style="top:464.5pt;left:402.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">in cold (4&#xb0;C) and normal </span></p>
<p style="top:464.5pt;left:410.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">temperature</span></p>
<p style="top:378.5pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (8+7)  </span></p>
<p style="top:322.1pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:402.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (7)  </span></p>
<p style="top:322.1pt;left:410.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill</span><span style="font-family:Arial,serif;font-size:4.4pt">cold</span><span style="font-family:Arial,serif;font-size:6.8pt">+saline (6)</span></p>
<p style="top:220.3pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:168.4pt;left:393.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:384.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:423.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Kavazis, 2014</span><span style="font-family:Arial,serif;font-size:4.4pt">18</span></p>
<p style="top:654.2pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;mo</span></p>
<p style="top:536.2pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (6)</span></p>
<p style="top:464.5pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 1 time per d for </span></p>
<p style="top:464.5pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d. 30&#xa0;m/min, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:441.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:432.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:423.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:454.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Lee, 2020</span><span style="font-family:Arial,serif;font-size:4.4pt">43</span></p>
<p style="top:654.2pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">C57BL6 mice</span></p>
<p style="top:601.2pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">8&#xa0;wk</span></p>
<p style="top:536.2pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (10)</span></p>
<p style="top:464.5pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 4&#xa0;wk. </span></p>
<p style="top:464.5pt;left:463.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">13&#xa0;m/min, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Postconditioning</span></p>
<p style="top:322.1pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (10)  </span></p>
<p style="top:322.1pt;left:463.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (10)</span></p>
<p style="top:220.3pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:463.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24 Before </span></p>
<p style="top:168.4pt;left:463.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exerciseE</span></p>
<p style="top:119.5pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:454.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">4 (4&#xa0;wk)</span></p>
<p style="top:720.3pt;left:52.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">(Continued)</span></b></p>
<p style="top:91.7pt;left:533.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">8</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:718.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference</span></p>
<p style="top:626.1pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study population</span></p>
<p style="top:390.2pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study characteristics</span></p>
<p style="top:158.6pt;left:72.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin characteristics</span></p>
<p style="top:654.0pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Patients/</span></p>
<p style="top:654.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animals*</span></p>
<p style="top:601.0pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sex</span></p>
<p style="top:569.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Age</span></p>
<p style="top:536.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental </span></p>
<p style="top:536.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">groups (n)</span></p>
<p style="top:464.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise specifications</span></p>
<p style="top:378.4pt;left:89.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise timing </span></p>
<p style="top:378.4pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with respect </span></p>
<p style="top:378.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to doxorubicin </span></p>
<p style="top:378.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">infusion</span></p>
<p style="top:321.9pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Control groups (n)</span></p>
<p style="top:220.1pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:220.1pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity </span></p>
<p style="top:220.1pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">assessment</span></p>
<p style="top:168.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:168.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin</span></p>
<p style="top:119.4pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dose, </span></p>
<p style="top:119.4pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mg/kg</span></p>
<p style="top:85.3pt;left:98.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No. of </span></p>
<p style="top:85.3pt;left:107.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses </span></p>
<p style="top:85.3pt;left:116.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(time)</span></p>
<p style="top:711.1pt;left:131.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Lien, 2015</span><span style="font-family:Arial,serif;font-size:4.4pt">44</span></p>
<p style="top:654.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:536.2pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+   </span></p>
<p style="top:536.2pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin 10&#xa0;mg/</span></p>
<p style="top:536.2pt;left:149.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (10)  </span></p>
<p style="top:536.2pt;left:157.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+   </span></p>
<p style="top:536.2pt;left:166.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin 15&#xa0;mg/</span></p>
<p style="top:536.2pt;left:175.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (13)  </span></p>
<p style="top:536.2pt;left:184.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+doxorubicin </span></p>
<p style="top:536.2pt;left:193.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;mg/kg (10)  </span></p>
<p style="top:536.2pt;left:201.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+doxorubicin </span></p>
<p style="top:536.2pt;left:210.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15&#xa0;mg/kg (12)</span></p>
<p style="top:464.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 1 time per d for </span></p>
<p style="top:464.5pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d. 24&#xa0;m/min, 60&#xa0;min/d.</span></p>
<p style="top:378.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (14)  </span></p>
<p style="top:322.1pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 10&#xa0;mg/</span></p>
<p style="top:322.1pt;left:149.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (10)  </span></p>
<p style="top:322.1pt;left:157.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 15&#xa0;mg/</span></p>
<p style="top:322.1pt;left:166.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (13)  </span></p>
<p style="top:322.1pt;left:175.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (13)  </span></p>
<p style="top:322.1pt;left:184.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (13)</span></p>
<p style="top:220.3pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR</span></p>
<p style="top:119.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10  </span></p>
<p style="top:119.5pt;left:140.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15</span></p>
<p style="top:85.5pt;left:131.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:223.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Mackay, 2019</span><span style="font-family:Arial,serif;font-size:4.4pt">45</span></p>
<p style="top:654.2pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">C57BL6 mice</span></p>
<p style="top:601.2pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;wk</span></p>
<p style="top:536.2pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (8)</span></p>
<p style="top:464.5pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 1 time per d </span></p>
<p style="top:464.5pt;left:232.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">for 5&#xa0;d. On 70% of max </span></p>
<p style="top:464.5pt;left:241.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">speed, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (9)  </span></p>
<p style="top:322.1pt;left:232.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8)  </span></p>
<p style="top:322.1pt;left:241.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (11)  </span></p>
<p style="top:322.1pt;left:249.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">MET+sedentary+saline (13)  </span></p>
<p style="top:322.1pt;left:258.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">MET+doxorubicin (7)</span></p>
<p style="top:220.3pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">3&#xa0;d After </span></p>
<p style="top:220.3pt;left:232.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1&#xa0;h After </span></p>
<p style="top:168.4pt;left:232.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15</span></p>
<p style="top:85.5pt;left:223.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Marques- Aleixo, </span></p>
<p style="top:711.1pt;left:280.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2015</span><span style="font-family:Arial,serif;font-size:4.4pt">46</span></p>
<p style="top:654.2pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;wk</span></p>
<p style="top:536.2pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (6)  </span></p>
<p style="top:536.2pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (6)</span></p>
<p style="top:464.5pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 12&#xa0;wk, </span></p>
<p style="top:464.5pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">18&#x2013; 27&#xa0;m/min, 60&#xa0;min/d. </span></p>
<p style="top:464.5pt;left:289.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Voluntary: 12 wk</span></p>
<p style="top:378.5pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:289.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)  </span></p>
<p style="top:322.1pt;left:297.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (6)</span></p>
<p style="top:220.3pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:280.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR, </span></p>
<p style="top:168.4pt;left:289.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">starting from </span></p>
<p style="top:168.4pt;left:297.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">wk 5</span></p>
<p style="top:119.5pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2</span></p>
<p style="top:85.5pt;left:271.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">7 (7&#xa0;wk)</span></p>
<p style="top:711.1pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Marques- Aleixo, </span></p>
<p style="top:711.1pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2018</span><span style="font-family:Arial,serif;font-size:4.4pt">47</span></p>
<p style="top:654.2pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;wk</span></p>
<p style="top:536.2pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (NS)  </span></p>
<p style="top:536.2pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (NS)</span></p>
<p style="top:464.5pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic:. 5&#xa0;d/wk for 14&#xa0;wk, </span></p>
<p style="top:464.5pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">18&#x2013; 27&#xa0;m/min, 60&#xa0;min/d. </span></p>
<p style="top:464.5pt;left:328.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Voluntary: 14 wk</span></p>
<p style="top:378.5pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (NS)  </span></p>
<p style="top:322.1pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (NS)  </span></p>
<p style="top:322.1pt;left:328.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (NS)  </span></p>
<p style="top:322.1pt;left:337.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (NS)</span></p>
<p style="top:220.3pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:319.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill/WR, </span></p>
<p style="top:168.4pt;left:328.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">starting from </span></p>
<p style="top:168.4pt;left:337.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">wk 5</span></p>
<p style="top:119.5pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2</span></p>
<p style="top:85.5pt;left:310.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">7 (7&#xa0;wk)</span></p>
<p style="top:711.1pt;left:349.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Morton, 2019</span><span style="font-family:Arial,serif;font-size:4.4pt">48</span></p>
<p style="top:654.2pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:358.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;mo</span></p>
<p style="top:536.2pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (10)</span></p>
<p style="top:464.5pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 2&#xa0;wk. </span></p>
<p style="top:464.5pt;left:358.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">30&#xa0;m/min, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (10)  </span></p>
<p style="top:322.1pt;left:358.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (10)  </span></p>
<p style="top:322.1pt;left:367.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (10)</span></p>
<p style="top:220.3pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:358.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:358.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:350.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Parry, 2015</span><span style="font-family:Arial,serif;font-size:4.4pt">49</span></p>
<p style="top:654.2pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Fischer 344 </span></p>
<p style="top:654.2pt;left:389.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">rats (inoculated </span></p>
<p style="top:654.2pt;left:398.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">with tumor cells </span></p>
<p style="top:654.2pt;left:406.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">after wk 11)</span></p>
<p style="top:601.2pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">12&#xa0;wk</span></p>
<p style="top:536.2pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (36)</span></p>
<p style="top:464.5pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: voluntary for </span></p>
<p style="top:464.5pt;left:389.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">12&#x2013; 13&#xa0;wk</span></p>
<p style="top:378.5pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (30)  </span></p>
<p style="top:322.1pt;left:389.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (36)  </span></p>
<p style="top:322.1pt;left:398.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR+saline (30)</span></p>
<p style="top:220.3pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1, 3, Or </span></p>
<p style="top:220.3pt;left:389.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d after </span></p>
<p style="top:220.3pt;left:398.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:389.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">tumor </span></p>
<p style="top:168.4pt;left:398.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">reached 1&#xa0;cm</span></p>
<p style="top:119.5pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">12</span></p>
<p style="top:85.5pt;left:380.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Pfannenstiel, </span></p>
<p style="top:711.1pt;left:428.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2018</span><span style="font-family:Arial,serif;font-size:4.4pt">50</span></p>
<p style="top:654.2pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:428.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:536.2pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">RT (15)</span></p>
<p style="top:464.5pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: RT for 12&#xa0;wk by </span></p>
<p style="top:464.5pt;left:428.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">encouraging rats to stand </span></p>
<p style="top:464.5pt;left:437.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">up heightening the food/</span></p>
<p style="top:464.5pt;left:446.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">water supply</span></p>
<p style="top:378.5pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (9)  </span></p>
<p style="top:322.1pt;left:428.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (15)  </span></p>
<p style="top:322.1pt;left:437.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">RT+saline (9)</span></p>
<p style="top:220.3pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:428.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After RT</span></p>
<p style="top:119.5pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">12.5</span></p>
<p style="top:85.5pt;left:419.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Phungphong, </span></p>
<p style="top:711.1pt;left:467.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2020</span><span style="font-family:Arial,serif;font-size:4.4pt">51</span></p>
<p style="top:654.2pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sprague- </span></p>
<p style="top:654.2pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Female</span></p>
<p style="top:569.2pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">9&#xa0;wk</span></p>
<p style="top:536.2pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill</span></p>
<p style="top:464.5pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 14&#xa0;d, </span></p>
<p style="top:464.5pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">21&#xa0;m/min, 2x 10&#x2013; 30&#xa0;min/d</span></p>
<p style="top:378.5pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary/sham operated (11)  </span></p>
<p style="top:322.1pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">OVX (12)  </span></p>
<p style="top:322.1pt;left:476.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">OVX+doxorubicin (11)  </span></p>
<p style="top:322.1pt;left:485.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">OVX+doxorubicin+estrogen (12)  </span></p>
<p style="top:322.1pt;left:494.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">OVX+doxorubicin+mast cell </span></p>
<p style="top:322.1pt;left:503.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">stabilizer (13)</span></p>
<p style="top:220.3pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:467.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2.5</span></p>
<p style="top:85.5pt;left:459.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6 (2&#xa0;d)</span></p>
<p style="top:720.3pt;left:52.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">(Continued)</span></b></p>
<p style="top:91.7pt;left:533.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:536.2pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">9</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:718.4pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference</span></p>
<p style="top:626.1pt;left:120.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study population</span></p>
<p style="top:390.2pt;left:120.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Study characteristics</span></p>
<p style="top:158.6pt;left:120.9pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin characteristics</span></p>
<p style="top:654.0pt;left:156.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Patients/</span></p>
<p style="top:654.0pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animals*</span></p>
<p style="top:601.0pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sex</span></p>
<p style="top:569.1pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Age</span></p>
<p style="top:536.1pt;left:156.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental </span></p>
<p style="top:536.1pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">groups (n)</span></p>
<p style="top:464.3pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise specifications</span></p>
<p style="top:378.4pt;left:138.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Exercise timing </span></p>
<p style="top:378.4pt;left:147.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with respect </span></p>
<p style="top:378.4pt;left:156.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to doxorubicin </span></p>
<p style="top:378.4pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">infusion</span></p>
<p style="top:321.9pt;left:165.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Control groups (n)</span></p>
<p style="top:220.1pt;left:147.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:220.1pt;left:156.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity </span></p>
<p style="top:220.1pt;left:165.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">assessment</span></p>
<p style="top:168.3pt;left:156.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Timing of </span></p>
<p style="top:168.3pt;left:165.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin</span></p>
<p style="top:119.4pt;left:156.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dose, </span></p>
<p style="top:119.4pt;left:165.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mg/kg</span></p>
<p style="top:85.3pt;left:147.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No. of </span></p>
<p style="top:85.3pt;left:156.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses </span></p>
<p style="top:85.3pt;left:165.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(time)</span></p>
<p style="top:711.1pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Shirinbayan, </span></p>
<p style="top:711.1pt;left:189.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2012</span><span style="font-family:Arial,serif;font-size:4.4pt">52</span></p>
<p style="top:654.2pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wistar rats</span></p>
<p style="top:601.2pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;wk</span></p>
<p style="top:536.2pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (8)</span></p>
<p style="top:464.5pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5&#xa0;d/wk for 3&#xa0;wk, </span></p>
<p style="top:464.5pt;left:189.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15&#x2013; 17&#xa0;m/min, 23&#x2013; 39&#xa0;min/d</span></p>
<p style="top:378.5pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (8)  </span></p>
<p style="top:322.1pt;left:189.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 10&#xa0;mg/</span></p>
<p style="top:322.1pt;left:197.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (8)  </span></p>
<p style="top:322.1pt;left:206.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin 20&#xa0;mg/</span></p>
<p style="top:322.1pt;left:215.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">kg (8)  </span></p>
<p style="top:322.1pt;left:224.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (8)</span></p>
<p style="top:220.3pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:189.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:168.4pt;left:189.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10  </span></p>
<p style="top:119.5pt;left:189.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:180.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:237.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Smuder, 2013</span><span style="font-family:Arial,serif;font-size:4.4pt">53</span></p>
<p style="top:654.2pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:246.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#xa0;mo</span></p>
<p style="top:536.2pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (6)</span></p>
<p style="top:464.5pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 1 time per d for </span></p>
<p style="top:464.5pt;left:246.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;d, building up to 30&#xa0;m/</span></p>
<p style="top:464.5pt;left:254.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">min, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (6)  </span></p>
<p style="top:322.1pt;left:246.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (6)  </span></p>
<p style="top:322.1pt;left:254.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (6)</span></p>
<p style="top:220.3pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:246.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Directly after </span></p>
<p style="top:168.4pt;left:246.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:237.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sturgeon, 2014</span><span style="font-family:Arial,serif;font-size:4.4pt">54</span></p>
<p style="top:654.2pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">C57BL6 mice </span></p>
<p style="top:654.2pt;left:276.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(injected with </span></p>
<p style="top:654.2pt;left:285.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">melanoma </span></p>
<p style="top:654.2pt;left:294.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">cells)</span></p>
<p style="top:601.2pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">6&#x2013; 8&#xa0;wk</span></p>
<p style="top:536.2pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (9)</span></p>
<p style="top:464.5pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 5 d/w for 2&#xa0;wk, </span></p>
<p style="top:464.5pt;left:276.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">10&#xa0;m/min, 45&#xa0;min/d</span></p>
<p style="top:378.5pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (7)  </span></p>
<p style="top:322.1pt;left:276.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8)  </span></p>
<p style="top:322.1pt;left:285.2pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (8)</span></p>
<p style="top:220.3pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">48&#xa0;h After </span></p>
<p style="top:220.3pt;left:276.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">During </span></p>
<p style="top:168.4pt;left:276.4pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2</span></p>
<p style="top:85.5pt;left:267.6pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">2 (2&#xa0;wk)</span></p>
<p style="top:711.1pt;left:306.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Werner, 2008</span><span style="font-family:Arial,serif;font-size:4.4pt">55</span></p>
<p style="top:654.2pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">C57BL6 mice  </span></p>
<p style="top:654.2pt;left:315.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">eNOS&#x2212;/&#x2212; </span></p>
<p style="top:654.2pt;left:324.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">micecmar  </span></p>
<p style="top:654.2pt;left:333.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">TERT&#x2212;/&#x2212; mice</span></p>
<p style="top:601.2pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">8&#xa0;wk</span></p>
<p style="top:536.2pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR (6&#x2013; 12)</span></p>
<p style="top:464.5pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: voluntary for 3&#xa0;wk Preconditioning</span></p>
<p style="top:322.1pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8&#x2013; 12)  </span></p>
<p style="top:322.1pt;left:315.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary (8&#x2013; 12)  </span></p>
<p style="top:322.1pt;left:324.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">WR</span><span style="font-family:Arial,serif;font-size:4.4pt">6&#xa0;mo</span><span style="font-family:Arial,serif;font-size:6.8pt">  </span></p>
<p style="top:322.1pt;left:333.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary</span><span style="font-family:Arial,serif;font-size:4.4pt">6&#xa0;mo</span></p>
<p style="top:220.3pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:168.4pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">After WR </span></p>
<p style="top:168.4pt;left:315.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">(further NS)</span></p>
<p style="top:119.5pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">22.5</span></p>
<p style="top:85.5pt;left:306.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1 (24&#xa0;h)</span></p>
<p style="top:711.1pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Wonders,2008</span><span style="font-family:Arial,serif;font-size:4.4pt">56</span></p>
<p style="top:654.2pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Spraque- </span></p>
<p style="top:654.2pt;left:354.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (NS)</span></p>
<p style="top:464.5pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Acute: single bout of </span></p>
<p style="top:464.5pt;left:354.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">60&#xa0;min, &#x2248;5&#xa0;min at 15&#xa0;m/</span></p>
<p style="top:464.5pt;left:363.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">min 0% gradient, &#x2248;10&#xa0;min </span></p>
<p style="top:464.5pt;left:372.5pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">23&#xa0;m/min 0% gradient, </span></p>
<p style="top:464.5pt;left:381.3pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">&#x2248;45&#xa0;min 25&#xa0;m/min 5% </span></p>
<p style="top:464.5pt;left:390.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">gradient</span></p>
<p style="top:378.5pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Preconditioning</span></p>
<p style="top:322.1pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (NS)  </span></p>
<p style="top:322.1pt;left:354.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (NS)  </span></p>
<p style="top:322.1pt;left:363.7pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill+saline (NS)</span></p>
<p style="top:220.3pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;d After </span></p>
<p style="top:220.3pt;left:354.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:168.4pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h after </span></p>
<p style="top:168.4pt;left:354.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">treadmill</span></p>
<p style="top:119.5pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15</span></p>
<p style="top:85.5pt;left:346.1pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">1</span></p>
<p style="top:711.1pt;left:402.9pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Yang, 2020</span><span style="font-family:Arial,serif;font-size:4.4pt">57</span></p>
<p style="top:654.2pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sprague- </span></p>
<p style="top:654.2pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Dawley rats</span></p>
<p style="top:601.2pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Male</span></p>
<p style="top:569.2pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">NS</span></p>
<p style="top:536.2pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Treadmill (8)</span></p>
<p style="top:464.5pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Chronic: 3&#xa0;d/wk for 4&#xa0;wk, </span></p>
<p style="top:464.5pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">12&#xa0;m/min, 60&#xa0;min/d</span></p>
<p style="top:378.5pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Concomitant</span></p>
<p style="top:322.1pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+saline (8)  </span></p>
<p style="top:322.1pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">Sedentary+doxorubicin (8)</span></p>
<p style="top:220.3pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24&#xa0;h After </span></p>
<p style="top:220.3pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">exercise</span></p>
<p style="top:168.4pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">24 After </span></p>
<p style="top:168.4pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">doxorubicin</span></p>
<p style="top:119.5pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">20</span></p>
<p style="top:85.5pt;left:403.0pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">15 (3/wk, </span></p>
<p style="top:85.5pt;left:411.8pt;line-height:6.8pt"><span style="font-family:Arial,serif;font-size:6.8pt">5&#xa0;wk)</span></p>
<p style="top:713.1pt;left:426.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Experimental groups refers to the intervention these groups underwent. All of the experimental groups also underwent doxorubicin administration. Details regarding doxorubicin are shown in the Doxorubicin </span></p>
<p style="top:721.1pt;left:435.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">characteristics columns. Doxorubicin dosages were specified in other columns in case multiple dosage groups were used. For studies reporting different numbers regarding the study populations, the largest number </span></p>
<p style="top:721.1pt;left:444.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">reported is shown. Doxorubicin administration during exercise was started in the first week of exercise, unless otherwise stated. For Hydock, 2012, &quot;dly&quot; and &quot;wk&quot; in subscript refers to the drug administration schemes, </span></p>
<p style="top:721.1pt;left:453.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">which were respectively daily in 15 consecutive days and weekly in 6&#xa0;weeks. CR indicates calorie restriction; GA, garlic extract; HRmax, maximum heart rate; MET, metformin; NS, not specified; OVX, ovariectomized; </span></p>
<p style="top:721.1pt;left:462.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">REC, 30&#xa0;minutes of recovering after exercise; RT, resistance training; ST, swimming training; VO</span><span style="font-family:Arial,serif;font-size:4.6pt">2max</span><span style="font-family:Arial,serif;font-size:7.0pt">, maxium oxygen consumption; and WR, voluntary wheel running.</span></p>
<p style="top:713.1pt;left:471.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">*The study population in the preclinical studies are animals without cancer, unless otherwise stated.</span></p>
<p style="top:720.3pt;left:101.5pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 1. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">(Continued)</span></b></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">10</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:682.8pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of a total of 4 bouts on subclinical cardiotoxicity (ie, </span></p>
<p style="top:694.8pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">strain and biomarkers) in the first and second report, </span></p>
<p style="top:706.8pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">respectively. The PE intervention consisted of four </span></p>
<p style="top:718.8pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">30- minute vigorous- intensity treadmill exercise bouts </span></p>
<p style="top:682.8pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">before each administration of doxorubicin. The study </span></p>
<p style="top:694.8pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">by Ma</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">21</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> (n=64) evaluated the effect of a 16- week PE </span></p>
<p style="top:706.8pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">program during chemotherapy. Women allocated to </span></p>
<p style="top:718.8pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the intervention grouped attended three 50- minute </span></p>
<p style="top:66.8pt;left:131.7pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">A</span></b></p>
<p style="top:298.4pt;left:131.7pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">B</span></b></p>
<p style="top:473.1pt;left:131.7pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">C</span></b></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">11</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:185.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">supervised treadmill sessions per week, while control </span></p>
<p style="top:197.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">group participants were asked to maintain their normal </span></p>
<p style="top:209.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">activity pattern. Cardiac function was assessed with </span></p>
<p style="top:221.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">echocardiography after 4 cycles of anthracyclines.</span></p>
<p style="top:246.9pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Characteristics of the Preclinical Studies</span></p>
<p style="top:262.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In the 37 animal studies, conducted in mice or rats, </span></p>
<p style="top:274.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the type and duration of PE interventions widely </span></p>
<p style="top:286.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">varied. The majority (n=21) used FTM interventions, </span></p>
<p style="top:298.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">5 studies used a VWR protocol,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">29,34,36,38,49,55</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and 6 </span></p>
<p style="top:310.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies included both FTM and VWR.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">35,37,39,44,46,47</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:322.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Three studies used a swimming training proto-</span></p>
<p style="top:334.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">col,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">27,33,41</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and 1 study used a protocol to mimic </span></p>
<p style="top:346.0pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">resistance training.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">50</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The duration varied from </span></p>
<p style="top:358.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a single bout</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">40,56</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> to a PE program that lasted </span></p>
<p style="top:370.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">21&#xa0; weeks.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">41</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Doxorubicin was the only anthracy-</span></p>
<p style="top:382.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cline administrated with variation in cumulative </span></p>
<p style="top:394.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">dose, number and frequency of doses, and timing </span></p>
<p style="top:406.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">with respect to the exercise intervention (ie, pre-</span></p>
<p style="top:418.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">conditioning, concomitant with doxorubicin treat-</span></p>
<p style="top:430.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ment, or postconditioning). Cumulative doxorubicin </span></p>
<p style="top:442.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">dose varied between 4&#xa0;mg/kg and 100&#xa0;mg/kg, with </span></p>
<p style="top:454.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">20&#xa0;mg/kg being the most used dosage (n=14). The </span></p>
<p style="top:466.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">majority of the studies (n=23) used a precondition-</span></p>
<p style="top:478.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ing protocol, where doxorubicin was administrated </span></p>
<p style="top:490.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">up to 24&#xa0;hours after completion of the intervention. </span></p>
<p style="top:502.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Twelve studies had protocols in which, at least to </span></p>
<p style="top:514.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">some extent, doxorubicin treatment ran parallel to </span></p>
<p style="top:526.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the PE intervention, and 2 studies used a postcon-</span></p>
<p style="top:538.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ditioning protocol.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">40,43</span></sup></p>
<p style="top:550.0pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Last, cardiotoxicity was described via various out-</span></p>
<p style="top:562.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">comes, including left ventricular (LV) function and mor-</span></p>
<p style="top:574.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">phology, histopathology, and biochemical analysis. </span></p>
<p style="top:586.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The former was assessed in vivo as well as ex vivo </span></p>
<p style="top:598.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">using echocardiography or isolated heart perfusion, </span></p>
<p style="top:610.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">respectively.</span></p>
<p style="top:622.0pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Risk- of- bias assessment is presented in Figure&#xa0; 2 </span></p>
<p style="top:634.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and Data S3. In brief, the 2 clinical reports by Kirkham </span></p>
<p style="top:646.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">et al were overall scored as low risk of bias, while the </span></p>
<p style="top:658.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study by Ma was rated as having relatively low meth-</span></p>
<p style="top:670.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">odological quality. The animal studies widely varied in </span></p>
<p style="top:682.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">terms of risk of bias, with most studies scoring low on </span></p>
<p style="top:694.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the items of selection and attrition bias, and relatively </span></p>
<p style="top:706.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">high on the risk of performance bias. Risk of publica-</span></p>
<p style="top:718.0pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion bias, ie, detected by asymmetry in the funnel plots, </span></p>
<p style="top:185.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was not assessed since no outcomes were reported </span></p>
<p style="top:197.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">by &#x2265;10 studies.</span></p>
<p style="top:222.9pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Effect of Exercise on DIC</span></p>
<p style="top:238.0pt;left:306.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Clinical Studies</span></i></b></p>
<p style="top:254.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">A total of 3 studies reported about PE on anthracycline- </span></p>
<p style="top:266.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced cardiotoxicity in patients with cancer. However, </span></p>
<p style="top:278.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">results were not pooled since 2 reports made use of </span></p>
<p style="top:290.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the same study population and had substantial clini-</span></p>
<p style="top:302.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cal differences (eg, duration of PE intervention and </span></p>
<p style="top:314.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">timing of outcome assessment) compared with the </span></p>
<p style="top:326.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">third study. The first study by Kirkham et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">19</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> showed </span></p>
<p style="top:338.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">that a single treadmill session mitigated an increase </span></p>
<p style="top:350.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in NT- proBNP (N- terminal pro- B- type natriuretic pep-</span></p>
<p style="top:362.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tide) 24 to 48&#xa0;hours after the first anthracycline treat-</span></p>
<p style="top:374.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ment. Nevertheless, echocardiographic parameters, </span></p>
<p style="top:386.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">including strain, were comparable between the exer-</span></p>
<p style="top:398.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cise (n=13) and control group (n=10). In the second re-</span></p>
<p style="top:410.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">port,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">20</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> the 4 exercise bouts did not prevent a rise in </span></p>
<p style="top:422.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiac biomarkers (NT- proBNP and cardiac troponin). </span></p>
<p style="top:434.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Longitudinal strain and LV ejection fraction remained </span></p>
<p style="top:446.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">unchanged in both groups before and after chemother-</span></p>
<p style="top:458.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">apy. However, the authors reported that the PE group </span></p>
<p style="top:470.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">had fewer changes in hemodynamics than the control </span></p>
<p style="top:482.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">group. The last study reported that, in the PE group </span></p>
<p style="top:494.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(n=31), LV ejection fraction significantly increased after </span></p>
<p style="top:506.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">chemotherapy (from 55%&#xb1;3.5% to 60%&#xb1;2.9%), while a </span></p>
<p style="top:518.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">decrease (51%&#xb1;5.6% to 47%&#xb1;2.6%, </span><i><span style="font-family:Arial,serif;font-size:10.0pt">P</span></i><span style="font-family:Arial,serif;font-size:10.0pt">&lt;0.05) was ob-</span></p>
<p style="top:530.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">served in the control group (n=33). However, between- </span></p>
<p style="top:542.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">group differences were not presented and risk of bias </span></p>
<p style="top:554.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was high.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">21</span></sup></p>
<p style="top:583.0pt;left:306.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Animal Studies: Pooled Analysis on In Vivo </span></i></b></p>
<p style="top:595.0pt;left:306.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Cardiotoxicity</span></i></b></p>
<p style="top:611.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">All animal studies that assessed in vivo parameters of </span></p>
<p style="top:623.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiotoxicity (n=13),</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">&#x2021;</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> used echocardiographic- derived </span></p>
<p style="top:635.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fractional shortening (FS) as a marker for systolic LV </span></p>
<p style="top:647.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">function. All studies used a treadmill intervention as PE </span></p>
<p style="top:659.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">program, except for 1 study that used a protocol to </span></p>
<p style="top:671.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mimic resistance training.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">50</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Results of this study, as </span></p>
<p style="top:683.0pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">well as those from a study where no numeric data </span></p>
<p style="top:720.4pt;left:306.6pt;line-height:6.0pt"><span style="font-family:Arial,serif;font-size:6.0pt">&#x2021;References 32,34,35,37&#x2013; 39,44,48,49,50,51,54,57</span></p>
<p style="top:58.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Figure 2. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Results of the risk of bias assessment for human studies (A), animal studies (B), and quality indicators for animal </span></b></p>
<p style="top:68.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">studies (C).</span></b></p>
<p style="top:78.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">A</span></b><span style="font-family:Arial,serif;font-size:8.0pt">, Results of the risk of bias assessment for human studies. The risk of bias was assessed using the Cochrane risk of bias tool. The </span></p>
<p style="top:88.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">color of the cells depicts the estimated risk of bias for the studies shown on the y- axis in the categories shown on the x- axis. Green, </span></p>
<p style="top:98.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">yellow, and red cells represent a low, unclear, and high risk of bias, respectively. Blinding of participants was not possible because </span></p>
<p style="top:108.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">of the nature of the intervention. </span><b><span style="font-family:Arial,serif;font-size:8.0pt">B</span></b><span style="font-family:Arial,serif;font-size:8.0pt">, Results of the risk of bias assessment for animal studies. The risk of bias was assessed using the </span></p>
<p style="top:118.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) risk of bias tool. Shown are the percentages of studies </span></p>
<p style="top:128.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">that were judged to have an &#x201c;unclear,&#x201d; &#x201c;low,&#x201d; or &#x201c;high&#x201d; risk of bias in the categories depicted on the y- axis. </span><b><span style="font-family:Arial,serif;font-size:8.0pt">C</span></b><span style="font-family:Arial,serif;font-size:8.0pt">, The reporting of quality </span></p>
<p style="top:138.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">indicators for animal studies. Shown are the percentages of studies that did or did not report (reported or not reported, respectively) </span></p>
<p style="top:148.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">the quality indicators depicted on the y- axis.</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">12</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:394.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">could be obtained,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">48</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> were excluded from quantitative </span></p>
<p style="top:406.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">analyses. Both of these studies found an absolute im-</span></p>
<p style="top:418.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">provement in FS in exercised rodents as compared </span></p>
<p style="top:430.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">with controls of 13% and &#x2248;15%, respectively.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">48,50</span></sup></p>
<p style="top:442.3pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Overall, the results of these studies demonstrated </span></p>
<p style="top:454.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">that PE interventions are able to mitigate doxorubicin- </span></p>
<p style="top:466.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced impairment in FS. For studies using FTM in-</span></p>
<p style="top:478.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">terventions (n=8),</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">32,35,37,39,44,51,54,57</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> FS was significantly </span></p>
<p style="top:490.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">higher in exercised versus nonexercised rodents </span></p>
<p style="top:502.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(8.4%; 95% CI, 5.4&#x2013; 11.5 [</span><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">=18.5]) (Figure&#xa0;3A). A pooled </span></p>
<p style="top:514.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">analysis of the 7 studies that used a VWR intervention </span></p>
<p style="top:526.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">revealed a slightly lower MD (5.4%; 95% CI, 3.6&#x2013; 7.2 </span></p>
<p style="top:538.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">[</span><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">=0])</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34,35,37,38,39,44,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> (Figure&#xa0;3B).</span></p>
<p style="top:550.3pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In a subanalysis regarding the timing of the PE </span></p>
<p style="top:562.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">intervention, ie, preconditioning (n=6)</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34,35,37,39,44,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:574.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">or concomitant with doxorubicin administration </span></p>
<p style="top:586.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(n=5),</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">32,38,51,54,57</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> the MD was 7.0% (95% CI, 5.2&#x2013; 8.7; </span></p>
<p style="top:598.3pt;left:54.6pt;line-height:10.0pt"><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">=0) and 5.9% (95% CI, 1.0&#x2013; 10.7; </span><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">=23.8) respec-</span></p>
<p style="top:610.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tively. Heterogeneity was substantial in the latter su-</span></p>
<p style="top:622.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">banalysis (</span><i><span style="font-family:Arial,serif;font-size:10.0pt">I</span></i><sup><span style="font-family:Arial,serif;font-size:6.5pt">2</span></sup><span style="font-family:Arial,serif;font-size:10.0pt">=78%, chi- square test: </span><i><span style="font-family:Arial,serif;font-size:10.0pt">P</span></i><span style="font-family:Arial,serif;font-size:10.0pt">&lt;0.01) (Data S4, </span></p>
<p style="top:634.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Figures&#xa0;S1 and S2).</span></p>
<p style="top:663.3pt;left:54.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Ex Vivo Parameter: Pooled Analysis on </span></i></b></p>
<p style="top:675.3pt;left:54.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">LV Pressure</span></i></b></p>
<p style="top:691.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Ex vivo cardiotoxicity was assessed in 12 animal stud-</span></p>
<p style="top:703.3pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ies via retrograde isolated heart perfusion,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">&#xa7;</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> in which </span></p>
<p style="top:394.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the myocardium is perfused via the coronary system to </span></p>
<p style="top:406.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">assess cardiac function in controlled loading condi-</span></p>
<p style="top:418.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tions. LV pressure (LVP), the maximum developed </span></p>
<p style="top:430.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pressure per time unit (dP/dt- max), and the maximum </span></p>
<p style="top:442.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">rate decline per time unit (dP/dt- min) were measured. </span></p>
<p style="top:454.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">LVP represents cardiac function as a whole, whereas </span></p>
<p style="top:466.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the latter are indicators of systolic and diastolic func-</span></p>
<p style="top:478.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion, respectively.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">58</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Protocols for isolated heart perfu-</span></p>
<p style="top:490.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sion were mostly comparable. One exception was a </span></p>
<p style="top:502.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study by Chicco et al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">29</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> where doxorubicin was admin-</span></p>
<p style="top:514.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">istrated ex vivo (ie, the hearts were transplanted before </span></p>
<p style="top:526.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin administration). This study, as well as a </span></p>
<p style="top:538.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study that used only a single exercise bout</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">56</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and a </span></p>
<p style="top:550.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study that used a resistance intervention,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">50</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> were there-</span></p>
<p style="top:562.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fore excluded from the pooled analyses.</span></p>
<p style="top:574.3pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">For LVP, all studies reported results significantly fa-</span></p>
<p style="top:586.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">voring PE (Figure&#xa0;3C and 3D). For studies using FTM </span></p>
<p style="top:598.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">interventions (n=6),</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">30,31,35,37,39,44</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> our meta- analysis </span></p>
<p style="top:610.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">yielded an MD of 19.7 mm&#xa0; Hg (95% CI, 14.3&#x2013; 25.1; </span></p>
<p style="top:622.3pt;left:306.6pt;line-height:10.0pt"><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><i><span style="font-family:Arial,serif;font-size:6.5pt">2</span></i></sup><span style="font-family:Arial,serif;font-size:10.0pt">=51.3) compared with the nonexercised rodents. </span></p>
<p style="top:634.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The MD was 16.1 mm&#xa0;Hg (95% CI, 11.5&#x2013; 20.8; </span><i><span style="font-family:Arial,serif;font-size:10.0pt">T</span></i><sup><i><span style="font-family:Arial,serif;font-size:6.5pt">2</span></i></sup><span style="font-family:Arial,serif;font-size:10.0pt">=50.3) </span></p>
<p style="top:646.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">for studies with VWR interventions versus controls </span></p>
<p style="top:658.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(n=7).</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34,35,37,38,39,44,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Results of dP/dt- max and dP/</span></p>
<p style="top:670.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">dt- min were comparable to those of LVP and are pre-</span></p>
<p style="top:682.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sented in Data S5 and Figures&#xa0;S3 through S6.</span></p>
<p style="top:694.3pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In addition to isolated heart perfusion, 5 studies </span></p>
<p style="top:706.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">used histology or electron microscopy to establish </span></p>
<p style="top:718.3pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">exercise- mediated cardioprotection ex vivo.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">26,33,41,46</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:719.9pt;left:54.6pt;line-height:3.9pt"><span style="font-family:Arial,serif;font-size:3.9pt">&#xa7;</span><span style="font-family:Arial,serif;font-size:6.0pt">References 29&#x2013; 31,34,35,37&#x2013; 39,44,49,50,56</span></p>
<p style="top:331.1pt;left:58.1pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Figure 3. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Forest plot of forced (A) or voluntary (B) physical exercise (PE) interventions on fractional shortening on </span></b></p>
<p style="top:341.1pt;left:58.1pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">echocardiography (in vivo) and of forced (C) or voluntary (D) PE interventions on isolated heart perfusion (ex vivo), compared </span></b></p>
<p style="top:351.1pt;left:58.1pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">with nonexercised controls in animal studies.</span></b></p>
<p style="top:361.1pt;left:58.1pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Results are presented as mean difference (MD) with 95% CI.</span></p>
<img style="position:absolute;transform:matrix(.34189863,0,-0,.34189863,-515.1496,-228.27503)" src="data:image/jpeg;base64,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">
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">13</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Although these studies were too clinically hetero-</span></p>
<p style="top:70.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">geneous for meta- analysis, all of them showed that </span></p>
<p style="top:82.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">microscopically established cardiac abnormalities in-</span></p>
<p style="top:94.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">duced by doxorubicin were mitigated through exercise, </span></p>
<p style="top:106.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">via swimming training,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">33,41</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> FTM,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">23,26,43,46,51,57</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> or VWR</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">46</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:118.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">interventions.</span></p>
<p style="top:130.7pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The analyses of echocardiography and perfusion </span></p>
<p style="top:142.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">parameters were repeated using fixed- effect models </span></p>
<p style="top:154.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and yielded no relevant differences from the results </span></p>
<p style="top:166.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">based on the random effects models (data not shown).</span></p>
<p style="top:192.6pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Mechanisms Underlying Exercise- </span></p>
<p style="top:206.6pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Mediated Cardioprotection</span></p>
<p style="top:221.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Multiple pathways were addressed by the included </span></p>
<p style="top:233.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies (Table&#xa0;2) and were grouped into those associ-</span></p>
<p style="top:245.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ated with increased oxidative stress and doxorubicin </span></p>
<p style="top:257.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">accumulation. An overview of the available studies per </span></p>
<p style="top:269.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pathway is presented in Table&#xa0;3.</span></p>
<p style="top:298.7pt;left:54.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Exercise and Oxidative Stress</span></i></b></p>
<p style="top:314.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The induction of oxidative stress through inciting over-</span></p>
<p style="top:326.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">production of reactive oxygen species is believed to </span></p>
<p style="top:338.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">play an important role in the pathogenesis of DIC, sup-</span></p>
<p style="top:350.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ported by increased levels of markers of oxidative </span></p>
<p style="top:362.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">stress, such as malondialdehyde, after doxorubicin </span></p>
<p style="top:374.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">administration.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">59- 61</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Increased oxidative stress is related </span></p>
<p style="top:386.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to a variety of other pathways or proteins, including up-</span></p>
<p style="top:398.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">regulation of antioxidants or heat- shock proteins, in-</span></p>
<p style="top:410.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">flammation, disruption of calcium homeostasis, </span></p>
<p style="top:422.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">autophagy, and apoptosis. Oxidative stress, or one of </span></p>
<p style="top:434.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the related pathways, is the most commonly reported </span></p>
<p style="top:446.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mechanism, with 21 studies focusing on how PE influ-</span></p>
<p style="top:458.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ences oxidative stress.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">3</span></sup></p>
<p style="top:470.7pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Eighteen studies investigated the effects of PE on </span></p>
<p style="top:482.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">antioxidants, which can counterbalance oxidative str</span></p>
<p style="top:494.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ess.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">22,23,24,25,26,27,28,29,30,31,32,33,40,41,42,43,46,51,52</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The major-</span></p>
<p style="top:506.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ity of these studies observed a beneficial effect of PE on </span></p>
<p style="top:518.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">antioxidants, meaning upregulation of antioxidants in the </span></p>
<p style="top:530.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">PE groups compared with controls. The most frequently </span></p>
<p style="top:542.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studied antioxidants were superoxide dismutase and </span></p>
<p style="top:554.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">catalase. Although the effect sizes widely varied, the rel-</span></p>
<p style="top:566.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ative increase observed most often was in the range of </span></p>
<p style="top:578.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">30% to 50%. In 4 of these studies, upregulation of antiox-</span></p>
<p style="top:590.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">idants coincided with a reduction of DIC on either echo-</span></p>
<p style="top:602.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiography</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">32</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> or histopathology.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">27,33,41</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Nonetheless, </span></p>
<p style="top:614.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the role of antioxidants is ambiguous, as not all stud-</span></p>
<p style="top:626.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ies reported upregulation of the same antioxidants and </span></p>
<p style="top:638.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">some studies reported conflicting results. For superox-</span></p>
<p style="top:650.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ide dismutase, for example, no attenuation was found </span></p>
<p style="top:662.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in 5 studies,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">25,27,29,30,31</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> while 1 of these studies reported </span></p>
<p style="top:674.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">upregulation of catalase</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">27</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and 3 studies found a cardi-</span></p>
<p style="top:686.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">oprotective effect of PE against DIC via isolated heart </span></p>
<p style="top:698.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">perfusion.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">29- 31</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> In contrast, in the study by Phungphong </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">et al using ovariectomized rats, attenuation of oxidative </span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">stress markers by PE was observed but without preser-</span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">vation of LV function on echocardiography.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">51</span></sup></p>
<p style="top:94.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Heat shock proteins (HSPs) are proteins that in-</span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">crease in various situations of cellular stress, eg, </span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">heat shock and ischemia.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">62</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> From the family of HSPs, </span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">HSP60, HSP70, and HSP72 were investigated by 10 </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies that yielded conflicting results. While the ma-</span></p>
<p style="top:154.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">jority described significant upregulation of HSPs by </span></p>
<p style="top:166.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a PE intervention,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">22,24,26,29,31,52</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> 1 study reported up-</span></p>
<p style="top:178.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">regulation of some, but not all HSPs2</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">27</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> or even a de-</span></p>
<p style="top:190.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">crease in HSP following exercise.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">33</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Moreover, Kavazis </span></p>
<p style="top:202.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">42</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> found that a swimming intervention, performed </span></p>
<p style="top:214.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">under cold conditions, which prevented upregulation </span></p>
<p style="top:226.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of HSP72, still yielded cardioprotection in doxorubicin- </span></p>
<p style="top:238.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">treated rodents.</span></p>
<p style="top:250.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Cardiac inflammation and remodeling as a result </span></p>
<p style="top:262.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of oxidative stress and impaired mitochondrial func-</span></p>
<p style="top:274.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">63</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> is hypothesized to be an important pathway </span></p>
<p style="top:286.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in the development of DIC and may eventually lead </span></p>
<p style="top:298.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to increased myocardial fibrosis.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">57</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Ahmadian et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">22</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:310.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">demonstrated that a 3- week preconditioning program </span></p>
<p style="top:322.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">resulted in lower levels of C- reactive protein in animals </span></p>
<p style="top:334.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">&lt;3&#xa0;months of age compared with controls. Similarly, </span></p>
<p style="top:346.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a treadmill program concomitant with doxorubicin ad-</span></p>
<p style="top:358.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ministration counteracted activation of an inflammatory </span></p>
<p style="top:370.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">response (interleukin 8, tumor nectrosis factor </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt">) and </span></p>
<p style="top:382.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">upregulation of fibrotic markers (transforming growth </span></p>
<p style="top:394.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">factor </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt">1), which was supported by reduced cardiac </span></p>
<p style="top:406.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fibrosis and preserved systolic function on histology </span></p>
<p style="top:418.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and echocardiography, respectively.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">57</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Phungphong et </span></p>
<p style="top:430.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">51</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> using a 2- week treadmill program during doxoru-</span></p>
<p style="top:442.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">bicin treatment, found no attenuation of inflammatory </span></p>
<p style="top:454.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">markers (interleukin 6 and interleukin 10), but reported </span></p>
<p style="top:466.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">significantly less myocardial fibrosis in the exercise </span></p>
<p style="top:478.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">group compared with controls (7.0%&#xb1;0.13% versus </span></p>
<p style="top:490.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">8.0%&#xb1;0.27% collagen deposition, respectively).</span></p>
<p style="top:502.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Deregulation of intracellular calcium homeosta-</span></p>
<p style="top:514.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sis has also been proposed as a mechanism under-</span></p>
<p style="top:526.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lying DIC. This is often attributed to downregulation </span></p>
<p style="top:538.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of sarcoendoplasmic reticulum calcium ATPase 2a </span></p>
<p style="top:550.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(SERCA2a).</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">64</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> SERCA2a is the most often expressed </span></p>
<p style="top:562.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">isoform of sarcoendoplasmic reticulum calcium ATPase </span></p>
<p style="top:574.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in cardiomyocytes and is responsible for pumping cal-</span></p>
<p style="top:586.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cium from the cytosol into the sarcoplasmatic reticu-</span></p>
<p style="top:598.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lum.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">37</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Calcium is of key importance in many cardiac </span></p>
<p style="top:610.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">functions and an interruption could result in a variety </span></p>
<p style="top:622.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of diseases, including systolic and diastolic dysfunc-</span></p>
<p style="top:634.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion and arrhythmias.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">65</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> In 2 studies, treadmill inter-</span></p>
<p style="top:646.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ventions of 5&#xa0;days and 8&#xa0;weeks, respectively, before </span></p>
<p style="top:658.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and during doxorubicin treatment partially prevented </span></p>
<p style="top:670.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">downregulation of SERCA2a.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">32,44</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Lien et al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">44</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> investi-</span></p>
<p style="top:682.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">gating doxorubicin dosages of 10&#xa0;mg/kg and 15&#xa0;mg/</span></p>
<p style="top:694.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">kg in forced and voluntary exercise groups, suggested </span></p>
<p style="top:706.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">that both exercise modalities can preserve SERCA2a, </span></p>
<p style="top:718.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">although FTM appeared more effective with the higher </span></p>
<p style="top:720.9pt;left:54.6pt;line-height:3.9pt"><span style="font-family:NotoSans,serif;font-size:3.9pt">&#x2016;</span><span style="font-family:Arial,serif;font-size:6.0pt">References 22&#x2013; 24,26&#x2013; 33,40,42,43,45,46,50&#x2013; 52,56,57</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">14</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 2. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Overview of Pathways Studied by the Animal Studies and Their Main Results</span></b></p>
<p style="top:77.4pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference of </span></p>
<p style="top:86.4pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animal study</span></p>
<p style="top:86.4pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Pathway(s)</span></p>
<p style="top:77.4pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Effect of PE </span></p>
<p style="top:86.4pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">intervention</span></p>
<p style="top:86.4pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Summary of main results</span></p>
<p style="top:101.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ahmadian, 2018</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">22</span></sup></p>
<p style="top:101.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:110.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD), </span></p>
<p style="top:119.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP (HSP70),  </span></p>
<p style="top:128.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">inflammation markers (IL- 10, CRP)</span></p>
<p style="top:101.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:101.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning exercise program had a beneficial effect on </span></p>
<p style="top:110.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidant capacity in all 3 age groups, yet the strongest effect </span></p>
<p style="top:119.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">was observed in the group of young rats</span></p>
<p style="top:141.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Alihemmati, 2019</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">23</span></sup></p>
<p style="top:141.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Apoptosis (Bax, BCL2, caspase 6, and </span></p>
<p style="top:150.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">gene and microRNA expression)</span></p>
<p style="top:141.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:141.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Preconditioning high- intensity interval training attenuated </span></p>
<p style="top:150.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">expression proapoptotic and apoptotic factors and microRNA, </span></p>
<p style="top:159.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">counteracting myocardial apoptosis</span></p>
<p style="top:172.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ascens&#xe3;o, 2006</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">24</span></sup></p>
<p style="top:172.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress (gluthatione </span></p>
<p style="top:181.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">analysis), Antioxidants (SOD), HSPs </span></p>
<p style="top:190.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(HSP60, HSP70), mitochondrial </span></p>
<p style="top:199.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">respiratory functioning</span></p>
<p style="top:172.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:172.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Heart mitochondria of DOX- treated animals submitted to an </span></p>
<p style="top:181.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">endurance training protocol seemed less susceptible to in vitro </span></p>
<p style="top:190.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">anoxia- reoxygenation compared to DOX- treated sedentary </span></p>
<p style="top:199.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">controls</span></p>
<p style="top:212.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ascens&#xe3;o, 2011</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">25</span></sup></p>
<p style="top:212.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Antioxidants (SOD), mPTP, apoptosis </span></p>
<p style="top:221.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(eg, Bax, Bcl2, caspase), mitochondrial </span></p>
<p style="top:230.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">functioning</span></p>
<p style="top:212.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:212.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A single exercise bout mitigated doxorubicin- induced mPTP </span></p>
<p style="top:221.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">susceptibility and mitochondrial dysfunction and altered </span></p>
<p style="top:230.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">apoptotic signaling compared with nonexercised controls</span></p>
<p style="top:243.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ascens&#xe3;o, 2005</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">26</span></sup></p>
<p style="top:243.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress </span></p>
<p style="top:252.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde, aconitase), </span></p>
<p style="top:261.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidants (SOD), HSPs (HSP60, </span></p>
<p style="top:270.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP70), mPTP, apoptosis (Bax, Ncl- 2),  </span></p>
<p style="top:279.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial functioning</span></p>
<p style="top:243.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:243.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">An endurance treadmill exercise intervention improved </span></p>
<p style="top:252.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidant capacity and attenuated myocardial apoptosis. </span></p>
<p style="top:261.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Histopathology confirmed significant attenuation of cardiotoxic </span></p>
<p style="top:270.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">changes in the exercise vs the control group</span></p>
<p style="top:292.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ascens&#xe3;o, 2005</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">27</span></sup></p>
<p style="top:292.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress (gluthatione </span></p>
<p style="top:301.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">analysis), antioxidants (SOD, catalase), </span></p>
<p style="top:310.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSPs (HSP60, HSP70), cardiac troponin </span></p>
<p style="top:319.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">I</span></p>
<p style="top:292.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:292.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">An endurance swimming exercise program mitigated </span></p>
<p style="top:301.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced oxidative damage compared with controls </span></p>
<p style="top:310.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with positive effects on the glutathione system and HSP60</span></p>
<p style="top:332.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ashrafi, 2012</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">28</span></sup></p>
<p style="top:332.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress </span></p>
<p style="top:341.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde, NO), antioxidants </span></p>
<p style="top:350.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(SOD, apelin)</span></p>
<p style="top:332.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:332.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A short- term PE preconditioning program counteracted </span></p>
<p style="top:341.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced oxidative stress and upregulated oxidative </span></p>
<p style="top:350.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">capacity compared with nonexercised controls</span></p>
<p style="top:363.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Chicco, 2005</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">29</span></sup></p>
<p style="top:363.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:372.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD), </span></p>
<p style="top:381.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP (HSP72)</span></p>
<p style="top:363.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:363.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A voluntary wheel- running preconditioning protocol attenuated </span></p>
<p style="top:372.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced alterations in lipid peroxidation compared </span></p>
<p style="top:381.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with nonexercised controls. In addition, higher levels of HSP72 </span></p>
<p style="top:390.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">were observed in the intervention group. Cardiac function </span></p>
<p style="top:399.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">tended to be less impaired in the trained group</span></p>
<p style="top:412.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Chicco, 2006</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">30</span></sup></p>
<p style="top:412.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:421.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD), </span></p>
<p style="top:430.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP (HSP72), apoptosis (caspase 3), </span></p>
<p style="top:439.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC distribution isoforms</span></p>
<p style="top:412.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:412.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A low- intensity treadmill exercise protocol mitigated </span></p>
<p style="top:421.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced cardiac dysfunction, HSP72 and </span></p>
<p style="top:430.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">apoptotic signaling compared with nonexercised controls. </span></p>
<p style="top:439.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No significant effect on lipid peroxidation, SOD, or MHC </span></p>
<p style="top:448.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">distribution was observed</span></p>
<p style="top:461.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Chicco, 2006</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">31</span></sup></p>
<p style="top:461.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:470.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD), </span></p>
<p style="top:479.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP (HSP72)</span></p>
<p style="top:461.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:461.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning exercise program significantly mitigated </span></p>
<p style="top:470.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced impairments in cardiac function </span></p>
<p style="top:479.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">compared with nonexercised controls. In addition, an increase </span></p>
<p style="top:488.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in lipid peroxidation and greater expression of HSP72 following </span></p>
<p style="top:497.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise was observed</span></p>
<p style="top:510.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Dolinsky, 2013</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">32</span></sup></p>
<p style="top:510.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress (HNE), </span></p>
<p style="top:519.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidants (SOD, glutathione, catalase), </span></p>
<p style="top:528.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">SERCA2a expression</span></p>
<p style="top:510.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:510.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning treadmill program counteracted doxorubicin- </span></p>
<p style="top:519.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">induced LV dysfunction, lowered lipid peroxidation, and </span></p>
<p style="top:528.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">increased the expression of SER2CA and SOD compared with </span></p>
<p style="top:537.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">nonexercised controls</span></p>
<p style="top:550.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Farzanegi, 2019</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">33</span></sup></p>
<p style="top:550.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:559.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD, </span></p>
<p style="top:568.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">catalase), HSP (HSP70), inflammation </span></p>
<p style="top:577.6pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">marker (TNF- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:550.6pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:550.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A swimming program concomitant with doxorubicin treatment </span></p>
<p style="top:559.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">decreased inflammatory markers (TNF- a), HSP70, and lipid </span></p>
<p style="top:568.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">peroxidation, while improving antioxidant enzymatic activity </span></p>
<p style="top:577.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">compared with nonexercised controls</span></p>
<p style="top:590.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hall, 2019</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">34</span></sup></p>
<p style="top:590.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin accumulation</span></p>
<p style="top:590.5pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:590.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Voluntary wheel running partially prevented doxorubicin- </span></p>
<p style="top:599.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">induced LV dysfunction in vivo and ex vivo and doxorubicin </span></p>
<p style="top:608.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">accumulation in cardiac tissue. PE combined with caloric </span></p>
<p style="top:617.6pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">restriction yielded the most cardioprotection</span></p>
<p style="top:630.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hydock, 2008</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">35</span></sup></p>
<p style="top:630.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC distribution isoforms</span></p>
<p style="top:630.5pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:630.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning forced and voluntary treadmill program </span></p>
<p style="top:639.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">prevented doxorubicin- induced LV dysfunction in vivo and </span></p>
<p style="top:648.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ex vivo. MHC isoform distribution was preserved following </span></p>
<p style="top:657.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise in doxorubicin- treated animals</span></p>
<p style="top:670.5pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hydock, 2009</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">36</span></sup></p>
<p style="top:670.5pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC distribution isoforms</span></p>
<p style="top:670.5pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:670.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Access to voluntary wheel running before doxorubicin </span></p>
<p style="top:679.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">treatment significantly increased expression of </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">- MHC isoform </span></p>
<p style="top:688.5pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">compared with nonexercised controls</span></p>
<p style="top:721.1pt;left:502.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">15</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:76.9pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference of </span></p>
<p style="top:85.9pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animal study</span></p>
<p style="top:85.9pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Pathway(s)</span></p>
<p style="top:76.9pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Effect of PE </span></p>
<p style="top:85.9pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">intervention</span></p>
<p style="top:85.9pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Summary of main results</span></p>
<p style="top:101.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hydock, 2011</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">37</span></sup></p>
<p style="top:101.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">SERCA2a, MHC isoform distribution</span></p>
<p style="top:101.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:101.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Both forced and voluntary exercise interventions before </span></p>
<p style="top:110.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin treatment prevented decline in doxorubicin- </span></p>
<p style="top:119.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">induced LV dysfunction in vivo and ex vivo. The exercise </span></p>
<p style="top:128.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">interventions led to a preservation of MHC isoform distribution. </span></p>
<p style="top:137.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No effect of PE on SER2CA was observed</span></p>
<p style="top:150.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hydock, 2012</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">38</span></sup></p>
<p style="top:150.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC distribution isoforms</span></p>
<p style="top:150.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:150.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Compared with nonexercised controls, voluntary wheel running </span></p>
<p style="top:159.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">prevented in vivo and ex vivo doxorubicin- induced impairments </span></p>
<p style="top:168.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in LV function and preserved MHC isoform distribution</span></p>
<p style="top:181.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Jensen, 2013</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">39</span></sup></p>
<p style="top:181.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin accumulation</span></p>
<p style="top:181.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:181.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Both forced and voluntary PE interventions preserved LV </span></p>
<p style="top:190.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">function (in vivo and ex vivo) and reduced doxorubicin </span></p>
<p style="top:199.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">accumulation in cardiac tissue compared with nonexercised </span></p>
<p style="top:208.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">controls. No difference was observed between the 2 exercise </span></p>
<p style="top:217.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">programs</span></p>
<p style="top:230.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Ji, 1993</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">40</span></sup></p>
<p style="top:230.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:239.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), antioxidants (SOD, </span></p>
<p style="top:248.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">catalase, glutathione)</span></p>
<p style="top:230.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No</span></p>
<p style="top:230.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Low- dose doxorubicin administration did not substantially </span></p>
<p style="top:239.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">impair oxidative functioning in cardiomyocytes, both at rest and </span></p>
<p style="top:248.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">during PE</span></p>
<p style="top:261.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Kanter, 1985</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">41</span></sup></p>
<p style="top:261.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Antioxidants (SOD, catalase, glutathione)</span></p>
<p style="top:261.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:261.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">An endurance swimming protocol concomitant with </span></p>
<p style="top:270.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin administration mitigated doxorubicin- induced </span></p>
<p style="top:279.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">histopathological changes compared with nonexercised </span></p>
<p style="top:288.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">controls. No significant differences in antioxidants between </span></p>
<p style="top:297.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise and nonexercised doxorubicin- treated animals were </span></p>
<p style="top:306.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">found</span></p>
<p style="top:319.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Kavazis, 2010</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">42</span></sup></p>
<p style="top:319.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress (HNE), </span></p>
<p style="top:328.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidants (SOD, glutathione, catalase), </span></p>
<p style="top:337.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP apoptosis (caspase 3, ubiquitine, </span></p>
<p style="top:346.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">calpain, TUNEL)</span></p>
<p style="top:319.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:319.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A short- term preconditioning PE program increased antioxidant </span></p>
<p style="top:328.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">capacity and HSP72 and against mitochondrial damage </span></p>
<p style="top:337.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and apoptosis. Exercise- induced cardioprotection occurred </span></p>
<p style="top:346.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">independently of HSP72</span></p>
<p style="top:359.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Kavazis, 2014</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">18</span></sup></p>
<p style="top:359.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Gene expression (FoxO target genes), </span></p>
<p style="top:368.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial biogenesis (PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt"> </span></p>
<p style="top:377.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">receptor)</span></p>
<p style="top:359.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:359.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Compared with nonexercised controls, the short- term PE </span></p>
<p style="top:368.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">intervention before doxorubicin administration attenuated </span></p>
<p style="top:377.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced alteration in gene expression and protein </span></p>
<p style="top:386.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">abundance (PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt"> receptor)</span></p>
<p style="top:399.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Lee, 2020</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">43</span></sup></p>
<p style="top:399.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Antioxidants (eg, SOD, catalase), </span></p>
<p style="top:408.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">autophagy/mitophagy (eg, AMPK, </span></p>
<p style="top:417.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mTOR), apoptosis (Bax, BCL2)</span></p>
<p style="top:399.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:399.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A postconditioning PE program improved basal autophagy and </span></p>
<p style="top:408.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitophagy and counteracted doxorubicin- induced oxidative </span></p>
<p style="top:417.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">stress compared with nonexercised controls</span></p>
<p style="top:430.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Lien, 2015</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">44</span></sup></p>
<p style="top:430.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">SERCA2a</span></p>
<p style="top:430.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:430.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Short- term forced and voluntary exercise interventions </span></p>
<p style="top:439.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">prevented doxorubicin- induced LV dysfunction in vivo and ex </span></p>
<p style="top:448.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">vivo compared with nonexercised controls. Both programs </span></p>
<p style="top:457.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">preserved SER2CA expression, yet the FTM intervention </span></p>
<p style="top:466.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">appeared to be more effective in the higher doxorubicin dose</span></p>
<p style="top:479.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Mackay, 2019</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">45</span></sup></p>
<p style="top:479.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress </span></p>
<p style="top:488.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde, glutathione), iron </span></p>
<p style="top:497.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">regulation</span></p>
<p style="top:479.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No</span></p>
<p style="top:479.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin treatment significantly altered myocardial iron </span></p>
<p style="top:488.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">regulation, which was not prevented by a PE program nor </span></p>
<p style="top:497.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">metformin treatment before doxorubicin administration</span></p>
<p style="top:510.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marques- Aleixo, </span></p>
<p style="top:519.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2015</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">46</span></sup></p>
<p style="top:510.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress </span></p>
<p style="top:519.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde, aconitase), </span></p>
<p style="top:528.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">antioxidants (SOD), mitochondrial </span></p>
<p style="top:537.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">biogensis (PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt"> receptor), </span></p>
<p style="top:546.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial functioning</span></p>
<p style="top:510.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:510.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Both FTM and voluntary wheel running interventions prevented </span></p>
<p style="top:519.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced increase in oxidative stress and preserved </span></p>
<p style="top:528.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial functioning. Cardiac ultrastructure alterations </span></p>
<p style="top:537.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(eg, percentage of abnormal mitochondria) were counteracted </span></p>
<p style="top:546.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">by the 2 PE programs. No major differences between the 2 PE </span></p>
<p style="top:555.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">programs were found</span></p>
<p style="top:568.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marques- Aleixo, </span></p>
<p style="top:577.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2018</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">47</span></sup></p>
<p style="top:568.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mPTP, autophagy/mitophagy (eg, </span></p>
<p style="top:577.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Beclin2, Pink, Parkin, P62) apoptosis </span></p>
<p style="top:586.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(caspases, Bax, Bcl2)</span></p>
<p style="top:568.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:568.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Compared with nonexercised controls, forced and voluntary PE </span></p>
<p style="top:577.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">programs during doxorubicin treatment mitigated doxorubicin- </span></p>
<p style="top:586.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">induced mPTP susceptibility, and increased autophagic and </span></p>
<p style="top:595.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">apoptotic signaling, without substantial differences between </span></p>
<p style="top:604.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">the two exercise modalities</span></p>
<p style="top:617.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Morton, 2019</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">48</span></sup></p>
<p style="top:617.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mPTP, doxorubicin accumulation, </span></p>
<p style="top:626.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">reactive oxygen species emission, ABC- </span></p>
<p style="top:635.0pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">transporter expression</span></p>
<p style="top:617.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:617.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A short- term preconditioning PE program prevented </span></p>
<p style="top:626.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced LV dysfunction on echocardiography </span></p>
<p style="top:635.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and mitigated alteration in mPTP susceptibility compared </span></p>
<p style="top:644.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with nonexercised controls. In addition, less mitochondrial </span></p>
<p style="top:653.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin accumulation and increased expression of ABC </span></p>
<p style="top:662.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">transporters were found</span></p>
<p style="top:58.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 2. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Continued</span></b></p>
<p style="top:721.1pt;left:502.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> (</span><i><span style="font-family:Arial,serif;font-size:7.0pt">Continued</span></i><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">16</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:584.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin dosage. Both studies reported simultane-</span></p>
<p style="top:596.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ous preservation of systolic function. However, 1 study </span></p>
<p style="top:608.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in which doxorubicin administration significantly low-</span></p>
<p style="top:620.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ered SERCA2a by &#x2248;80% found no effect of a 10- week </span></p>
<p style="top:632.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">preconditioning PE intervention.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">37</span></sup></p>
<p style="top:644.4pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Induction and opening of the mitochondrial per-</span></p>
<p style="top:656.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">meability transition pore (mPTP) could result from </span></p>
<p style="top:668.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin- induced oxidative stress and associated </span></p>
<p style="top:680.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">deregulation in calcium homeostasis.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">66</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The mPTP is </span></p>
<p style="top:692.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a channel in the mitochondrial membrane susceptible </span></p>
<p style="top:704.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to calcium loading conditions. Opening of this channel </span></p>
<p style="top:716.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">enhances membrane permeability, which can lead to </span></p>
<p style="top:584.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mitochondrial dysfunction via cessation of ATP synthe-</span></p>
<p style="top:596.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sis and apoptosis.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">66</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Four studies investigated the effect </span></p>
<p style="top:608.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of PE on mPTP susceptibility, all of which found that </span></p>
<p style="top:620.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a forced preconditioning PE program, varying from a </span></p>
<p style="top:632.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">single bout to an endurance protocol of 14&#xa0;weeks, had </span></p>
<p style="top:644.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a positive effect on doxorubicin- induced increased </span></p>
<p style="top:656.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">susceptibility to mPTP opening.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">25,26,47,48</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> These findings </span></p>
<p style="top:668.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">were corroborated by simultaneous reduction in DIC </span></p>
<p style="top:680.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">on echocardiography</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">48</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and histopathology.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">26</span></sup></p>
<p style="top:692.4pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Another pathway related to oxidative metabolism </span></p>
<p style="top:704.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">is the peroxisome proliferator- activated receptor- </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b3;</span><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:716.4pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">coactivator 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt"> (PGC- 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt">). The PGC- 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt"> plays a pivotal </span></p>
<p style="top:76.9pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Reference of </span></p>
<p style="top:85.9pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">animal study</span></p>
<p style="top:85.9pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Pathway(s)</span></p>
<p style="top:76.9pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Effect of PE </span></p>
<p style="top:85.9pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">intervention</span></p>
<p style="top:85.9pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Summary of main results</span></p>
<p style="top:101.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Parry, 2015</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">49</span></sup></p>
<p style="top:101.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin accumulation, multi- drug </span></p>
<p style="top:110.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">resistance protein expression</span></p>
<p style="top:101.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:101.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">In tumor- inoculated rats, a voluntary wheel running program </span></p>
<p style="top:110.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">before doxorubicin treatment preserved cardiac function in </span></p>
<p style="top:119.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">vivo as well as ex vivo and reduced doxorubicin accumulation </span></p>
<p style="top:128.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in cardiac tissue compared with nonexercised controls. </span></p>
<p style="top:137.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">The exercise program did not interfere with doxorubicin&#x2019;s </span></p>
<p style="top:146.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">therapeutic efficacy</span></p>
<p style="top:159.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Pfannenstiel, </span></p>
<p style="top:168.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2018</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">50</span></sup></p>
<p style="top:159.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:168.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde), MHC distribution </span></p>
<p style="top:177.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">isoforms</span></p>
<p style="top:159.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:159.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A resistance training protocol before doxorubicin treatment </span></p>
<p style="top:168.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">preserved cardiac function in doxorubicin- treated animals and </span></p>
<p style="top:177.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">protected against MHC isoform distribution changes compared </span></p>
<p style="top:186.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">with nonexercised controls. No effect was found in the exercise </span></p>
<p style="top:195.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">program with lipid peroxidation</span></p>
<p style="top:208.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Phungphong, </span></p>
<p style="top:217.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2020</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">51</span></sup></p>
<p style="top:208.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress (LDH, lipid </span></p>
<p style="top:217.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">peroxidation), inflammatory markers </span></p>
<p style="top:226.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(IL- 6), calcium homeostasis, MHC </span></p>
<p style="top:235.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">distribution isoforms</span></p>
<p style="top:208.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Moderately</span></p>
<p style="top:208.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">In ovariectomized rats, preconditioning exercise program </span></p>
<p style="top:217.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">attenuated doxorubicin- induced oxidative stress and cardiac </span></p>
<p style="top:226.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">inflammation compared with nonexercised controls. No </span></p>
<p style="top:235.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">protective effect on cardiac function following exercise was </span></p>
<p style="top:244.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">found</span></p>
<p style="top:257.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Shirinbayan, 2012</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">52</span></sup></p>
<p style="top:257.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Markers of oxidative stress </span></p>
<p style="top:266.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde, creatine kinase, </span></p>
<p style="top:275.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">creatine phosphokinase- myocardial </span></p>
<p style="top:284.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">band), antioxidants (SOD), HSP (HSP70)</span></p>
<p style="top:257.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:257.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning PE program significantly increased HSP70 </span></p>
<p style="top:266.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and SOD and decreased malondialdehyde as opposed to </span></p>
<p style="top:275.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">nonexercised controls, regardless of differences in doxorubicin </span></p>
<p style="top:284.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doses (10 or 20&#xa0;mg/kg)</span></p>
<p style="top:297.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Smuder, 2013</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">53</span></sup></p>
<p style="top:297.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Autophagy (mRNA and protein synthesis)</span></p>
<p style="top:297.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:297.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Compared with nonexercised controls, a preconditioning </span></p>
<p style="top:306.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">treadmill program prevented doxorubicin- induced increase in </span></p>
<p style="top:315.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">autophagic signaling</span></p>
<p style="top:328.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Sturgeon, 2014</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">54</span></sup></p>
<p style="top:328.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC distribution isoforms</span></p>
<p style="top:328.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No</span></p>
<p style="top:328.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">In a murine model with melanoma, a PE program before </span></p>
<p style="top:337.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin treatment did not mitigate doxorubicin- induced LV </span></p>
<p style="top:346.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">dysfunction on echocardiography nor changes in MHC isoform </span></p>
<p style="top:355.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">distribution but improved doxorubicin&#x2019;s antitumor efficacy </span></p>
<p style="top:364.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">compared with nonexercised controls</span></p>
<p style="top:377.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Werner, 2008</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">55</span></sup></p>
<p style="top:377.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Apoptosis (telomere- regulating proteins, </span></p>
<p style="top:386.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">TUNEL, p53)</span></p>
<p style="top:377.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:377.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A preconditioning voluntary wheel running program reduced </span></p>
<p style="top:386.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced p53 expression and might prevent </span></p>
<p style="top:395.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiomyocyte apoptosis. In animals not treated with </span></p>
<p style="top:404.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin, the exercise program upregulated telomere </span></p>
<p style="top:413.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">stabilizing proteins compared with nonexercised controls</span></p>
<p style="top:426.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Wonders,2008</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">56</span></sup></p>
<p style="top:426.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marker of oxidative stress </span></p>
<p style="top:435.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(malondialdehyde)</span></p>
<p style="top:426.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:426.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">An exercise bout before doxorubicin treatment mitigated </span></p>
<p style="top:435.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced LV dysfunction on isolated heart perfusion </span></p>
<p style="top:444.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and attenuated an increase in oxidative stress compared with </span></p>
<p style="top:453.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">nonexercised controls</span></p>
<p style="top:466.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yang, 2020</span><sup><span style="font-family:Arial,serif;font-size:4.6pt">57</span></sup></p>
<p style="top:466.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Inflammation markers (AKT, COX- 2), </span></p>
<p style="top:475.1pt;left:134.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">fibrotic markers (TGF- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:7.0pt">)</span></p>
<p style="top:466.1pt;left:273.0pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yes</span></p>
<p style="top:466.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">A PE program during doxorubicin treatment ameliorated </span></p>
<p style="top:475.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced expression of fibrosis factors and reduced </span></p>
<p style="top:484.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiac fibrosis on histopathology compared with nonexercised </span></p>
<p style="top:493.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">controls. On echocardiography, LV function was preserved in </span></p>
<p style="top:502.1pt;left:338.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">the exercise group</span></p>
<p style="top:516.7pt;left:62.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">AMPK indicates 5&#x2019;- adenosine monophosphate- activated protein kinase; COX- 2, cyclooxygenase- 2; CRP, C- reactive protein; eNOS, endothelial nitric </span></p>
<p style="top:525.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">oxide synthase; FTM, forced treadmill; HNE, 4- hydroxy- 2- nonenal protein; HSP, heat shock protein; IL- 6, interleukin 6; IL- 8, interleukin 8; IL- 10, interleukin 10; </span></p>
<p style="top:534.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">LDH, lactate dehydrogenase; LV, left ventricular; MHC, myosin heavy chain; mPTP, mitochondrial permeability transition pore; NO, nitric oxide; PE, physical </span></p>
<p style="top:543.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise; PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">, peroxisome proliferator- activated receptor- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b3;</span><span style="font-family:Arial,serif;font-size:7.0pt"> coactivator 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">; SERCA2a, sarcoendoplasmatic reticulum calcium ATPase 2a; SOD, superoxide </span></p>
<p style="top:552.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">dismutase; TERT, telomerase reverse transcriptase; TGF- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:7.0pt">, transforming growth factor </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:7.0pt">; TNF- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">, tumor necrosis factor </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">; and TUNEL, terminal deoxynucleotidal </span></p>
<p style="top:561.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">transferase&#x2013; mediated biotin&#x2013; deoxyuridine triphosphate nick- end labeling.</span></p>
<p style="top:58.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 2. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Continued</span></b></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">17</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:270.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">role in mitochondrial biogenesis as well as lipid and </span></p>
<p style="top:282.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">carbohydrate metabolism,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">67</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and is believed to be </span></p>
<p style="top:294.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardioprotective, since knockout of PGC- 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt"> in mice </span></p>
<p style="top:306.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">leads to cardiomyopathy.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">68</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> One study found that </span></p>
<p style="top:318.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a short- term PE program induced the expression </span></p>
<p style="top:330.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of PGC- 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt"> protein in cardiac (and skeletal muscle) </span></p>
<p style="top:342.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tissue by &#x2248;50%.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">18</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The authors proposed that this </span></p>
<p style="top:354.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">could prevent downstream doxorubicin- induced </span></p>
<p style="top:366.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiac and skeletal muscle wasting.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">18</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Another </span></p>
<p style="top:378.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study found a trend for preservation of PGC- 1</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:390.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">expression by both forced and voluntary PE inter-</span></p>
<p style="top:402.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ventions during doxorubicin administration, which </span></p>
<p style="top:414.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">corresponded with fewer cardiotoxic changes on </span></p>
<p style="top:426.4pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">histopathology.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">46</span></sup></p>
<p style="top:438.4pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The distribution of myosin heavy chain (MHC) iso-</span></p>
<p style="top:450.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">forms, ie, the ratio of fast </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC to slower yet more </span></p>
<p style="top:462.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">metabolically efficient </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC is of importance for </span></p>
<p style="top:474.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiac contractility. Upregulation of </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC at a cost </span></p>
<p style="top:486.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC is reported after exposure to doxorubicin</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">69</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:498.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and has been attributed, in part, to doxorubicin- </span></p>
<p style="top:510.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced oxidative stress.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">38</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Six studies found that </span></p>
<p style="top:522.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the distribution of MHC isoforms was unfavorably </span></p>
<p style="top:534.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">affected by doxorubicin.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">35&#x2013; 38,50,51</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Studies by Hydock </span></p>
<p style="top:546.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">35,37,38</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> using both forced and voluntary PE pro-</span></p>
<p style="top:558.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">grams found a consistent trend towards lower ex-</span></p>
<p style="top:570.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pression of </span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC (&#x2248;5%&#x2013; 15% reduction) following </span></p>
<p style="top:582.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">exercise. These results were corroborated by studies </span></p>
<p style="top:594.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">by Pfannenstiel et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">50</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> and Phungphong et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">51</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> using </span></p>
<p style="top:606.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a resistance and FTM PE program, respectively. </span></p>
<p style="top:618.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">However, 2 other studies found no significant effect </span></p>
<p style="top:630.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of PE on MHC isoform distribution by doxorubicin </span></p>
<p style="top:642.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">administration alone or in combination with an FTM </span></p>
<p style="top:654.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">intervention.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">30,54</span></sup></p>
<p style="top:666.4pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The process of autophagy is important for cellu-</span></p>
<p style="top:678.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lar survival by regulation of energy sources, removing </span></p>
<p style="top:690.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">damaged organelles (eg, mitochondria) or intracel-</span></p>
<p style="top:702.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lular pathogens.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">70</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Dysregulation of autophagy could </span></p>
<p style="top:714.4pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">occur via doxorubicin- induced oxidative stress and </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">could eventually lead to nonapoptotic cell death.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">71</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Two </span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies showed that both a 12- day and a 14- week PE </span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">intervention during treatment can effectively prevent </span></p>
<p style="top:94.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a doxorubicin- mediated increase in autophagy.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">47,53</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">However, using a postconditioning protocol, Lee et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">43</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">found no attenuation of autophagy in nonexercised an-</span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">imals, while autophagy was significantly promoted in </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the exercised animals.</span></p>
<p style="top:154.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Apoptosis is an important and final step in the de-</span></p>
<p style="top:166.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">velopment of DIC, which can be promoted through ox-</span></p>
<p style="top:178.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">idative stress (among others via increased mPTP </span></p>
<p style="top:190.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">opening) and the formation of topoisomerase II</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt">- </span></p>
<p style="top:202.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin- DNA complexes.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">5,72</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> The latter is believed </span></p>
<p style="top:214.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to be a key mechanism underlying DIC, since depletion </span></p>
<p style="top:226.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of topoisomerase II</span><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b2;</span><span style="font-family:Arial,serif;font-size:10.0pt"> can prevent cardiac toxicity </span></p>
<p style="top:238.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">caused by doxorubicin.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">72</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Attenuation of apoptotic sig-</span></p>
<p style="top:250.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">naling by exercise was investigated in 10 studies,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">&#xb6;</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> of </span></p>
<p style="top:262.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">which the majority measured caspase 3 or Bcl2 family </span></p>
<p style="top:274.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">proteins (proapoptotic and antiapoptotic protein Bax </span></p>
<p style="top:286.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and Bcl2, respectively). All of the studies of caspase 3 </span></p>
<p style="top:298.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">activity reported that various PE programs counter-</span></p>
<p style="top:310.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">acted doxorubicin- induced increase in caspase 3 ac-</span></p>
<p style="top:322.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tivity.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">25,26,30,42,43,47,51</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Results from studies of the Bcl2 </span></p>
<p style="top:334.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">proteins are less consistent. Alihemmati et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">23</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> found </span></p>
<p style="top:346.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">that a 6- week preconditioning high- intensity interval </span></p>
<p style="top:358.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">training </span></p>
<p style="top:358.7pt;left:357.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">program </span></p>
<p style="top:358.7pt;left:414.1pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">significantly </span></p>
<p style="top:358.7pt;left:483.4pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">counteracted </span></p>
<p style="top:370.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin- induced upregulation of Bax from &#x2248;50% </span></p>
<p style="top:382.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to &#x2248;10% change and downregulation of Bcl2 from </span></p>
<p style="top:394.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">&#x2248;80% to &#x2248;55% change. Two other studies using a 14- </span></p>
<p style="top:406.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">week preconditioning</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">26</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> or concomitant</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">47</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> PE protocol </span></p>
<p style="top:418.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">also found relatively lower expression of Bax in the ex-</span></p>
<p style="top:430.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ercise groups but no significant changes or trend in </span></p>
<p style="top:442.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Bcl2.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">26,47</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> No attenuation of either Bax or Bcl2 was </span></p>
<p style="top:454.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">found by the other studies that investigated these pro-</span></p>
<p style="top:466.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">teins.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">25,43</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Werner et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">55</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> demonstrated that a 3- week </span></p>
<p style="top:478.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">voluntary running protocol mitigated expression of </span></p>
<p style="top:490.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">proapoptotic proteins, including p53, compared with </span></p>
<p style="top:502.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">nonexercised controls. However, another study using </span></p>
<p style="top:514.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">levels of cleaved poly(ADP- ribose) polymerase as a </span></p>
<p style="top:526.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">marker for apoptosis found no effect of either a 2- week </span></p>
<p style="top:538.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">FTM intervention or doxorubicin administration alone </span></p>
<p style="top:550.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">on apoptotic signaling.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">54</span></sup></p>
<p style="top:579.7pt;left:306.6pt;line-height:10.0pt"><b><i><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">Doxorubicin Accumulation</span></i></b></p>
<p style="top:595.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Compared with other cytosolic compartments of </span></p>
<p style="top:607.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a cell, doxorubicin predominantly localizes in mito-</span></p>
<p style="top:619.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">chondria.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">48</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Four studies using FTM</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">39,48</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> or VWR</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34,39,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:631.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">interventions investigated whether a PE program can </span></p>
<p style="top:643.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">counteract doxorubicin accumulation. Three of these </span></p>
<p style="top:655.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies found significantly lower concentrations of </span></p>
<p style="top:667.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin, varying from &#x2248;25% to 40%, in the left </span></p>
<p style="top:679.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ventricles of exercised animals compared with non-</span></p>
<p style="top:691.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">exercised animals within 2&#xa0;days after injection.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">39,48,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:719.9pt;left:306.6pt;line-height:3.9pt"><span style="font-family:Arial,serif;font-size:3.9pt">&#xb6;</span><span style="font-family:Arial,serif;font-size:6.0pt">References 23,25,26,30,42,43,47,51,54,55</span></p>
<p style="top:58.8pt;left:54.6pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Table 3. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Overview of Available Evidence Per Pathway</span></b></p>
<p style="top:77.4pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Pathway</span></p>
<p style="top:77.4pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">No.</span></p>
<p style="top:92.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Antioxidants</span></p>
<p style="top:92.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">18</span></p>
<p style="top:105.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSPs</span></p>
<p style="top:105.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10</span></p>
<p style="top:118.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Cardiac inflammation</span></p>
<p style="top:118.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2</span></p>
<p style="top:131.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Calcium homeostasis</span></p>
<p style="top:131.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">3</span></p>
<p style="top:144.6pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mPTP</span></p>
<p style="top:144.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">4</span></p>
<p style="top:160.1pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span></p>
<p style="top:157.6pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2</span></p>
<p style="top:173.0pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">MHC isoform distribution</span></p>
<p style="top:173.0pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">6</span></p>
<p style="top:186.0pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Autophagy</span></p>
<p style="top:186.0pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">3</span></p>
<p style="top:199.0pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Apoptosis</span></p>
<p style="top:199.0pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10</span></p>
<p style="top:212.0pt;left:60.8pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Doxorubicin accumulation</span></p>
<p style="top:212.0pt;left:212.3pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">4</span></p>
<p style="top:226.7pt;left:62.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP indicates heat shock protein; MHC, myosin heavy chain; mPTP, </span></p>
<p style="top:235.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial permeability transition pore; and PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">, peroxisome </span></p>
<p style="top:244.7pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">proliferator- activated receptor- </span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b3;</span><span style="font-family:Arial,serif;font-size:7.0pt"> coactivator 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt">.</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">18</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">A study by Hall et al</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> reported a nonsignificant trend </span></p>
<p style="top:70.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of a 38% reduction of doxorubicin accumulation in </span></p>
<p style="top:82.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the left ventricle, favoring the 4- month precondi-</span></p>
<p style="top:94.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tioning group. Parry et al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> using tumor- inoculated </span></p>
<p style="top:106.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">animals, reported no differences between the study </span></p>
<p style="top:118.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">groups in changes in doxorubicin accumulation </span></p>
<p style="top:130.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">within the tumor, indicating that the PE program did </span></p>
<p style="top:142.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">not interfere with doxorubicin&#x2019;s therapeutic efficacy. </span></p>
<p style="top:154.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">All 4 studies described preservation of myocardial </span></p>
<p style="top:166.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">function (on echocardiography or isolated heart per-</span></p>
<p style="top:178.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fusion) or histology.</span></p>
<p style="top:211.3pt;left:54.6pt;line-height:13.0pt"><span style="font-family:Arial,serif;font-size:13.0pt;color:#cd171e">DISCUSSION</span></p>
<p style="top:229.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The aim of this meta- analysis and systematic review </span></p>
<p style="top:241.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">was to generate an estimate of the effect of PE on </span></p>
<p style="top:253.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">DIC and to systematically evaluate mechanisms un-</span></p>
<p style="top:265.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">derlying exercise- induced cardioprotection. The in-</span></p>
<p style="top:277.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cluded clinical studies reported favorable results for </span></p>
<p style="top:289.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">some but not all outcomes related to cardiac function </span></p>
<p style="top:301.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">and the available data are therefore not sufficient to </span></p>
<p style="top:313.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">demonstrate a protective effect of PE in humans. For </span></p>
<p style="top:325.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">animal studies, our meta- analysis indicated that both </span></p>
<p style="top:337.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">forced and voluntary PE interventions significantly im-</span></p>
<p style="top:349.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">prove in vivo (echocardiography) and ex vivo (isolated </span></p>
<p style="top:361.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">heart perfusion) cardiac parameters compared with </span></p>
<p style="top:373.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">nonexercised doxorubicin- treated animals. We iden-</span></p>
<p style="top:385.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tified oxidative stress and related mechanisms, and </span></p>
<p style="top:397.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">less doxorubicin accumulation in cardiac tissue, as </span></p>
<p style="top:409.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pathways through which exercise could exert a pro-</span></p>
<p style="top:421.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tective effect on DIC.</span></p>
<p style="top:447.6pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Clinical Studies</span></p>
<p style="top:462.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In the 2 reports by Kirkham et al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">19,20</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> no conclusive </span></p>
<p style="top:474.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">evidence was provided that treadmill interventions are </span></p>
<p style="top:486.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">effective in preserving cardiac function following treat-</span></p>
<p style="top:498.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ment with doxorubicin. However, the sample size was </span></p>
<p style="top:510.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">small (n=24) and imaging was limited to 2- dimensional </span></p>
<p style="top:522.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">echocardiography. Given the limitations of this modal-</span></p>
<p style="top:534.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ity in terms of temporal variability in serial LV assess-</span></p>
<p style="top:546.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ment,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">73,74</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> subtle between-  and within- group changes </span></p>
<p style="top:558.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in this small sample could remain unrecognized. </span></p>
<p style="top:570.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Although the study by Ma was rated as having rela-</span></p>
<p style="top:582.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tively low methodological quality and high risk of bias, </span></p>
<p style="top:594.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">their results were sufficiently promising to warrant rep-</span></p>
<p style="top:606.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lication in a larger sample of patients with cancer, with </span></p>
<p style="top:618.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">adequate follow- up. Currently, several clinical initia-</span></p>
<p style="top:630.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tives are ongoing. An example is the EXACT2 (Exercise </span></p>
<p style="top:642.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to Prevent Anthracycline- based CardioToxicity 2.0) </span></p>
<p style="top:654.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">study,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">75,76</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> which is investigating the effect of a 12- </span></p>
<p style="top:666.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">week supervised PE program during chemotherapy. </span></p>
<p style="top:678.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The primary outcome of this randomized controlled </span></p>
<p style="top:690.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">trial (estimated study sample of n=100) is change in </span></p>
<p style="top:702.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">LV ejection fraction on 2- dimensional echocardiogra-</span></p>
<p style="top:714.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">phy from baseline to post- treatment (13&#xa0; weeks) and </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">6&#xa0;months after baseline. Another example is the on-</span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">going Pact- Paces- Heart (Evaluation of Heart Function </span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">After Physical Activity During Adjuvant Chemotherapy </span></p>
<p style="top:94.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in Breast Cancer Patients) study,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">77</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> which evaluates </span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the effect a moderate-  to- high- intensity supervised </span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">PE program during breast cancer treatment on car-</span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">diotoxicity after a long period of follow- up (&#x2248;8&#xa0; years </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">after treatment). This study has a relatively large sam-</span></p>
<p style="top:154.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ple size (n&#x2248;180) and an extensive cardiac assessment, </span></p>
<p style="top:166.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">including cardiac magnetic resonance imaging and </span></p>
<p style="top:178.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">3- dimensional echocardiography. Results of these </span></p>
<p style="top:190.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies are expected to provide new insights into the </span></p>
<p style="top:202.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">effect of PE on cardiotoxicity in humans.</span></p>
<p style="top:228.6pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Meta- Analysis in Animal Studies on the </span></p>
<p style="top:242.6pt;left:306.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Effect of Exercise on Cardiotoxicity</span></p>
<p style="top:257.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The animal studies in our quantitative analysis yielded </span></p>
<p style="top:269.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">evidence that PE interventions that vary in terms of </span></p>
<p style="top:281.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">type, duration, timing, and intensity can provide pro-</span></p>
<p style="top:293.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tection against DIC. The effects of forced exercise in-</span></p>
<p style="top:305.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">terventions appeared slightly stronger than those of </span></p>
<p style="top:317.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">voluntary interventions. Also, contrary to other studies </span></p>
<p style="top:329.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">included in our review, the study by Sturgeon et al,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">54</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:341.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">which used an exercise program with a lower intensity </span></p>
<p style="top:353.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">compared with other studies, found no protective ef-</span></p>
<p style="top:365.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fect of PE on cardiotoxicity. This could suggest that </span></p>
<p style="top:377.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a certain threshold of exercise intensity is needed in </span></p>
<p style="top:389.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">order to achieve cardioprotection. Similarly, both ex-</span></p>
<p style="top:401.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ercise programs starting before as well as during </span></p>
<p style="top:413.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin administration appeared to be cardiopro-</span></p>
<p style="top:425.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tective, although effects of the former were somewhat </span></p>
<p style="top:437.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">stronger. It seems intuitive that exercise interventions </span></p>
<p style="top:449.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">during doxorubicin administration would be (more) ef-</span></p>
<p style="top:461.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fective, given that our qualitative analysis on underlying </span></p>
<p style="top:473.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pathways identified accelerated doxorubicin clear-</span></p>
<p style="top:485.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ance as an important mechanism underlying exercise- </span></p>
<p style="top:497.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mediated cardioprotection. Nonetheless, initiating a PE </span></p>
<p style="top:509.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">program before the start of treatment is likely to have </span></p>
<p style="top:521.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">added value because of preconditioning of the cardio-</span></p>
<p style="top:533.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">myocytes via, among other pathways, upregulation of </span></p>
<p style="top:545.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:NotoSans,serif;font-size:10.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:10.0pt">- MHC expression or ABC transporters (as discussed </span></p>
<p style="top:557.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in a later section). These hypotheses, however, need to </span></p>
<p style="top:569.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">be investigated in future studies.</span></p>
<p style="top:581.7pt;left:319.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The reported effect sizes of our meta- analysis cor-</span></p>
<p style="top:593.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">respond with absolute changes in percentage points in </span></p>
<p style="top:605.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">FS for FTM and VWR of 8.5% and 5.8%, respectively. </span></p>
<p style="top:617.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In rodents, echocardiography is the modality of choice </span></p>
<p style="top:629.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">for evaluating cardiac function, since it is noninvasive, </span></p>
<p style="top:641.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">versatile, cheap, and reproducible. Recently, reference </span></p>
<p style="top:653.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">values for FS for adult rats and mice were published, </span></p>
<p style="top:665.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">which ranged from 41% to 48% and 31% to 43%, re-</span></p>
<p style="top:677.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">spectively.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">78</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> This indicates that the observed effects </span></p>
<p style="top:689.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">are likely to be of clinical importance in rodents. In ad-</span></p>
<p style="top:701.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">dition, for LVP, beneficial results were found for both </span></p>
<p style="top:713.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">FTM and VWR interventions as compared with control. </span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">19</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:436.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Isolated heart perfusion has been proposed as a reli-</span></p>
<p style="top:448.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">able model for the assessment of myocardial function, </span></p>
<p style="top:460.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">especially since it provides insight into cardiac perfor-</span></p>
<p style="top:472.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mance in the absence of neurohumeral influences and </span></p>
<p style="top:484.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">variation in loading conditions.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">79</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Thus, these results, </span></p>
<p style="top:496.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">complemented by the in vivo&#x2013; derived evidence, sup-</span></p>
<p style="top:508.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">port the notion that exercise indeed has cardioprotec-</span></p>
<p style="top:520.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tive potential in rodents.</span></p>
<p style="top:546.5pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Mechanisms Underlying Exercise- </span></p>
<p style="top:560.5pt;left:54.6pt;line-height:12.0pt"><span style="font-family:Arial,serif;font-size:12.0pt;color:#cd171e">Mediated Cardioprotection</span></p>
<p style="top:575.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">In a previous study, reduction of doxorubicin- induced </span></p>
<p style="top:587.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">oxidative stress and less doxorubicin accumulation </span></p>
<p style="top:599.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">have been described as pathways underlying exercise- </span></p>
<p style="top:611.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mediated cardioprotection.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">10</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Our results complement </span></p>
<p style="top:623.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the results of that study by providing an update of the </span></p>
<p style="top:635.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">novel articles on these topics, as well as describing a </span></p>
<p style="top:647.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">number of additional underlying pathways.</span></p>
<p style="top:659.6pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Oxidative stress and related pathways are the most </span></p>
<p style="top:671.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">extensively studied mechanisms, and many studies </span></p>
<p style="top:683.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">found that PE can counterbalance doxorubicin- </span></p>
<p style="top:695.6pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced increased markers of oxidative stress.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">#</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> </span></p>
<p style="top:436.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Research on how exercise could alleviate doxorubicin- </span></p>
<p style="top:448.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">induced oxidative stress has yielded more ambiguous </span></p>
<p style="top:460.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">results. Most studies have focused on upregulation of </span></p>
<p style="top:472.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">antioxidants or HSPs. Although some of these studies </span></p>
<p style="top:484.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">yielded positive effects, others reported that attenua-</span></p>
<p style="top:496.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion of these proteins/enzymes is not necessary in </span></p>
<p style="top:508.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">order for exercise to exert its cardioprotective effect. </span></p>
<p style="top:520.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">This is supported by clinical studies in which no signif-</span></p>
<p style="top:532.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">icant effect of antioxidants (eg, </span><span style="font-family:Arial,serif;font-size:7.0pt">l</span><span style="font-family:Arial,serif;font-size:10.0pt">- carnitine, coenzyme </span></p>
<p style="top:544.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Q10) on the incidence or extent of cardiotoxicity was </span></p>
<p style="top:556.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">found.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">80</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> Studies of the other proposed mechanisms </span></p>
<p style="top:568.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">are limited in number and have yielded varying results. </span></p>
<p style="top:580.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">For example, caspase 3, a marker for apoptotic signal-</span></p>
<p style="top:592.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ing, has been investigated in 7 studies, all of which re-</span></p>
<p style="top:604.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ported that PE mitigated a doxorubicin- induced </span></p>
<p style="top:616.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">increase in activity of the enzyme. Nevertheless, the </span></p>
<p style="top:628.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">only study that investigated whether this corresponded </span></p>
<p style="top:640.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to less DIC in vivo reported no attenuation in LV func-</span></p>
<p style="top:652.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tion by PE.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">51</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> This finding, as well as those investigating </span></p>
<p style="top:664.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">antioxidants, suggest that other, more upstream path-</span></p>
<p style="top:676.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ways are also involved. In this regard, it is conceivable </span></p>
<p style="top:688.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">that accumulation of doxorubicinin cardiac tissue acts </span></p>
<p style="top:700.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">as an overarching mechanism, since blocking this </span></p>
<p style="top:712.6pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">phenomenon effectively enables PE interventions to </span></p>
<p style="top:720.4pt;left:54.6pt;line-height:3.9pt"><span style="font-family:Arial,serif;font-size:3.9pt">#</span><span style="font-family:Arial,serif;font-size:6.0pt">References 22,25&#x2013; 27,29,31&#x2013; 33,42,43,45,46,51,52,56</span></p>
<p style="top:377.1pt;left:56.7pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt;color:#cd171e">Figure 4. </span></b><b><span style="font-family:Arial,serif;font-size:8.0pt">Suggested pathways underlying exercise- mediated protection against doxorubicin- induced cardiotoxicity (DIC) </span></b></p>
<p style="top:387.1pt;left:56.7pt;line-height:8.0pt"><b><span style="font-family:Arial,serif;font-size:8.0pt">in rodents.</span></b></p>
<p style="top:397.1pt;left:56.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Exercise prevents accumulation of doxorubicin in cardiac tissue, thereby inhibiting downstream pathways, through which doxorubicin </span></p>
<p style="top:407.1pt;left:56.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">can induce cardiotoxicity. HSP indicates heat sock protein; MHC, myosin heavy chain; and PGC- 1</span><span style="font-family:NotoSans,serif;font-size:8.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:8.0pt">, peroxisome proliferator- activated </span></p>
<p style="top:417.1pt;left:56.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">receptor- </span><span style="font-family:NotoSans,serif;font-size:8.0pt">&#x3b3;</span><span style="font-family:Arial,serif;font-size:8.0pt"> coactivator 1</span><span style="font-family:NotoSans,serif;font-size:8.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:8.0pt">.</span></p>
<img style="position:absolute;transform:matrix(.55620577,0,-0,.55620577,-167.19483,-67.785739)" src="data:image/jpeg;base64,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">
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">20</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tackle all downstream doxorubicin- induced effects </span></p>
<p style="top:70.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">(Figure&#xa0;4). This is supported by the fact that all included </span></p>
<p style="top:82.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies demonstrated that lowered doxorubicin accu-</span></p>
<p style="top:94.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">mulation coincided with reduced DIC.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">34,39,48,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> As for </span></p>
<p style="top:106.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">how PE mitigates doxorubicin accumulation, current </span></p>
<p style="top:118.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">evidence suggests that doxorubicin accumulation is </span></p>
<p style="top:130.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">influenced by exercise through upregulation of ABC </span></p>
<p style="top:142.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">transporters.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">39,48,49</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> These transporters can export a </span></p>
<p style="top:154.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">wide range of substances, eg, doxorubicin, out of cells </span></p>
<p style="top:166.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">or cell organelles. Knockout mice, lacking these recep-</span></p>
<p style="top:178.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">tors, show prolonged presence of doxorubicinin car-</span></p>
<p style="top:190.7pt;left:54.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">diac tissue.</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">81</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> However, since causality between </span></p>
<p style="top:202.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">upregulation of ABC transporters and reduction of </span></p>
<p style="top:214.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin accumulation has not been established, </span></p>
<p style="top:226.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">lower doxorubicin accumulation might equally result </span></p>
<p style="top:238.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">from exercise- mediated alterations in doxorubicin up-</span></p>
<p style="top:250.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">take or metabolism. Further research is therefore </span></p>
<p style="top:262.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">needed to elucidate the exact underlying mechanisms </span></p>
<p style="top:274.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of </span></p>
<p style="top:274.7pt;left:74.7pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">exercise- mediated </span></p>
<p style="top:274.7pt;left:166.3pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">reduction </span></p>
<p style="top:274.7pt;left:219.0pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in </span></p>
<p style="top:274.7pt;left:238.2pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">doxorubicin </span></p>
<p style="top:286.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">accumulation.</span></p>
<p style="top:298.7pt;left:67.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">The strengths of the study are the large number of </span></p>
<p style="top:310.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">studies included using various PE protocols and the </span></p>
<p style="top:322.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">systematic approach to evaluate the effect of PE on </span></p>
<p style="top:334.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiotoxicity and underlying mechanisms. A limitation </span></p>
<p style="top:346.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">is that many components of the methodology of the </span></p>
<p style="top:358.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">included animal studies were not adequately reported, </span></p>
<p style="top:370.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">which could limit the internal validity of these studies, </span></p>
<p style="top:382.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">as well as the comparison of results among studies. </span></p>
<p style="top:394.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">For the current report, authors were contacted in case </span></p>
<p style="top:406.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">a component was scored as &quot;unclear.&quot; This resulted </span></p>
<p style="top:418.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in clarification of a substantial amount of risk- of- bias </span></p>
<p style="top:430.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">information, thereby improving the quality of the evi-</span></p>
<p style="top:442.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">dence. In addition, the wide variety of study protocols </span></p>
<p style="top:454.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">made it challenging to quantify the protective effects of </span></p>
<p style="top:466.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">specific forms of PE and to draw definitive conclusions </span></p>
<p style="top:478.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">regarding underlying mechanisms. Last, the majority </span></p>
<p style="top:490.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of the preclinical studies used FS as a parameter for </span></p>
<p style="top:502.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">LV function. Since LV ejection fraction is currently rec-</span></p>
<p style="top:514.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ommended in clinical guidelines,</span><sup><span style="font-family:Arial,serif;font-size:6.5pt">74</span></sup><span style="font-family:Arial,serif;font-size:10.0pt"> this hampers the </span></p>
<p style="top:526.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">generalizability to patients with cancer. Limitations of </span></p>
<p style="top:538.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">the clinical studies are the small sample sizes and the </span></p>
<p style="top:550.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">fact that imaging was limited to 2- dimensional echo-</span></p>
<p style="top:562.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiography. In addition, follow- up time was too short </span></p>
<p style="top:574.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">to detect all relevant cases of cardiotoxicity, given that </span></p>
<p style="top:586.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">anthracycline- induced cardiotoxicity can manifest </span></p>
<p style="top:598.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">within a year after treatment (ie, not necessarily directly </span></p>
<p style="top:610.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">after completion of treatment). This limited our ability to </span></p>
<p style="top:622.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">draw any conclusions about the effects of PE on DIC </span></p>
<p style="top:634.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">in humans.</span></p>
<p style="top:670.3pt;left:54.6pt;line-height:13.0pt"><span style="font-family:Arial,serif;font-size:13.0pt;color:#cd171e">CONCLUSIONS</span></p>
<p style="top:688.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">Our meta- analysis and systematic review indi-</span></p>
<p style="top:700.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cate that PE is an effective intervention for reducing </span></p>
<p style="top:712.7pt;left:54.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">DIC in rodents. Less doxorubicin accumulation in </span></p>
<p style="top:58.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cardiomyocytes could act as an overarching mecha-</span></p>
<p style="top:70.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">nism underlying the protective effects of exercise </span></p>
<p style="top:82.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">against DIC. While clinical studies in humans are lim-</span></p>
<p style="top:94.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">ited, the observed effects are congruent with the hy-</span></p>
<p style="top:106.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">pothesis that PE yields cardioprotection. Larger, more </span></p>
<p style="top:118.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">sophisticated clinical studies with an adequate period </span></p>
<p style="top:130.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">of follow- up are needed in order to document the </span></p>
<p style="top:142.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">role of PE in preventing cardiotoxicity in patients with </span></p>
<p style="top:154.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">cancer.</span></p>
<p style="top:186.7pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">ARTICLE INFORMATION</span></p>
<p style="top:202.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Received April 1, 2021; accepted June 1, 2021.</span></p>
<p style="top:217.5pt;left:306.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">Affiliations</span></p>
<p style="top:229.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Division of Psychosocial Research and Epidemiology (W.R.N., M.M.S., </span></p>
<p style="top:238.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">N.K.A., W.H.v.H., W.G.G.) and Center for Quality of Life (M.M.S.), The </span></p>
<p style="top:247.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Netherlands Cancer Institute, Amsterdam, the Netherlands; Julius Center for </span></p>
<p style="top:256.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Health Sciences and Primary Care (W.R.N., D.B., A.M.M.) and Department </span></p>
<p style="top:265.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of Cardiology (A.J.T.), University Medical Center Utrecht, Utrecht University, </span></p>
<p style="top:274.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Utrecht, The Netherlands; Centre of Expertise Urban Vitality, Faculty of </span></p>
<p style="top:283.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Health, Amsterdam University of Applied Sciences, Amsterdam, The </span></p>
<p style="top:292.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Netherlands (M.M.S.); and Department of Health Technology and Services </span></p>
<p style="top:301.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Research, University of Twente, Enschede, The Netherlands (W.H.v.H.).</span></p>
<p style="top:317.0pt;left:306.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">Sources of Funding</span></p>
<p style="top:329.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">This work was supported by the Dutch Cancer Society (KWF/Alpe, </span></p>
<p style="top:338.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10325/2016- 1).</span></p>
<p style="top:353.5pt;left:306.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">Disclosures</span></p>
<p style="top:365.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">None.</span></p>
<p style="top:381.0pt;left:306.6pt;line-height:9.0pt"><span style="font-family:Arial,serif;font-size:9.0pt;color:#cd171e">Supplementary Material</span></p>
<p style="top:393.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Data S1&#x2013; S5</span></p>
<p style="top:402.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">References 82&#x2013; 95</span></p>
<p style="top:439.2pt;left:306.6pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt;color:#cd171e">REFERENCES</span></p>
<p style="top:454.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 1. Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens </span></p>
<p style="top:463.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">AL. Doxorubicin- induced cardiomyopathy: from molecular mechanisms </span></p>
<p style="top:472.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">to therapeutic strategies. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Mol Cell Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2012;52:1213&#x2013; 1225. DOI: </span></p>
<p style="top:481.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1016/j.yjmcc.2012.03.006.</span></p>
<p style="top:490.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 2. Jain D. Cardiotoxicity of doxorubicin and other anthracycline deriva-</span></p>
<p style="top:499.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">tives. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Nucl Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2000;7:53&#x2013; 62. DOI: 10.1067/mnc.2000.103324.</span></p>
<p style="top:508.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 3. Lotrionte M, Biondi- Zoccai G, Abbate A, Lanzetta G, D&#x2019;Ascenzo F, </span></p>
<p style="top:517.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Malavasi V, Peruzzi M, Frati G, Palazzoni G. Review and meta- analysis </span></p>
<p style="top:526.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of incidence and clinical predictors of anthracycline cardiotoxi-</span></p>
<p style="top:535.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">city. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2013;112:1980&#x2013; 1984. DOI: 10.1016/j.amjca rd.2013.  </span></p>
<p style="top:544.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">08.026.</span></p>
<p style="top:553.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 4. Henriksen PA. Anthracycline cardiotoxicity: an update on mechanisms, </span></p>
<p style="top:562.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">monitoring and prevention. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Heart</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;104:971&#x2013; 977. DOI: 10.1136/</span></p>
<p style="top:571.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">heart jnl- 2017- 312103.</span></p>
<p style="top:580.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 5. Angsutararux P, Luanpitpong S, Issaragrisil S. Chemotherapy- induced </span></p>
<p style="top:589.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity: overview of the roles of oxidative stress. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Oxid Med Cell </span></i></p>
<p style="top:598.6pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Longev</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2015;2015:1&#x2013; 13. DOI: 10.1155/2015/795602.</span></p>
<p style="top:607.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 6. Kalyanaraman B. Teaching the basics of the mechanism of </span></p>
<p style="top:616.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced cardiotoxicity: have we been barking up the </span></p>
<p style="top:625.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">wrong tree? </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Redox Biol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2020;29:101394. DOI: 10.1016/j.redox.2019.  </span></p>
<p style="top:634.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">101394.</span></p>
<p style="top:643.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 7. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, </span></p>
<p style="top:652.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Howard DL, Baughman KL, Kasper EK. Underlying causes and long- </span></p>
<p style="top:661.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">term survival in patients with initially unexplained cardiomyopathy. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">N </span></i></p>
<p style="top:670.6pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Engl J Med</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2000;342:1077&#x2013; 1084. DOI: 10.1056/NEJM2 00004 13342 </span></p>
<p style="top:679.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">1502.</span></p>
<p style="top:688.6pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 8. Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson T- L, Myklebust </span></p>
<p style="top:697.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">T&#xc5;, Tervonen H, Thursfield V, Ransom D, Shack L, et al. Progress </span></p>
<p style="top:706.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in cancer survival, mortality, and incidence in seven high- income </span></p>
<p style="top:715.6pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> countries 1995&#x2013; 2014 (ICBP SURVMARK- 2): a population- based </span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">21</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">study. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Lancet Oncol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;20:1493&#x2013; 1505. DOI: 10.1016/S1470 - 2045(19) </span></p>
<p style="top:67.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">30456 - 5.</span></p>
<p style="top:76.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 9. Scott JM, Nilsen TS, Gupta D, Jones LW. Exercise therapy and car-</span></p>
<p style="top:85.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">diovascular toxicity in cancer. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Circulation</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;137:1176&#x2013; 1191. DOI: </span></p>
<p style="top:94.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1161/CIRCU LATIO NAHA.117.024671.</span></p>
<p style="top:103.9pt;left:54.7pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 10. Chen JJ, Wu PT, Middlekauff HR, Nguyen KL. Aerobic exercise in </span></p>
<p style="top:112.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">anthracycline- induced cardiotoxicity: a systematic review of cur-</span></p>
<p style="top:121.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">rent evidence and future directions. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Heart Circ Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:130.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2016;312:H213&#x2013; H222. DOI: 10.1152/ajphe art.00646.2016.</span></p>
<p style="top:139.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 11. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, Atkins </span></p>
<p style="top:148.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">D, Barbour V, Barrowman N, Berlin JA, et al. Preferred reporting items </span></p>
<p style="top:157.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">for systematic reviews and meta- analyses: the PRISMA statement </span></p>
<p style="top:166.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">(Chinese edition). </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Chin Integr Med</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2009;7:889&#x2013; 896. DOI: 10.3736/</span></p>
<p style="top:176.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">jcim2 0090918.</span></p>
<p style="top:185.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 12. Morales JS, Valenzuela PL, Herrera- Olivares AM, Ba&#xf1;o- Rodrigo A, </span></p>
<p style="top:194.0pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Castillo- Garc&#xed;a A, Rinc&#xf3;n- Castanedo C, Mart&#xed;n- Ruiz A, San- Juan </span></p>
<p style="top:203.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">AF, Fiuza- Luces C, Lucia A. Exercise interventions and cardiovas-</span></p>
<p style="top:212.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cular health in childhood cancer: a meta- analysis. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Int J Sports Med</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:221.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2020;41:141&#x2013; 153. DOI: 10.1055/a- 1073- 8104.</span></p>
<p style="top:230.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 13. Krischke M, Hempel G, V&#xf6;ller S, Andr&#xe9; N, D&#x2019;Incalci M, Bisogno G, </span></p>
<p style="top:239.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">K&#xf6;pcke W, Borowski M, Herold R, Boddy AV, et al. Pharmacokinetic </span></p>
<p style="top:248.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and pharmacodynamic study of doxorubicin in children with cancer: </span></p>
<p style="top:257.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">results of a &#x201c;European Pediatric Oncology Off- patents Medicines </span></p>
<p style="top:266.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Consortium&#x201d; trial. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cancer Chemother Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2016;78:1175&#x2013; 1184. </span></p>
<p style="top:275.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DOI: 10.1007/s0028 0- 016- 3174- 8.</span></p>
<p style="top:284.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 14. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, </span></p>
<p style="top:293.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Colan SD. Chronic progressive cardiac dysfunction years after doxoru-</span></p>
<p style="top:302.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">bicin therapy for childhood acute lymphoblastic leukemia. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Clin Oncol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:311.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2005;23:2629&#x2013; 2636. DOI: 10.1200/jco.2005.12.121.</span></p>
<p style="top:320.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 15. Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch </span></p>
<p style="top:329.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">VA. Cochrane handbook for systematic reviews of interventions. In: </span></p>
<p style="top:338.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Cochrane Handbook for Systematic Reviews of Interventions. Version </span></i></p>
<p style="top:347.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">6.0</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. Chichester, United Kingdom: John Wiley &amp; Sons Ltd; 2019.</span></p>
<p style="top:356.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 16. Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ristkes- Hoitinga </span></p>
<p style="top:365.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">M, Langendam MW. SYRCLE&#x2019;s risk of bias tool for animal studies. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">BMC </span></i></p>
<p style="top:374.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Med Res Methodol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2014;14:1&#x2013; 9. DOI: 10.1186/1471- 2288- 14- 43.</span></p>
<p style="top:383.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 17. Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman </span></p>
<p style="top:392.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">AD, Savovi</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x107;</span><span style="font-family:Arial,serif;font-size:7.0pt"> J, Schulz KF, Weeks L, Sterne JAC. The Cochrane </span></p>
<p style="top:401.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Collaboration&#x2019;s tool for assessing risk of bias in randomised trials. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">BMJ</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:410.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2011;343:1&#x2013; 9. DOI: 10.1136/bmj.d5928.</span></p>
<p style="top:419.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 18. Kavazis AN, Smuder AJ, Powers SK. Effects of short- term endurance </span></p>
<p style="top:428.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise training on acute doxorubicin- induced FoxO transcription in </span></p>
<p style="top:437.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiac and skeletal muscle. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Appl Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2014;117:223&#x2013; 230. DOI: </span></p>
<p style="top:446.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1152/jappl physi ol.00210.2014.</span></p>
<p style="top:455.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 19. Kirkham AA, Shave RE, Bland KA, Bovard JM, Eves ND, Gelmon KA, </span></p>
<p style="top:464.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">McKenzie DC, Virani SA, St&#xf6;hr EJ, Warburton D, et al. Protective effects </span></p>
<p style="top:473.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of acute exercise prior to doxorubicin on cardiac function of breast can-</span></p>
<p style="top:482.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cer patients: a proof- of- concept RCT. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Int J Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2017;245:263&#x2013; 270. </span></p>
<p style="top:491.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DOI: 10.1016/j.ijcard.2017.07.037.</span></p>
<p style="top:500.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 20. Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, </span></p>
<p style="top:509.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Virani SA, McKenzie DC, St&#xf6;hr EJ, Waburton DE, et al. The effect of </span></p>
<p style="top:518.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">an aerobic exercise bout 24 h prior to each doxorubicin treatment for </span></p>
<p style="top:527.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">breast cancer on markers of cardiotoxicity and treatment symptoms: a </span></p>
<p style="top:536.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">RCT. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Breast Cancer Res Treat</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;167:719&#x2013; 729. DOI: 10.1007/s1054 </span></p>
<p style="top:545.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">9- 017- 4554- 4.</span></p>
<p style="top:554.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 21. Ma Z. Effect of anthracycline combined with aerobic exercise on the </span></p>
<p style="top:563.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">treatment of breast cancer. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Pak J Pharm Sci</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;31:1125&#x2013; 1129.</span></p>
<p style="top:572.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 22. Ahmadian M, Dabidi RV. Modulatory effect of aerobic exercise train-</span></p>
<p style="top:581.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ing on doxorubicin- induced cardiotoxicity in rats with different ages. </span></p>
<p style="top:590.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiovasc Toxicol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;18:33&#x2013; 42. DOI: 10.1007/s1201 2- 017- 9411- 5.</span></p>
<p style="top:599.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 23. Alihemmati A, Ebadi F, Moghadaszadeh M, Asadi M, Zare P, Badalzadeh </span></p>
<p style="top:608.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">R. Effects of high- intensity interval training on the expression of mi-</span></p>
<p style="top:617.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">croRNA- 499 and pro- and anti- apoptotic genes in doxorubicin- </span></p>
<p style="top:626.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiotoxicity in rats. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Electrocardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;55:9&#x2013; 15. DOI: 10.1016/j.</span></p>
<p style="top:635.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">jelec troca rd.2019.02.009.</span></p>
<p style="top:644.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 24. Ascens&#xe3;o A, Ferreira R, Oliveira PJ, Magalh&#xe3;es J. Effects of endurance </span></p>
<p style="top:653.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">training and acute doxorubicin treatment on rat heart mitochondrial al-</span></p>
<p style="top:662.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">terations induced by in vitro anoxia- reoxygenation. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiovasc Toxicol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:671.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2006;6:159&#x2013; 172. DOI: 10.1385/CT:6:3:159.</span></p>
<p style="top:680.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 25. Ascens&#xe3;o A, Lumini- Oliveira J, Machado NG, Ferreira RM, Gon&#xe7;alves </span></p>
<p style="top:689.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">IO, Moreira AC, Marques F, Sard&#xe3;o VA, Oliveira PJ, Magalh&#xe3;es J. Acute </span></p>
<p style="top:698.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">exercise protects against calcium- induced cardiac mitochondrial per-</span></p>
<p style="top:707.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">meability transition pore opening in doxorubicin- treated rats. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Clin Sci</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:716.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2011;120:37&#x2013; 49. DOI: 10.1042/CS201 00254.</span></p>
<p style="top:59.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 26. Ascens&#xe3;o A, Magalh&#xe3;es J, Soares JM, Ferreira R, Neuparth MJ, </span></p>
<p style="top:68.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marques F, Oliveira PJ, Duarte JA. Moderate endurance training pre-</span></p>
<p style="top:77.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">vents doxorubicin- induced in vivo mitochondriopathy and reduces the </span></p>
<p style="top:86.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">development of cardiac apoptosis. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Heart Circ Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:95.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2005;289:H722&#x2013; H731. DOI: 10.1152/ajphe art.01249.2004.</span></p>
<p style="top:104.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 27. Ascens&#xe3;o A, Magalh&#xe3;es J, Soares J, Ferreira R, Neuparth M, Marques </span></p>
<p style="top:113.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">F, Oliveira J, Duarte J. Endurance training attenuates doxorubicin- </span></p>
<p style="top:122.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">induced cardiac oxidative damage in mice. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Int J Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2005;100:451&#x2013; </span></p>
<p style="top:131.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">460. DOI: 10.1016/j.ijcard.2004.11.004.</span></p>
<p style="top:140.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 28. Ashrafi J, Roshan VD. Is short- term exercise a therapeutic tool for im-</span></p>
<p style="top:149.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">provement of cardioprotection against DOX- induced cardiotoxicity? </span></p>
<p style="top:158.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">An experimental controlled protocol in rats. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Asian Pac J Cancer Prev</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:167.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2012;13:4025&#x2013; 4030. DOI: 10.7314/APJCP.2012.13.8.4025.</span></p>
<p style="top:176.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 29. Chicco AJ, Schneider CM, Hayward R. Voluntary exercise protects </span></p>
<p style="top:185.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">against acute doxorubicin cardiotoxicity in the isolated perfused rat </span></p>
<p style="top:194.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">heart. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Integr Comp Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2005;289:R424&#x2013; R431. DOI: </span></p>
<p style="top:203.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1152/ajpre gu.00636.2004.</span></p>
<p style="top:212.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 30. Chicco AJ, Hydock DS, Schneider CM, Hayward R. Low- intensity ex-</span></p>
<p style="top:221.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ercise training during doxorubicin treatment protects against cardio-</span></p>
<p style="top:230.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">toxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Appl Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2006;100:519&#x2013; 527. DOI: 10.1152/jappl physi </span></p>
<p style="top:239.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ol.00148.2005.</span></p>
<p style="top:248.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 31. Chicco AJ, Schneider CM, Hayward R. Exercise training attenuates acute </span></p>
<p style="top:257.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced cardiac dysfunction. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Cardiovasc Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:266.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2006;47:182&#x2013; 189. DOI: 10.1097/01.fjc.00001 99682.43448.2d.</span></p>
<p style="top:275.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 32. Dolinsky VW, Rogan KJ, Sung MM, Zordoky BN, Haykowsky MJ, Young </span></p>
<p style="top:284.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ME, Jones LW, Dyck JR. Both aerobic exercise and resveratrol sup-</span></p>
<p style="top:293.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">plementation attenuate doxorubicin- induced cardiac injury in mice. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am </span></i></p>
<p style="top:302.1pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">J Physiol Endocrinol Metab</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2013;305:E243&#x2013; E253. DOI: 10.1152/ajpen </span></p>
<p style="top:311.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">do.00044.2013.</span></p>
<p style="top:320.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 33. Farzanegi P, Asadi M, Abdi A, Etemadian M, Amani M, Amrollah V, </span></p>
<p style="top:329.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Shahri F, Gholami V, Abdi Z, Moradi L, et al. Swimming exercise in </span></p>
<p style="top:338.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">combination with garlic extract administration as a therapy against </span></p>
<p style="top:347.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced hepatic, heart and renal toxicity to rats. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Toxin Rev</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:356.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2019;39:434&#x2013; 443. DOI: 10.1080/15569 543.2018.1559194.</span></p>
<p style="top:365.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 34. Hall SE, Smuder AJ, Hayward R. Effects of calorie restriction and volun-</span></p>
<p style="top:374.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">tary exercise on doxorubicin- induced cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Integr Cancer Ther</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:383.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2019;18:1534735419843999. DOI: 10.1177/15347 35419 843999.</span></p>
<p style="top:392.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 35. Hydock DS, Lien CY, Schneider CM, Hayward R. Exercise precondi-</span></p>
<p style="top:401.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">tioning protects against doxorubicin- induced cardiac dysfunction. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Med </span></i></p>
<p style="top:410.2pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Sci Sports Exerc</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2008;40:808&#x2013; 817. DOI: 10.1249/MSS.0b013 e3181 </span></p>
<p style="top:419.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">63744a.</span></p>
<p style="top:428.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 36. Hydock DS, Wonders KY, Schneider CM, Hayward R. Voluntary wheel </span></p>
<p style="top:437.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">running in rats receiving doxorubicin: effects on running activity and </span></p>
<p style="top:446.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiac myosin heavy chain. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Anticancer Res</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2009;29:4401&#x2013; 4407.</span></p>
<p style="top:455.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 37. Hydock DS, Lien CY, Jensen BT, Schneider CM, Hayward R. Exercise </span></p>
<p style="top:464.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">preconditioning provides long- term protection against early chronic </span></p>
<p style="top:473.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Integr Cancer Ther</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2011;10:47&#x2013; 57. DOI: </span></p>
<p style="top:482.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1177/15347 35410 392577.</span></p>
<p style="top:491.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 38. Hydock DS, Lien CY, Jensen BT, Parry TL, Schneider CM, Hayward R. </span></p>
<p style="top:500.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Exp </span></i></p>
<p style="top:509.2pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Biol Med</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2012;237:1483&#x2013; 1492. DOI: 10.1258/ebm.2012.012137.</span></p>
<p style="top:518.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 39. Jensen BT, Lien CY, Hydock DS, Schneider CM, Hayward R. Exercise </span></p>
<p style="top:527.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitigates cardiac doxorubicin accumulation and preserves function </span></p>
<p style="top:536.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in the rat. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Cardiovasc Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2013;62:263&#x2013; 269. DOI: 10.1097/</span></p>
<p style="top:545.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">FJC.0b013 e3182 982ce0.</span></p>
<p style="top:554.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 40. Ji LL, Mitchell EW. Effects of adriamycin on heart mitochondrial function </span></p>
<p style="top:563.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in rested and exercised rats. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Biochem Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 1994;47:877&#x2013; 885. </span></p>
<p style="top:572.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DOI: 10.1016/0006- 2952(94)90488 - X.</span></p>
<p style="top:581.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 41. Kanter MM, Hamlin RL, Unverferth DV, Davis HW, Merola AJ. Effect </span></p>
<p style="top:590.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of exercise training on antioxidant enzymes and cardiotoxicity of </span></p>
<p style="top:599.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Appl Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 1985;59:1298&#x2013; 1303. DOI: 10.1152/</span></p>
<p style="top:608.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">jappl.1985.59.4.1298.</span></p>
<p style="top:617.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 42. Kavazis AN, Smuder AJ, Min K, T&#xfc;mer N, Powers SK. Short- term ex-</span></p>
<p style="top:626.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ercise training protects against doxorubicin- induced cardiac mitochon-</span></p>
<p style="top:635.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">drial damage independent of HSP72. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Heart Circ Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:644.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2010;299:H1515&#x2013; H1524. DOI: 10.1152/ajphe art.00585.2010.</span></p>
<p style="top:653.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 43. Lee Y, Kwon I, Jang Y, Cosio- Lima L, Barrington P. Endurance exercise </span></p>
<p style="top:662.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">attenuates doxorubicin- induced cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Med Sci Sports Exerc</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:671.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2020;52:25&#x2013; 36. DOI: 10.1249/MSS.00000 00000 002094.</span></p>
<p style="top:680.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 44. Lien CY, Jensen BT, Hydock DS, Hayward R. Short- term exercise train-</span></p>
<p style="top:689.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ing attenuates acute doxorubicin cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Physiol Biochem</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:698.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2015;71:669&#x2013; 678. DOI: 10.1007/s1310 5- 015- 0432- x.</span></p>
<p style="top:707.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 45. Mackay AD, Marchant ED, Munk DJ, Watt RK, Hansen JM, Thomson </span></p>
<p style="top:716.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DM, Hancock CR. Multitissue analysis of exercise and metformin on </span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">22</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced iron dysregulation. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Endocrinol </span></i></p>
<p style="top:67.9pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Metab</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;316:E922&#x2013; E930. DOI: 10.1152/ajpen do.00140.2018.</span></p>
<p style="top:76.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 46. Marques- Aleixo I, Santos- Alves E, Mariani D, Rizo- Roca D, Padr&#xe3;o AI, </span></p>
<p style="top:85.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Rocha- Rodrigues S, Viscor G, Torrella JR, Ferreira R, Oliveira PJ, et </span></p>
<p style="top:94.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">al. Physical exercise prior and during treatment reduces sub- chronic </span></p>
<p style="top:103.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced mitochondrial toxicity and oxidative stress. </span></p>
<p style="top:112.9pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Mitochondrion</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2015;20:22&#x2013; 33. DOI: 10.1016/j.mito.2014.10.008.</span></p>
<p style="top:121.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 47. Marques- Aleixo I, Santos- Alves E, Torrella JR, Oliveira PJ, Magalh&#xe3;es </span></p>
<p style="top:130.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">J, Ascens&#xe3;o A. Exercise and doxorubicin treatment modulate cardiac </span></p>
<p style="top:139.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mitochondrial quality control signaling. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiovasc Toxicol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;18:43&#x2013; </span></p>
<p style="top:148.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">55. DOI: 10.1007/s1201 2- 017- 9412- 4.</span></p>
<p style="top:157.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 48. Morton AB, Mor Huertas A, Hinkley JM, Ichinoseki- Sekine N, </span></p>
<p style="top:166.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Christou DD, Smuder AJ. Mitochondrial accumulation of doxorubicin </span></p>
<p style="top:176.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in cardiac and diaphragm muscle following exercise preconditioning. </span></p>
<p style="top:185.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Mitochondrion</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;45:52&#x2013; 62. DOI: 10.1016/j.mito.2018.02.005.</span></p>
<p style="top:194.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 49. Parry TL, Hayward R. Exercise training does not affect doxorubicin </span></p>
<p style="top:203.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">anti- tumor efficacy while attenuating cardiac dysfunction. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol </span></i></p>
<p style="top:212.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Regul Integr Comp Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2015;309:R675&#x2013; R683. DOI: 10.1152/ajpre </span></p>
<p style="top:221.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">gu.00185.2015.</span></p>
<p style="top:230.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 50. Pfannenstiel K, Hayward R. Effects of resistance exercise training </span></p>
<p style="top:239.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">on doxorubicin- induced cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Cardiovasc Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:248.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2018;71:332&#x2013; 339. DOI: 10.1097/FJC.00000 00000 000574.</span></p>
<p style="top:257.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 51. Phungphong S, Kijtawornrat A, Kampaengsri T, Wattanapermpool J, </span></p>
<p style="top:266.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Bupha- Intr T. Comparison of exercise training and estrogen supple-</span></p>
<p style="top:275.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">mentation on mast cell- mediated doxorubicin- induced cardiotoxicity. </span></p>
<p style="top:284.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Regul Integr Comp Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2020;318:R829&#x2013; R842. DOI: </span></p>
<p style="top:293.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1152/ajpre gu.00224.2019.</span></p>
<p style="top:302.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 52. Shirinbayan V, Roshan VD. Pretreatment effect of running exercise on </span></p>
<p style="top:311.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">HSP 70 and DOX- induced cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Asian Pac J Cancer Prev</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:320.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2012;13:5849&#x2013; 5855. DOI: 10.7314/apjcp.2012.13.11.5849.</span></p>
<p style="top:329.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 53. Smuder AJ, Kavazis AN, Min K, Powers SK. Doxorubicin- induced </span></p>
<p style="top:338.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">markers of myocardial autophagic signaling in sedentary and exercise </span></p>
<p style="top:347.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">trained animals. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Appl Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2013;115:176&#x2013; 185. DOI: 10.1152/jappl </span></p>
<p style="top:356.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">physi ol.00924.2012.</span></p>
<p style="top:365.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 54. Sturgeon K, Schadler K, Muthukumaran G, Ding D, Bajulaiye A, Thomas </span></p>
<p style="top:374.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">NJ, Ferrari V, Ryeom S, Libonati JR. Concomitant low- dose doxorubi-</span></p>
<p style="top:383.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cin treatment and exercise. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J Physiol Regul Integr Comp Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:392.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2014;307:R685&#x2013; R692. DOI: 10.1152/ajpre gu.00082.2014.</span></p>
<p style="top:401.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 55. Werner C, Hanhoun M, Widmann T, Kazakov A, Semenov A, P&#xf6;ss </span></p>
<p style="top:410.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">J, Bauersachs J, Thum T, Pfreundschuh M, M&#xfc;ller P, et al. Effects of </span></p>
<p style="top:419.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">physical exercise on myocardial telomere- regulating proteins, survival </span></p>
<p style="top:428.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">pathways, and apoptosis. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Am Coll Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2008;52:470&#x2013; 482. DOI: </span></p>
<p style="top:437.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1016/j.jacc.2008.04.034.</span></p>
<p style="top:446.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 56. Wonders KY, Hydock DS, Schneider CM, Hayward R. Acute exer-</span></p>
<p style="top:455.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cise protects against doxorubicin cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Integr Cancer Ther</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:464.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2008;7:21&#x2013; 24. DOI: 10.1177/15347 35408 322848.</span></p>
<p style="top:473.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 57. Yang HL, Hsieh PL, Hung CH, Cheng HC, Chou WC, Chu PM, Chang </span></p>
<p style="top:482.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">YC, Tsai KL. Early moderate intensity aerobic exercise intervention </span></p>
<p style="top:491.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">prevents doxorubicin- caused cardiac dysfunction through inhibition of </span></p>
<p style="top:500.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiac fibrosis and inflammation. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cancers (Basel)</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2020;12:1102. DOI: </span></p>
<p style="top:509.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.3390/cance rs120 51102.</span></p>
<p style="top:518.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 58. Kolwicz SC, Tian R. Assessment of cardiac function and energetics </span></p>
<p style="top:527.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in isolated mouse hearts using 31P NMR spectroscopy. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Vis Exp</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:536.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2010;42:2069. DOI: 10.3791/2069.</span></p>
<p style="top:545.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 59. &#x160;im</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x16f;</span><span style="font-family:Arial,serif;font-size:7.0pt">nek T, &#x160;t</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x11b;</span><span style="font-family:Arial,serif;font-size:7.0pt">rba M, Popelov&#xe1; O, Adamcov&#xe1; M, Hrdina R, Ger&#x161;i V. </span></p>
<p style="top:554.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Anthracycline- induced cardiotoxicity: overview of studies examining </span></p>
<p style="top:563.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">the roles of oxidative stress and free cellular iron. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Pharmacol Rep</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:572.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2009;61:154&#x2013; 171. DOI: 10.1016/S1734 - 1140(09)70018 - 0.</span></p>
<p style="top:581.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 60. Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad </span></p>
<p style="top:590.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">SV, Mutharasan RK, Jairaj Naik T, Ardehali H. Cardiotoxicity of doxoru-</span></p>
<p style="top:599.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">bicin is mediated through mitochondrial iron accumulation. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Clin Invest</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:608.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2014;124:617&#x2013; 630. DOI: 10.1172/JCI72931.</span></p>
<p style="top:617.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 61. Takemura G, Fujiwara H Doxorubicin- induced cardiomyopathy. From </span></p>
<p style="top:626.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">the cardiotoxic mechanisms to management. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Prog Cardiovasc Dis</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:635.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2007;49:330&#x2013; 352. DOI: 10.1016/j.pcad.2006.10.002.</span></p>
<p style="top:644.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 62. Benjamin IJ, McMillan DR. Stress (heat shock) proteins: molecular chap-</span></p>
<p style="top:653.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">erones in cardiovascular biology and disease. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Circ Res</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 1998;83:117&#x2013; </span></p>
<p style="top:662.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">132. DOI: 10.1161/01.RES.83.2.117.</span></p>
<p style="top:671.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 63. Tanaka R, Umemura M, Narikawa M, Hikichi M, Osaw K, Fujita T, </span></p>
<p style="top:680.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Yokoyama U, Ishigami T, Tamura K, Ishikawa Y. Reactive fibrosis pre-</span></p>
<p style="top:689.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cedes doxorubicin- induced heart failure through sterile inflammation. </span></p>
<p style="top:698.1pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">ESC Heart Fail</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2020;7:588&#x2013; 603. DOI: 10.1002/ehf2.12616.</span></p>
<p style="top:707.1pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 64. Arai M, Tomaru K, Takizawa T, Sekiguchi K, Yokoyama T, Suzuki T, </span></p>
<p style="top:716.1pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Nagai R. Sarcoplasmic reticulum genes are selectively down- regulated </span></p>
<p style="top:59.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in cardiomyopathy produced by doxorubicin in rabbits. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Mol Cell </span></i></p>
<p style="top:68.1pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 1998;30:243&#x2013; 254. DOI: 10.1006/jmcc.1997.0588.</span></p>
<p style="top:77.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 65. Hof IE, van der Heijden JF, Kranias EG, Sanoudou D, de Boer RA, van </span></p>
<p style="top:86.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Tintelen JP, van der Zwaag PA, Doevendans PA. Prevalence and car-</span></p>
<p style="top:95.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">diac phenotype of patients with a phospholamban mutation. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Neth Heart </span></i></p>
<p style="top:104.1pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">J</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;27:64&#x2013; 69. DOI: 10.1007/s1247 1- 018- 1211- 4.</span></p>
<p style="top:113.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 66. Parks RJ, Murphy E, Liu JC. Mitochondrial permeability transition pore </span></p>
<p style="top:122.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and calcium handling. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Methods Mol Biol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;1782:187&#x2013; 196. DOI: </span></p>
<p style="top:131.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1007/978- 1- 4939- 7831- 1_11.</span></p>
<p style="top:140.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 67. Liang H, Ward WF. PGC- 1alpha: a key regulator of energy metabolism. </span></p>
<p style="top:149.1pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Adv Physiol Educ</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2006;30:145&#x2013; 151. DOI: 10.1152/advan.00052.2006.</span></p>
<p style="top:158.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 68. K&#xe4;rkk&#xe4;inen O, Tuomainen T, Mutikainen M, Lehtonen M, Ruas JL, </span></p>
<p style="top:167.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Hanhineva K, Tavi P. Heart specific PGC- 1</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x3b1;</span><span style="font-family:Arial,serif;font-size:7.0pt"> deletion identifies metab-</span></p>
<p style="top:176.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">olome of cardiac restricted metabolic heart failure. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiovasc Res</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:185.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2019;115:107&#x2013; 118. DOI: 10.1093/cvr/cvy155.</span></p>
<p style="top:194.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 69. de Beer EL, Bottone AE, van Der Velden J, Voest EE. Doxorubicin </span></p>
<p style="top:203.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">impairs crossbridge turnover kinetics in skinned cardiac trabec-</span></p>
<p style="top:212.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ulae after acute and chronic treatment. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Mol Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2000;57:   </span></p>
<p style="top:221.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">1152&#x2013; 1157.</span></p>
<p style="top:230.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 70. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mech-</span></p>
<p style="top:239.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">anisms. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Pathol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2010;221:3&#x2013; 12. DOI: 10.1002/path.2697.</span></p>
<p style="top:248.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 71. Koleini N, Kardami E. Autophagy and mitophagy in the context of </span></p>
<p style="top:257.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">doxorubicin- induced cardiotoxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Oncotarget</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2017;8:46663&#x2013; 46680. </span></p>
<p style="top:266.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DOI: 10.18632/ oncot arget.16944.</span></p>
<p style="top:275.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 72. Zhang S, Liu X, Bawa- Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. </span></p>
<p style="top:284.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Identification of the molecular basis of doxorubicin- induced cardiotox-</span></p>
<p style="top:293.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">icity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Nat Med</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2012;18:1639&#x2013; 1642. DOI: 10.1038/nm.2919.</span></p>
<p style="top:302.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 73. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovi</span><span style="font-family:NotoSans,serif;font-size:7.0pt">&#x107;</span><span style="font-family:Arial,serif;font-size:7.0pt"> ZB, </span></p>
<p style="top:311.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Marwick TH. Reproducibility of echocardiographic techniques for se-</span></p>
<p style="top:320.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">quential assessment of left ventricular ejection fraction and volumes: </span></p>
<p style="top:329.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">application to patients undergoing cancer chemotherapy. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Am Coll </span></i></p>
<p style="top:338.1pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2013;61:77&#x2013; 84. DOI: 10.1016/j.jacc.2012.09.035.</span></p>
<p style="top:347.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 74. Plana JC, Thavendiranathan P, Bucciarelli- Ducci C, Lancellotti P. Multi- </span></p>
<p style="top:356.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">modality imaging in the assessment of cardiovascular toxicity in the </span></p>
<p style="top:365.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cancer patient. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">JACC Cardiovasc Imaging</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;11:1173&#x2013; 1186. DOI: </span></p>
<p style="top:374.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1016/j.jcmg.2018.06.003.</span></p>
<p style="top:383.1pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 75. Keats MR, Grandy SA, Giacomantonio N, MacDonald D, Rajda M, Younis </span></p>
<p style="top:392.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">T. EXercise to prevent AnthrCycline- based Cardio- Toxicity (EXACT) </span></p>
<p style="top:401.1pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in individuals with breast or hematological cancers: a feasibility study </span></p>
<p style="top:410.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">protocol. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Pilot Feasibility Stud</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2016;2:44. DOI: 10.1186/s4081 4- 016-   </span></p>
<p style="top:419.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">0084- 9.</span></p>
<p style="top:428.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 76. ClinicalTrials.gov [Internet]. Clin. Identifier NCT03748550. Available at: </span></p>
<p style="top:437.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">https://www.clini caltr ials.gov/ct2/show/NCT03 74855 0?cond=NCT03 </span></p>
<p style="top:446.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">74855 0&amp;draw=2&amp;rank=1. Accessed December 20, 2020.</span></p>
<p style="top:455.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 77. Netherlands Trial Register [Internet]. NTR 7042. Available at: https://</span></p>
<p style="top:464.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">www.trial regis ter.nl/trial/ 7042. Accessed October 16, 2020.</span></p>
<p style="top:473.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 78. Zacchigna S, Paldino A, Falc&#xe3;o- Pires I, Daskalopoulos EP, Dal Ferro </span></p>
<p style="top:482.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">M, Vodret S, Lesizza P, Cannat&#xe0; A, Miranda- Silva D, Louren&#xe7;o AP, et </span></p>
<p style="top:491.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">al. Toward standardization of echocardiography for the evaluation of </span></p>
<p style="top:500.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">left ventricular function in adult rodents: a position paper of the ESC </span></p>
<p style="top:509.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Working Group on Myocardial Function. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cardiovasc Res</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2021;117:43&#x2013; </span></p>
<p style="top:518.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">59. DOI: 10.1093/cvr/cvaa110.</span></p>
<p style="top:527.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 79. Reichelt ME, Willems L, Hack BA, Peart JN, Headrick JP. Cardiac and </span></p>
<p style="top:536.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">coronary function in the Langendorff- perfused mouse heart model. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Exp </span></i></p>
<p style="top:545.2pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2009;94:54&#x2013; 70. DOI: 10.1113/expph ysiol.2008.043554.</span></p>
<p style="top:554.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 80. Vincent DT, Ibrahim YF, Espey MG, Suzuki YJ. The role of antioxi-</span></p>
<p style="top:563.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">dants in the era of cardio- oncology. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cancer Chemother Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:572.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2013;72:1157&#x2013; 1168. DOI: 10.1007/s0028 0- 013- 2260- 4.</span></p>
<p style="top:581.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 81. van Asperen J, van Tellingen O, Tijssen F, Schinkel AH, Beijnen JH. </span></p>
<p style="top:590.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Increased accumulation of doxorubicin and doxorubicinol in cardiac </span></p>
<p style="top:599.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">tissue of mice lacking mdr1a P- glycoprotein. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Br J Cancer</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 1999;79:108&#x2013; </span></p>
<p style="top:608.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">113. DOI: 10.1038/sj.bjc.6690019.</span></p>
<p style="top:617.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 82. Wang F, Iskra B, Kleinerman E, Alvarez- Florez C, Andrews T, Shaw A, </span></p>
<p style="top:626.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Chandra J, Schadler K, Aune GJ. Aerobic exercise during early mu-</span></p>
<p style="top:635.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">rine doxorubicin exposure mitigates cardiac toxicity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Pediatr Hematol </span></i></p>
<p style="top:644.2pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Oncol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2018;40:208&#x2013; 215. DOI: 10.1097/MPH.00000 00000 001112.</span></p>
<p style="top:653.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 83. Sturgeon K, Muthukumaran G, Ding D, Bajulaiye A, Ferrari V, Libonati </span></p>
<p style="top:662.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">JR. Moderate- intensity treadmill exercise training decreases murine </span></p>
<p style="top:671.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiomyocyte cross- sectional area. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Physiol Rep</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2015;3:e12406. DOI: </span></p>
<p style="top:680.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.14814/ phy2.12406.</span></p>
<p style="top:689.2pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 84. Parry TL, Hydock DS, Jensen BT, Lien CY, Schneider CM, Hayward </span></p>
<p style="top:698.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">R. Endurance exercise attenuates cardiotoxicity induced by androgen </span></p>
<p style="top:707.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">deprivation and doxorubicin. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Can J Physiol Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2014;92:356&#x2013; </span></p>
<p style="top:716.2pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">362. DOI: 10.1139/cjpp- 2013- 0294.</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:751.9pt;left:54.6pt;line-height:8.0pt"><i><span style="font-family:Arial,serif;font-size:8.0pt">J Am Heart Assoc.</span></i><span style="font-family:Arial,serif;font-size:8.0pt"> 2021;10:e021580. DOI: 10.1161/JAHA.121.021580</span><span style="font-family:Arial,serif;font-size:8.0pt"> </span></p>
<p style="top:751.9pt;left:531.7pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">23</span></p>
<p style="top:24.8pt;left:54.6pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Naaktgeboren et al </span></p>
<p style="top:24.8pt;left:414.4pt;line-height:8.0pt"><span style="font-family:Arial,serif;font-size:8.0pt">Physical Exercise and Cardiotoxicity</span></p>
<p style="top:58.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 85. Sharifi F, Roshan VD, Mazaheri Z. Effect of pretreatment of aerobic </span></p>
<p style="top:67.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">training on doxorubicininduced left ventricular apoptosis gene ex-</span></p>
<p style="top:76.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">pression in aging rat model. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Modares J Med Sci Pathobiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2016;19:   </span></p>
<p style="top:85.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">29&#x2013; 43.</span></p>
<p style="top:94.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 86. Shimauchi T, Numaga- Tomita T, Ito T, Nishimura A, Matsukane R, Oda </span></p>
<p style="top:103.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">S, Hoka S, Ide T, Koitabashi N, Uchida K, et al. TRPC3- Nox2 com-</span></p>
<p style="top:112.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">plex mediates doxorubicin- induced myocardial atrophy. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">JCI insight</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. </span></p>
<p style="top:121.9pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">2017;2:e93358. DOI: 10.1172/jci.insig ht.93358.</span></p>
<p style="top:130.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 87. Wonders KY, Hydock DS, Greufe S, Schneider CM, Hayward R. </span></p>
<p style="top:139.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Endurance exercise training preserves cardiac function in rats receiv-</span></p>
<p style="top:148.9pt;left:70.2pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ing doxorubicin and the HER- 2 inhibitor GW2974. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cancer Chemother </span></i></p>
<p style="top:157.9pt;left:70.2pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2009;64:1105&#x2013; 1113. DOI: 10.1007/s0028 0- 009- 0967- z.</span></p>
<p style="top:166.9pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 88. Calv&#xe9; A, Haddad R, Barama SN, Meilleur M, Sebag IA, Chalifour LE. </span></p>
<p style="top:176.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Cardiac response to doxorubicin and dexrazoxane in intact and ova-</span></p>
<p style="top:185.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">riectomized young female rats at rest and after swim training. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Am J </span></i></p>
<p style="top:194.0pt;left:70.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Physiol Heart Circ Physiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2012;302:H2048&#x2013; H2057. DOI: 10.1152/ajphe </span></p>
<p style="top:203.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">art.01069.2011.</span></p>
<p style="top:212.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 89. Hayward R, Lien CY, Jensen BT, Hydock DS, Schneider CM. Exercise </span></p>
<p style="top:221.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">training mitigates anthracycline- induced chronic cardiotoxicity in a juve-</span></p>
<p style="top:230.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">nile rat model. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Pediatr Blood Cancer</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2012;59:149&#x2013; 154. DOI: 10.1002/</span></p>
<p style="top:239.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">pbc.23392.</span></p>
<p style="top:248.0pt;left:54.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 90. Howden EJ, Bigaran A, Beaudry R, Fraser S, Selig S, Foulkes S, Antill </span></p>
<p style="top:257.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Y, Nightingale S, Loi S, Haykowsky MJ, et al. Exercise as a diagnostic </span></p>
<p style="top:266.0pt;left:70.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">and therapeutic tool for the prevention of cardiovascular dysfunction </span></p>
<p style="top:59.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">in breast cancer patients. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Eur J Prev Cardiol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2019;26:305&#x2013; 315. DOI: </span></p>
<p style="top:68.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.1177/20474 87318 811181.</span></p>
<p style="top:77.0pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 91. Hydock DS, Parry TL, Jensen BT, Lien CY, Schneider CM, Hayward R. </span></p>
<p style="top:86.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Effects of endurance training on combined goserelin acetate and doxo-</span></p>
<p style="top:95.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">rubicin treatment- induced cardiac dysfunction. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cancer Chemother </span></i></p>
<p style="top:104.0pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Pharmacol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2011;68:685&#x2013; 692. DOI: 10.1007/s0028 0- 010- 1523- 6.</span></p>
<p style="top:113.0pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 92. Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, </span></p>
<p style="top:122.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Kwan ML, Quesenberry CP, Scott J, Sternfeld B, et al. Exercise and risk </span></p>
<p style="top:131.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of cardiovascular events in women with nonmetastatic breast cancer. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J </span></i></p>
<p style="top:140.0pt;left:322.1pt;line-height:7.0pt"><i><span style="font-family:Arial,serif;font-size:7.0pt">Clin Oncol</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2016;34:2743&#x2013; 2749. DOI: 10.1200/JCO.2015.65.6603.</span></p>
<p style="top:149.0pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 93. Krause MS, Oliveira LP, Silveira EM, Vianna DR, Rossato JS, Almeida </span></p>
<p style="top:158.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">BS, Rodrigues MF, Fernandes AJ, Costa JA, Curi R, et al. MRP1/GS- X </span></p>
<p style="top:167.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">pump ATPase expression: is this the explanation for the cytoprotection </span></p>
<p style="top:176.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">of the heart against oxidative stress- induced redox imbalance in com-</span></p>
<p style="top:185.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">parison to skeletal muscle cells? </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Cell Biochem Funct</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2007;25:23&#x2013; 32. </span></p>
<p style="top:194.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">DOI: 10.1002/cbf.1343.</span></p>
<p style="top:203.0pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 94. Matsuura C, Brunini TM, Carvalho LC, Resende AC, Carvalho JJ, de </span></p>
<p style="top:212.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">Castro JP, Mendes- Ribeiro AC. Exercise training in doxorubicin- induced </span></p>
<p style="top:221.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">heart failure: effects on the L- arginine- NO pathway and vascular reactiv-</span></p>
<p style="top:230.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">ity. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">J Am Soc Hypertens</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2010;4:7&#x2013; 13. DOI: 10.1016/j.jash.2009.10.005.</span></p>
<p style="top:239.0pt;left:306.6pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt"> 95. Nagy AC, GulAcsi- BArdos P, CserEp Z, Hangody L, Forster T. Late </span></p>
<p style="top:248.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cardiac effect of anthracycline therapy in physically active breast can-</span></p>
<p style="top:257.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">cer survivors -  a prospective study. </span><i><span style="font-family:Arial,serif;font-size:7.0pt">Neoplasma</span></i><span style="font-family:Arial,serif;font-size:7.0pt">. 2017;64:92&#x2013; 100. DOI: </span></p>
<p style="top:266.0pt;left:322.1pt;line-height:7.0pt"><span style="font-family:Arial,serif;font-size:7.0pt">10.4149/neo_2017_111.</span></p>
<p style="top:388.8pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:87.2pt;left:297.5pt;line-height:28.0pt"><span style="font-family:Calibri,sans-serif;font-size:28.0pt"> </span></p>
<p style="top:135.7pt;left:297.5pt;line-height:28.0pt"><span style="font-family:Calibri,sans-serif;font-size:28.0pt"> </span></p>
<p style="top:184.1pt;left:297.5pt;line-height:28.0pt"><span style="font-family:Calibri,sans-serif;font-size:28.0pt"> </span></p>
<p style="top:232.5pt;left:297.5pt;line-height:28.0pt"><span style="font-family:Calibri,sans-serif;font-size:28.0pt"> </span></p>
<p style="top:281.0pt;left:169.0pt;line-height:28.0pt"><span style="font-family:Calibri,sans-serif;font-size:28.0pt">Supplemental Material </span></p>
<p style="top:316.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:343.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:74.0pt;left:70.9pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Data S1. </span></b></p>
<p style="top:100.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:129.1pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Supplemental Methods  </span></p>
<p style="top:161.9pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Search strings </span></p>
<p style="top:194.7pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Pubmed</span><span style="font-family:SegoeUI,sans-serif;font-size:16.0pt"> </span><span style="font-family:Calibri,sans-serif;font-size:16.0pt"> </span></p>
<p style="top:217.1pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">PubMed </span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:245.0pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Chemotherapy</span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:245.0pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Anthracyclines[Mesh] OR Chemotherapy, Adjuvant[Majr:NoExp] OR </span></p>
<p style="top:261.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Mitoxantrone[Mesh] OR doxorubicin[Title/Abstract] OR </span></p>
<p style="top:278.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">DOX[Title/Abstract] OR Adriamycin[Title/Abstract] OR </span></p>
<p style="top:295.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Daunorubicin[Title/Abstract] OR  Cerubidine[Title/Abstract] OR </span></p>
<p style="top:312.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Idarubicin[Title/Abstract] OR Idamycin[Title/Abstract] OR </span></p>
<p style="top:329.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Epirubicin[Title/Abstract] OR Ellence[Title/Abstract] OR </span></p>
<p style="top:345.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Mitoxantrone[Title/Abstract] OR Novantrone[Title/Abstract]</span><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></p>
<p style="top:373.8pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Cardiotoxicity</span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:373.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Cardiotoxicity[MeSH Terms] OR Cardiovascular Diseases[Majr:NoExp]  </span></p>
<p style="top:390.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR Heart Failure[Majr] </span></p>
<p style="top:417.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR cardiotoxicity[Title/Abstract] OR cardiomyopathy[Title/Abstract] </span></p>
<p style="top:434.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR cardiomyopathies[Title/Abstract] OR cardiotoxic[Title/Abstract] OR </span></p>
<p style="top:451.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">CTRCD[Title/Abstract] OR Cardiac Failure[Title/Abstract] OR Cardiac </span></p>
<p style="top:468.0pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">damage[Title/Abstract] OR Cardiac dysfunction[Title/Abstract] OR </span></p>
<p style="top:484.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Cardiac myopathy[Title/Abstract] OR cardiac apoptosis[Title/Abstract] </span></p>
<p style="top:501.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR heart failure[Title/Abstract]  OR heart toxicity[Title/Abstract]  OR </span></p>
<p style="top:518.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">heart damage[Title/Abstract] OR heart dysfunction[Title/Abstract] OR </span></p>
<p style="top:535.2pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">myocardial failure[Title/Abstract] OR Myocardial </span></p>
<p style="top:552.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity[Title/Abstract] OR myocardial damage[Title/Abstract] OR </span></p>
<p style="top:568.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">myocardial dysfunction[Title/Abstract] OR &#x201c;ventricular </span></p>
<p style="top:585.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">failure&#x201d;[Title/Abstract] OR &#x201c;ventricular toxicity&#x201d;[Title/Abstract] OR </span></p>
<p style="top:602.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;ventricular damage&#x201d;[Title/Abstract] OR &#x201c;ventricular </span></p>
<p style="top:619.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x201d;[Title/Abstract] OR cardiomyocyte damage</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">[Title/Abstract] </span></p>
<p style="top:636.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR cardiomyocyte toxicity[Title/Abstract] OR cardiomyocyte </span></p>
<p style="top:653.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction[Title/Abstract] OR cardiomyocyte </span></p>
<p style="top:669.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">apoptosis[Title/Abstract] OR &#x201c;cardiomyocytes damage&#x201d;[Title/Abstract] </span></p>
<p style="top:686.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x201c;cardiomyocytes toxicity&#x201d;[Title/Abstract] OR &#x201c;cardiomyocytes </span></p>
<p style="top:703.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">ap</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">optosis&#x201d;[Title/Abstract] OR &#x201c;cardiomyocytes </span></p>
<p style="top:720.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x201d;[Title/Abstract] OR cardiac injury[Title/Abstract]</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:456.1pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Embase </span></p>
<p style="top:74.0pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR heart failures[Title/Abstract]  OR heart toxicities[Title/Abstract] OR </span></p>
<p style="top:90.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;ventricular toxicities[Title/Abstract] OR myocardial oxidative </span></p>
<p style="top:107.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">damage[Title/Abstract] OR cardiac oxidative damage[Title/Abstract]</span><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></p>
<p style="top:134.9pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Exercise </span></b></p>
<p style="top:134.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Exercise[MeSH Terms] OR sports[MeSH Terms] OR Exercise </span></p>
<p style="top:151.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Therapy[MeSH Terms]  </span></p>
<p style="top:178.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR kinesiotherapy[Title/Abstract] OR walking[Title/Abstract] OR </span></p>
<p style="top:195.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">weight lifting[Title/Abstract] OR sport[Title/Abstract] OR </span></p>
<p style="top:212.2pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">sports[Title/Abstract]  </span></p>
<p style="top:239.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((Physical[Title/Abstract] OR Aerobic[Title/Abstract] OR </span></p>
<p style="top:255.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">exercise[Title/Abstract] OR endurance[Title/Abstract] OR </span></p>
<p style="top:272.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">fitness[Title/Abstract] OR training[Title/Abstract]) AND </span></p>
<p style="top:289.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">(activity[Title/Abstract] OR exercise[Title/Abstract] OR </span></p>
<p style="top:306.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">therapy[Title/Abstract] OR program[Title/Abstract] OR </span></p>
<p style="top:323.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">training[Title/Abstract] OR conditioning[Title/Abstract] OR </span></p>
<p style="top:340.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">activities[Title/Abstract] OR exercises[Title/Abstract] OR </span></p>
<p style="top:356.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">therapies[Title/Abstract] OR programs[Title/Abstract] OR </span></p>
<p style="top:373.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">trainings[Title/Abstract]))  </span></p>
<p style="top:400.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((Activity[Title/Abstract]) AND (program[Title/Abstract] OR </span></p>
<p style="top:417.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">conditioning[Title/Abstract]))) </span></p>
<p style="top:478.6pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">EmBase</span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:506.4pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Chemotherapy</span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:506.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&apos;anthracycline antibiotic agent&apos;/exp OR &apos;cancer chemotherapy&apos;/mj OR </span></p>
<p style="top:523.2pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&apos;mitoxantrone&apos;/de OR &#x2018;doxorubicin&#x2019;:ti,ab,kw OR &#x2018;DOX&#x2019;:ti,ab,kw OR </span></p>
<p style="top:540.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Adriamycin&#x2019;:ti,ab,kw OR &#x2018;Daunorubicin&#x2019;:ti,ab,kw OR </span></p>
<p style="top:556.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Cerubidine&#x2019;:ti,ab,kw OR &#x2018;Idarubicin&#x2019;:ti,ab,kw OR &#x2018;Idamycin&#x2019;:ti,ab,kw O</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">R </span></p>
<p style="top:573.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Epirubicin&#x2019;:ti,ab,kw OR &#x2018;Ellence&#x2019;:ti,ab,kw OR &#x2018;Mitoxantrone&#x2019;:ti,ab,kw OR </span></p>
<p style="top:590.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Novantrone&#x2019;:ti,ab,kw</span><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></p>
<p style="top:618.4pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Cardiotoxicity</span></b><b><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></b></p>
<p style="top:618.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Cardiotoxicity&#x2019;/exp OR &apos;cardiovascular disease&apos;/mj OR &#x2018;Heart </span></p>
<p style="top:635.2pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Failure&#x2019;/exp </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:662.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;cardiotoxicity&#x2019;:ti,ab,kw</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;cardiomyopathy&#x2019;:ti,ab,kw OR </span></p>
<p style="top:678.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;cardiomyopathies&#x2019;:ti,ab,kw OR &#x2018;cardiotoxic&#x2019;:ti,ab,kw OR </span></p>
<p style="top:695.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;CTRCD&#x2019;:ti,ab,kw</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:722.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;Cardiac Failure&#x2019;:ti,ab,kw OR &#x2018;Cardiac damage&#x2019;:ti,ab,kw OR &#x2018;Cardiac </span></p>
<p style="top:739.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x2019;:ti,ab,kw OR &#x2018;Cardiac myopathy&#x2019;:ti,ab,kw OR &#x2018;cardiac </span></p>
<p style="top:756.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">apoptosis&#x2019;:ti,ab,kw OR &#x2018;heart failure&#x2019;:ti,ab,kw  OR &#x2018;heart </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:522.0pt;left:70.9pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></b></p>
<p style="top:547.8pt;left:70.9pt;line-height:13.0pt"><span style="font-family:Calibri,sans-serif;font-size:13.0pt">Cochrane </span></p>
<p style="top:566.3pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#1 </span></b></p>
<p style="top:566.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Anthracyclines] this term only </span></p>
<p style="top:593.6pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#2 </span></b></p>
<p style="top:593.6pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSh descriptor: [Chemotherapy, Adjuvant] this term only </span></p>
<p style="top:620.9pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#3 </span></b></p>
<p style="top:620.9pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSh descriptor: [Mitoxantrone] this term only </span></p>
<p style="top:648.3pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#4 </span></b></p>
<p style="top:648.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;doxorubicin&#x2019; OR &#x2018;DOX&#x2019; OR &#x2018;Adriamycin&#x2019; OR &#x2018;Daunorubicin&#x2019; OR </span></p>
<p style="top:665.1pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Cerubidine&#x2019; OR &#x2018;Idarubicin&#x2019; OR &#x2018;Idamycin&#x2019; OR &#x2018;Epirubicin&#x2019; OR &#x2018;Ellence&#x2019; </span></p>
<p style="top:681.9pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Mitoxantrone&#x2019; OR &#x2018;Novantrone&#x2019; </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:709.2pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#5 </span></b></p>
<p style="top:709.2pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSh descriptor: [Cardiotoxicity] explode all trees </span></p>
<p style="top:736.6pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#6 </span></b></p>
<p style="top:736.6pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Cardiovascular Diseases] this term only </span></p>
<p style="top:74.0pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity&#x2019;:ti,ab,kw OR &#x2018;heart damage&#x2019;:ti,ab,kw OR &#x2018;heart </span></p>
<p style="top:90.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x2019;:ti,ab,kw OR &#x2018;myocardial failure&#x2019;:ti,ab,kw OR &#x2018;Myocardial </span></p>
<p style="top:107.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity&#x2019;:ti,ab,kw OR &#x2018;myocardial damage&#x2019;:ti,ab,kw OR &#x2018;myocardial </span></p>
<p style="top:124.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x2019;:ti,ab,kw OR &#x2018;ventricular failure&#x2019;:ti,ab,kw OR &#x2018;ventricular </span></p>
<p style="top:141.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity&#x2019;:ti,ab,kw OR &#x2018;ventricular damage&#x2019;:ti,ab,kw OR &#x2018;ventricular </span></p>
<p style="top:158.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x2019;:ti,ab,kw OR &#x2018;cardiomyocyte damage&#x2019;:ti,ab,kw OR </span></p>
<p style="top:174.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;cardiomyocyte toxicity&#x2019;:ti,ab,kw OR &#x2018;cardiomyocyte </span></p>
<p style="top:191.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x2019;:ti,ab,kw OR &#x2018;cardiomyocyte apoptosis&#x2019;:ti,ab,kw OR </span></p>
<p style="top:208.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;cardiac injury&#x2019;:ti,ab,kw</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:235.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;heart failures&#x2019;:ti,ab,kw  OR &#x2018;heart toxicities&#x2019;:ti,ab,kw OR &#x2018;ventricular </span></p>
<p style="top:252.2pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicities&#x2019;:ti,ab,kw OR &#x2018;myocardial oxidative damage&#x2019;:ti,ab,kw OR </span></p>
<p style="top:269.0pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;cardiac oxidative damage&#x2019;:ti,ab,kw</span><span style="font-family:Calibri,sans-serif;font-size:12.0pt"> </span></p>
<p style="top:296.4pt;left:76.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Exercise </span></b></p>
<p style="top:296.4pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;Exercise&#x2019;/exp OR &apos;sport&apos;/exp</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> OR &apos;kinesiotherapy&apos;/exp </span></p>
<p style="top:323.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;sport&#x2019;:ti,ab,kw OR &#x2018;sports&#x2019;:ti,ab,kw OR &#x2018;walking&#x2019;:ti,ab,kw OR &#x2018;weight </span></p>
<p style="top:340.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">lifting&#x2019;:ti,ab,kw</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:366.9pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((&#x2018;Physical&#x2019;:ti,ab,kw OR &#x2018;Aerobic&#x2019;:ti,ab,kw OR &#x2018;exercise&#x2019;:ti,ab,kw OR </span></p>
<p style="top:383.7pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;endurance&#x2019;:ti,ab,kw</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x2018;fitness&#x2019;:ti,ab,kw OR &#x2018;training&#x2019;:ti,ab,kw) AND </span></p>
<p style="top:400.5pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">(&#x2018;activity&#x2019;:ti,ab,kw OR &#x2018;exercise&#x2019;:ti,ab,kw OR &#x2018;therapy&#x2019;:ti,ab,kw OR </span></p>
<p style="top:417.3pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;program&#x2019;:ti,ab,kw OR &#x2018;training&#x2019;:ti,ab,kw OR &#x2018;conditioning&#x2019;:ti,ab,kw OR </span></p>
<p style="top:434.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;activities&#x2019;:ti,ab,kw OR &#x2018;exercises&#x2019;:ti,ab,kw OR &#x2018;therapies&#x2019;:ti,</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">ab,kw OR </span></p>
<p style="top:451.1pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;programs&#x2019;:ti,ab,kw OR &#x2018;trainings&#x2019;:ti,ab,kw)) </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:477.8pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((&#x2018;Activity&#x2019;:ti,ab,kw) AND (&#x2018;program&#x2019;:ti,ab,kw OR </span></p>
<p style="top:494.6pt;left:177.5pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2018;conditioning&#x2019;:ti,ab,kw))</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:74.4pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#7 </span></b></p>
<p style="top:74.4pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Heart Failure] explode all trees </span></p>
<p style="top:101.8pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#8 </span></b></p>
<p style="top:101.8pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;cardiotoxicity&#x201d;   OR &#x201c;cardiomyopathy&#x201d; OR &#x201c;cardiomyopathies&#x201d; OR </span></p>
<p style="top:118.6pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;cardiotoxic&#x201d; OR &#x201c;CTRCD&#x201d;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:145.4pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x201c;Cardiac Failure&#x201d; OR &#x201c;Cardiac damage&#x201d; OR &#x201c;Cardiac dysfunction&#x201d; </span></p>
<p style="top:162.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x201c;Cardiac myopathy&#x201d; OR &#x201c;cardiac apoptosis&#x201d; OR &#x201c;heart failure&#x201d;  OR </span></p>
<p style="top:179.1pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;heart toxicity&#x201d; OR &#x201c;heart damage&#x201d; OR &#x201c;heart dysfunction&#x201d; OR </span></p>
<p style="top:195.9pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;myocardial failure&#x201d; OR &#x201c;Myocardial toxicity&#x201d; OR &#x201c;myocardial </span></p>
<p style="top:212.7pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">damage&#x201d; OR &#x201c;myocardial dysfunction&#x201d; OR &#x201c;ventricular failure&#x201d; OR </span></p>
<p style="top:229.6pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;ventricular toxicity&#x201d; OR &#x201c;ventricular damage&#x201d; OR &#x201c;ventricular </span></p>
<p style="top:246.4pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dysfunction&#x201d; OR &#x201c;cardiomyocyte damage&#x201d; OR &#x201c;cardiomyocyte </span></p>
<p style="top:263.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity&#x201d; OR &#x201c;cardiomyocyte dysfunction&#x201d; OR &#x201c;cardiomyocyte </span></p>
<p style="top:280.1pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">apoptosis&#x201d; OR &#x201c;cardiomyocytes damage&#x201d; OR &#x201c;cardiomyocytes </span></p>
<p style="top:296.9pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">toxicity&#x201d; OR &#x201c;cardiomyocytes dysfunction&#x201d; OR &#x201c;cardiomyocytes </span></p>
<p style="top:313.8pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">apoptosis&#x201d; OR &#x201c;cardiac injury&#x201d;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:340.5pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR &#x201c;heart failures&#x201d;  OR &#x201c;heart toxicities&#x201d; OR &#x201c;ventricular toxicities&#x201d; OR </span></p>
<p style="top:357.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">myo</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">cardial oxidative damage&#x201d; OR &#x201c;cardiac oxidative damage&#x201d;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:384.7pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#9 </span></b></p>
<p style="top:384.7pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Exercise] explode all trees </span></p>
<p style="top:412.1pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#10 </span></b></p>
<p style="top:412.1pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Sports] explode all trees </span></p>
<p style="top:439.3pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#11 </span></b></p>
<p style="top:439.3pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">MeSH descriptor: [Exercise Therapy] explode all trees </span></p>
<p style="top:466.7pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#12 </span></b></p>
<p style="top:466.7pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;sport&#x201d; OR &#x201c;sports&#x201d; OR &#x201c;walking&#x201d; OR &#x201c;weight lifting&#x201d; OR </span></p>
<p style="top:483.5pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;kinesiotherapy&#x201d;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:510.4pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((&#x201c;Physical&#x201d; OR &#x201c;Aerobic&#x201d; OR &#x201c;exercise&#x201d; OR &#x201c;endurance&#x201d; OR </span></p>
<p style="top:527.2pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;fitness&#x201d; OR &#x201c;training&#x201d;) AND (&#x201c;activity&#x201d; OR &#x201c;exercise&#x201d; OR &#x201c;therapy&#x201d;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> OR </span></p>
<p style="top:544.0pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;program&#x201d; OR &#x201c;training&#x201d; OR &#x201c;conditioning&#x201d; OR &#x201c;activities&#x201d; OR </span></p>
<p style="top:560.9pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x201c;exercises&#x201d; OR &#x201c;therapies&#x201d; OR &#x201c;programs&#x201d; OR &#x201c;trainings&#x201d;)) </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:587.6pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">OR ((&#x201c;Activity&#x201d;) AND (&#x201c;program&#x201d; OR &#x201c;conditioning&#x201d;))</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:615.0pt;left:76.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">Search </span></b></p>
<p style="top:615.0pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">(#1 OR #2 OR #3 OR #4) AND (#5 OR #6 OR #7 OR #8) AND (#9 OR </span></p>
<p style="top:631.8pt;left:179.4pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">#10 OR #11 OR #12) </span></p>
<p style="top:657.5pt;left:179.4pt;line-height:9.0pt"><span style="font-family:Source Sans Pro,serif;font-size:9.0pt">in Trials</span><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></b></p>
<p style="top:682.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:682.2pt;left:215.0pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:73.4pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Data S2. </span></p>
<p style="top:106.2pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">References of articles excluded on the basis of full-text screening </span></p>
<p style="top:127.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">All conference abstracts are not shown. </span><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt;color:#ffffff">82</span></sup><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt;color:#ffffff">&#x2013;</span></sup><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt;color:#ffffff">95</span></sup><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:153.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:174.4pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">82.  </span></p>
<p style="top:174.4pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Wang F, Iskra B, Kleinerman E, Alvarez-Florez C, Andrews T, Shaw A, Chandra J, Schadler K, </span></p>
<p style="top:187.9pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Aune GJ. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac  </span></p>
<p style="top:201.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Toxicity. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">J Pediatr Hematol Oncol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2018;40:208</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">215.  </span></p>
<p style="top:222.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">83.  </span></p>
<p style="top:222.7pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Sturgeon K, Muthukumaran G, Ding D, Bajulaiye A, Ferrari V, Libonati JR. Moderate-intensity </span></p>
<p style="top:236.1pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">treadmill exercise training decreases murine cardiomyocyte  cross-sectional area. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Physiol Rep</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. </span></p>
<p style="top:249.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">2015;3.  </span></p>
<p style="top:271.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">84.  </span></p>
<p style="top:271.1pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Parry TL, Hydock DS, Jensen BT, Lien C-Y, Schneider CM, Hayward R. Endurance exercise </span></p>
<p style="top:284.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">attenuates cardiotoxicity induced by androgen deprivation and  doxorubicin. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Can J Physiol </span></i></p>
<p style="top:297.9pt;left:103.0pt;line-height:11.0pt"><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Pharmacol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2014;92:356</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">362.  </span></p>
<p style="top:319.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">85.  </span></p>
<p style="top:319.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Sharifi F, Roshan VD, Mazaheri Z. Effect of pretreatment of aerobic training on </span></p>
<p style="top:332.7pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">doxorubicininduced left ventricular apoptosis gene expression in aging rat model. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Modares J </span></i></p>
<p style="top:346.2pt;left:103.0pt;line-height:11.0pt"><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Med Sci Pathobiol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> [Internet]. 2016;19:29</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">43. Available from: </span></p>
<p style="top:359.6pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">https://www.embase.com/search/results?subaction=viewrecord&amp;id=L615048850&amp;from=exp</span></p>
<p style="top:373.1pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">ort </span></p>
<p style="top:394.4pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">86.  </span></p>
<p style="top:394.4pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Shimauchi T, Numaga-Tomita T, Ito T, Nishimura A, Matsukane R, Oda S, Hoka S, Ide T, </span></p>
<p style="top:407.9pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Koitabashi N, Uchida K, Sumimoto H, Mori Y, Nishida M. TRPC3-Nox2 complex mediates </span></p>
<p style="top:421.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">doxorubicin-induced myocardial atrophy. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">JCI insight</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2017;2.  </span></p>
<p style="top:442.8pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">87.  </span></p>
<p style="top:442.8pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Wonders KY, Hydock DS, Greufe S, Schneider CM, Hayward R. Endurance exercise training </span></p>
<p style="top:456.2pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">preserves cardiac function in rats receiving doxorubicin  and the HER-2 inhibitor GW2974. </span></p>
<p style="top:469.7pt;left:103.0pt;line-height:11.0pt"><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Cancer Chemother Pharmacol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2009;64:1105</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">1113.  </span></p>
<p style="top:491.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">88.  </span></p>
<p style="top:491.0pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Calv&#xe9; A, Haddad R, Barama S-N, Meilleur M, Sebag IA, Chalifour LE. Cardiac response to </span></p>
<p style="top:504.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">doxorubicin and dexrazoxane in intact and ovariectomized young  female rats at rest and after </span></p>
<p style="top:517.9pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">swim training. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Am J Physiol Heart Circ Physiol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2012;302:H2048-57.  </span></p>
<p style="top:539.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">89.  </span></p>
<p style="top:539.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Hayward R, Lien C-Y, Jensen BT, Hydock DS, Schneider CM. Exercise training mitigates </span></p>
<p style="top:552.7pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">anthracycline-induced chronic cardiotoxicity in a  juvenile rat model. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Pediatr Blood Cancer</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. </span></p>
<p style="top:566.2pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">2012;59:149</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">154.  </span></p>
<p style="top:587.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">90.  </span></p>
<p style="top:587.6pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Howden EJ, Bigaran A, Beaudry R, Fraser S, Selig S, Foulkes S, Antill Y, Nightingale S, Loi S, </span></p>
<p style="top:601.1pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Haykowsky MJ, La Gerche A. Exercise as a diagnostic and therapeutic tool for the prevention </span></p>
<p style="top:614.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">of cardiovascular  dysfunction in breast cancer patients. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Eur J Prev Cardiol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2019;26:305</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">315.  </span></p>
<p style="top:635.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">91.  </span></p>
<p style="top:635.9pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Hydock DS, Parry TL, Jensen BT, Lien C-Y, Schneider CM, Hayward R. Effects of endurance </span></p>
<p style="top:649.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">training on combined goserelin acetate and doxorubicin  treatment-induced cardiac </span></p>
<p style="top:662.8pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">dysfunction. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Cancer Chemother Pharmacol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2011;68:685</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">692.  </span></p>
<p style="top:684.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">92.  </span></p>
<p style="top:684.1pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CPJ, </span></p>
<p style="top:697.6pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ. Exercise and Risk of Cardiovascular Events in </span></p>
<p style="top:711.0pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Women With Nonmetastatic Breast  Cancer. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">J Clin Oncol  Off J Am Soc Clin  Oncol</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. </span></p>
<p style="top:724.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">2016;34:2743</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">2749.  </span></p>
<p style="top:745.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">93.  </span></p>
<p style="top:745.9pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Krause MS, Oliveira LPJ, Silveira EMS, Vianna DR, Rossato JS, Almeida BS, Rodrigues MF, </span></p>
<p style="top:759.4pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Fernandes AJM, Costa JAB, Curi R, de Bittencourt PIHJ. MRP1/GS-X pump ATPase expression: </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:72.5pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">is this the explanation for the cytoprotection of  the heart against oxidative stress-induced </span></p>
<p style="top:86.0pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">redox imbalance in comparison to skeletal muscle cells? </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Cell Biochem Funct</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2007;25:23</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">32.  </span></p>
<p style="top:107.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">94.  </span></p>
<p style="top:107.3pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Matsuura C, Brunini TMC, Carvalho LCMM, Resende AC, Carvalho JJ, de Castro JPW, Mendes-</span></p>
<p style="top:120.8pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Ribeiro AC. Exercise training in doxorubicin-induced heart failure: effects on the L-arginine-NO  </span></p>
<p style="top:134.2pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">pathway and vascular reactivity. </span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">J Am Soc Hypertens</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2010;4:7</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">13.  </span></p>
<p style="top:155.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">95.  </span></p>
<p style="top:155.7pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Nagy AC, GulAcsi-BArdos P, CserEp Z, Hangody L, Forster T. Late cardiac effect of </span></p>
<p style="top:169.0pt;left:103.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">anthracycline therapy in physically active breast cancer  survivors - a prospective study. </span></p>
<p style="top:182.5pt;left:103.0pt;line-height:11.0pt"><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Neoplasma</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">. 2017;64:92</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">100.  </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:77.4pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Data S3. </span></p>
<p style="top:110.3pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Risk of bias assessment  </span></p>
<p style="top:131.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:157.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">The risk of bias assessment for the human studies is presented in Figure 2a. The two studies by </span></p>
<p style="top:177.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Kirkham et al.</span><sup><span style="font-family:Calibri,sans-serif;font-size:7.0pt">19,20</span></sup><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> were scored as one, since they made use of the same study population and largely </span></p>
<p style="top:197.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">the same methodology. These studies were scored as low risk of bias on all items. An exception was </span></p>
<p style="top:217.4pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">the item on performance bias which was scored as &#x2018;high&#x2019;, since blinding was not possible due to the </span></p>
<p style="top:237.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">nature of </span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">the intervention. For Ma, the items on selection bias were scored &#x2018;unclear&#x2019;, since no </span></p>
<p style="top:257.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">information on the randomization procedure was provided. Performance bias was scored as high risk </span></p>
<p style="top:277.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">of bias, similar to the reports by Kirkham et al. Since information on loss of participations was not </span></p>
<p style="top:298.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">adequately provided, the risk of attrition bias was rated as high. The item on selective reporting </span></p>
<p style="top:318.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">could not be assessed, as no pre-specified protocol was available.   </span></p>
<p style="top:346.3pt;left:106.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">The risk of bias assessment and reporting of quality indicators for the animal studies are </span></p>
<p style="top:366.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">presented in Figure 2b and Figure 2c, respectively. Many studies did not adequately report on </span></p>
<p style="top:386.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">important aspects of the methodology; hence most items were initially scored as &#x2018;unclear&#x2019;. After </span></p>
<p style="top:406.8pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">contacting authors (response rat</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">e: 73%, n=29/40), 127 of the &#x2018;unclear&#x2019; ratings were modified to </span></p>
<p style="top:426.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">either &#x2018;low&#x2019; (</span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">n=</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">109) or &#x2018;high&#x2019; (</span><i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">n=</span></i><span style="font-family:Calibri,sans-serif;font-size:11.0pt">18) risk of bias. Risk of selection bias, assessed via entries on random </span></p>
<p style="top:447.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">sequences generation, comparability of baseline characteristics and concealment of allocation, were </span></p>
<p style="top:467.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">scored low in approximately two-</span><span style="font-family:Calibri,sans-serif;font-size:11.0pt">thirds of the studies, &#x2018;unclear&#x2019; in about 25% and high in the </span></p>
<p style="top:487.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">remaining studies. Compared to other sources of bias, risk of performance bias comprising entries on </span></p>
<p style="top:507.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">random housing and blinding of the trial caregivers and researchers (when possible), was scored high </span></p>
<p style="top:527.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">in 14% and 35%, respectively. Risk of detection bias (random outcome assessment and blinding of </span></p>
<p style="top:547.8pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">outcome assessors) were scored relatively low. Drop-outs were inadequately reported in </span></p>
<p style="top:568.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">approximately one-fifth of the studies, leading to a high risk of attrition bias in these studies. The </span></p>
<p style="top:588.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">item on reporting bias, i.e. whether outcomes were selectively reported, was scored &#x2018;unclear&#x2019; for all </span></p>
<p style="top:608.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">studies, since no-preregistered protocols were available.  </span></p>
<p style="top:636.4pt;left:106.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">As for the reporting of methodology, none of the studies provided a sample size calculation, </span></p>
<p style="top:656.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">and many studies did not mention any form of blinding. Ethical approval was, however, reported in </span></p>
<p style="top:676.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">the vast majority of the studies.  </span></p>
<p style="top:704.8pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:704.8pt;left:215.0pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:73.4pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Data S4. </span></p>
<p style="top:106.2pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Sub-analysis on the timing of the physical exercise intervention  </span></p>
<p style="top:127.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:153.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">Forest plot (Figure S1) present the results of the preconditioning physical exercise interventions (i.e. </span></p>
<p style="top:173.1pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">started before DOX treatment) and plot (Figure S2)) presents the results of those interventions given </span></p>
<p style="top:193.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt">concomitant with DOX administration.  </span></p>
<p style="top:222.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:249.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:544.1pt;left:524.1pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<img style="position:absolute;transform:matrix(.65044859,0,-0,.6500291,-67.33331,264.86)" src="data:image/png;base64,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">
<p style="top:254.6pt;left:78.5pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">1  </span></b></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<img style="position:absolute;transform:matrix(.65044859,0,-0,.6500291,-67.33331,-5.233368)" src="data:image/png;base64,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">
<p style="top:131.3pt;left:78.5pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">2  </span></b></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:75.4pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Data S5. </span></p>
<p style="top:108.2pt;left:70.9pt;line-height:16.0pt"><span style="font-family:Calibri,sans-serif;font-size:16.0pt">Results on +dP/dt and </span><span style="font-family:Calibri,sans-serif;font-size:16.0pt">&#x2013;</span><span style="font-family:Calibri,sans-serif;font-size:16.0pt">dP/dt </span></p>
<p style="top:129.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:159.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">For both +dP/dt and </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dP/dt, results are favoring physical exercise groups (Figures S3-S6). In </span></p>
<p style="top:181.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">+dp/dt, a pooled analysis of studies using forced exercise interventions demonstrated a MD </span></p>
<p style="top:203.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">of 430.8 mm Hg (95CI%: 267.5; 594.1), T</span><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt">2</span></sup><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">=21392.1. Results were comparable, yet slighter </span></p>
<p style="top:225.4pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">stronger in the analysis on voluntary exercise interventions; MD of 500.3 mm Hg (95CI%: </span></p>
<p style="top:247.4pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">274.7; 725.9), T</span><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt">2</span></sup><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">=138438.2.  </span></p>
<p style="top:277.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> In </span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">&#x2013;</span><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">dP/dt, a MD of -374.5 (95%CI:-508.9; -240.1), T</span><sup><span style="font-family:SegoeUI,sans-serif;font-size:7.0pt">2</span></sup><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">=20895.3, and -407.5 (9%CI: -596.9; -</span></p>
<p style="top:299.3pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">218.1) mm Hg  was found for respectively forced and voluntary exercise interventions </span></p>
<p style="top:321.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">compared to non-exercised rodents.  </span></p>
<p style="top:351.2pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:378.0pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:404.9pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:431.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:458.5pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:322.4pt;left:524.1pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:582.6pt;left:524.1pt;line-height:11.0pt"><span style="font-family:Calibri,sans-serif;font-size:11.0pt"> </span></p>
<img style="position:absolute;transform:matrix(.60608497,0,-0,.6055847,-101.33331,-17.966706)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.60608497,0,-0,.6055847,-101.33331,329.03334)" src="data:image/png;base64,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">
<p style="top:101.1pt;left:78.5pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">3  </span></b></p>
<p style="top:338.1pt;left:73.8pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">4  </span></b></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>


<p style="top:322.4pt;left:524.1pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:571.7pt;left:524.1pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:595.7pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<p style="top:622.6pt;left:70.9pt;line-height:11.0pt"><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt"> </span></p>
<img style="position:absolute;transform:matrix(.60608497,0,-0,.6055847,-101.33331,-17.966706)" src="data:image/png;base64,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">
<img style="position:absolute;transform:matrix(.5804675,0,-0,.57998839,-123.33331,321.69996)" src="data:image/png;base64,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=">
<p style="top:102.3pt;left:78.6pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">5  </span></b></p>
<p style="top:338.0pt;left:85.9pt;line-height:11.0pt"><b><span style="font-family:SegoeUI,sans-serif;font-size:11.0pt">6  </span></b></p>
<p style="top:418.6pt;left:17.8pt;line-height:8.0pt"><span style="font-family:Times New Roman,serif;font-size:8.0pt">Downloaded from http://ahajournals.org by on December 30, 2022</span></p>

</div>
